<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>CAP Cancer Synoptic Generator</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, sans-serif;
            background-color: #f5f5f5;
            color: #333;
            line-height: 1.6;
        }
.header {
  background: linear-gradient(135deg, hsl(157, 100%, 22%) 0%, #1e293b 100%);
  color: white;
  padding: 15px 30px;
  display: flex;
  align-items: center;
  gap: 20px;
  border-bottom: 1px solid #334155;
}
.header img {
  height: 80px;
  width: auto;
  border-radius: 12px;
  background: white;
  padding: 6px;
  box-shadow: 0 4px 12px rgba(0, 0, 0, 0.25);
}
.header-text h1 {
  color: #f8fafc;
}
        .header-text p {
            font-size: 0.9rem;
            color: #ccc;
        }
        .main-container {
            display: flex;
            gap: 20px;
            padding: 20px;
            max-width: 1600px;
            margin: 0 auto;
            min-height: calc(100vh - 150px);
        }
        .form-panel {
            flex: 0 0 45%;
            background: white;
            border-radius: 8px;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            padding: 20px;
            overflow-y: auto;
            max-height: calc(100vh - 170px);
        }
        .preview-panel {
            flex: 1;
            background: white;
            border-radius: 8px;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            padding: 20px;
            display: flex;
            flex-direction: column;
            max-height: calc(100vh - 170px);
        }
        .panel-header {
            font-size: 1.2rem;
            font-weight: 600;
            color: #000;
            padding-bottom: 15px;
            border-bottom: 2px solid #CFB87C;
            margin-bottom: 20px;
        }
        .pdf-link {
            display: inline-block;
            margin-bottom: 15px;
            padding: 8px 16px;
            background: #CFB87C;
            color: #000;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 600;
            font-size: 0.9rem;
        }
        .pdf-link:hover {
            background: #b8a36e;
        }
        .selector-group {
            margin-bottom: 20px;
            padding-bottom: 20px;
            border-bottom: 1px solid #eee;
        }
        .selector-group label {
            display: block;
            font-weight: 600;
            margin-bottom: 8px;
            color: #333;
        }
        .selector-group select {
            width: 100%;
            padding: 12px;
            font-size: 1rem;
            border: 2px solid #ddd;
            border-radius: 6px;
            background: white;
            cursor: pointer;
            transition: border-color 0.2s;
        }
        .selector-group select:focus {
            outline: none;
            border-color: #CFB87C;
        }
        .form-fields-container {
            margin-top: 10px;
        }
        .form-group {
            margin-bottom: 18px;
        }
        .form-group label {
            display: block;
            font-weight: 600;
            margin-bottom: 6px;
            color: #333;
            font-size: 0.95rem;
        }
        .form-group select,
        .form-group input[type="text"] {
            width: 100%;
            padding: 10px;
            font-size: 0.95rem;
            border: 1px solid #ccc;
            border-radius: 4px;
            background: white;
        }
        .form-group select:focus,
        .form-group input[type="text"]:focus {
            outline: none;
            border-color: #CFB87C;
        }
        .form-group textarea {
            width: 100%;
            padding: 10px;
            font-size: 0.95rem;
            border: 1px solid #ccc;
            border-radius: 4px;
            min-height: 80px;
            resize: vertical;
            font-family: inherit;
        }
        .form-group textarea:focus {
            outline: none;
            border-color: #CFB87C;
        }
        .checkbox-group {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }
        .checkbox-item {
            display: flex;
            align-items: center;
            gap: 6px;
            padding: 6px 10px;
            background: #f8f8f8;
            border: 1px solid #ddd;
            border-radius: 4px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: background 0.2s;
        }
        .checkbox-item:hover {
            background: #eee;
        }
        .checkbox-item input[type="checkbox"] {
            cursor: pointer;
        }
        .checkbox-item.checked {
            background: #fff8e7;
            border-color: #CFB87C;
        }
        .comment-textarea {
            display: none;
            margin-top: 8px;
        }
        .comment-textarea.visible {
            display: block;
        }
        .preview-content {
            flex: 1;
            overflow-y: auto;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.5;
            padding: 15px;
            background: #fafafa;
            border: 1px solid #eee;
            border-radius: 4px;
            white-space: pre-wrap;
            margin-bottom: 15px;
        }
        .btn-copy {
            padding: 12px 24px;
            background: #000;
            color: #CFB87C;
            border: 2px solid #CFB87C;
            border-radius: 6px;
            font-size: 1rem;
            font-weight: 600;
            cursor: pointer;
            transition: all 0.2s;
        }
        .btn-copy:hover {
            background: #CFB87C;
            color: #000;
        }
        .btn-copy.copied {
            background: #28a745;
            border-color: #28a745;
            color: white;
        }
        .btn-clear {
            padding: 12px 24px;
            background: #dc3545;
            color: white;
            border: none;
            border-radius: 6px;
            font-size: 1rem;
            font-weight: 600;
            cursor: pointer;
            margin-left: 10px;
            transition: all 0.2s;
        }
        .btn-clear:hover {
            background: #c82333;
        }
        .button-row {
            display: flex;
            gap: 10px;
        }
        .footer {
            text-align: center;
            padding: 15px;
            color: #888;
            font-size: 0.8rem;
            border-top: 1px solid #eee;
        }
        .no-protocol {
            color: #888;
            font-style: italic;
            padding: 20px;
            text-align: center;
        }

        @media (prefers-color-scheme: dark) {
            body {
                background-color: #0f172a;
                color: #e2e8f0;
            }

            .form-panel,
            .preview-panel {
                background: #111827;
                border: 1px solid #334155;
                box-shadow: 0 2px 10px rgba(0, 0, 0, 0.45);
            }

            .panel-header,
            .selector-group label,
            .form-group label {
                color: #e2e8f0;
            }

            .selector-group {
                border-bottom-color: #334155;
            }

            .selector-group select,
            .form-group select,
            .form-group input[type="text"],
            .form-group textarea {
                background: #0f172a;
                color: #e2e8f0;
                border-color: #475569;
            }

            .checkbox-item {
                background: #1e293b;
                border-color: #475569;
                color: #e2e8f0;
            }

            .checkbox-item:hover {
                background: #334155;
            }

            .checkbox-item.checked {
                background: #3a2f18;
                border-color: #CFB87C;
            }

            .preview-content {
                background: #0b1220;
                border-color: #334155;
                color: #e2e8f0;
            }

            .footer,
            .no-protocol,
            .header-text p {
                color: #cbd5e1;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <img src="data:image/jpeg;base64,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" alt="University of Colorado Anschutz Medical Campus">
        <div class="header-text">
            <h1>CAP Cancer Synoptic Generator</h1>
            <p>University of Colorado Department of Pathology</p>
        </div>
    </div>

    <div class="main-container">
        <div class="form-panel">
            <div class="panel-header">Protocol Selection</div>
            <div class="selector-group">
                <label for="organSystem">Organ System</label>
                <select id="organSystem">
                    <option value="">-- Select Organ System --</option>
                </select>
            </div>
            <div class="selector-group">
                <label for="protocol">Protocol</label>
                <select id="protocol" disabled>
                    <option value="">-- Select Protocol --</option>
                </select>
            </div>
            <div id="pdfLinkContainer"></div>
            <div id="formFieldsContainer" class="form-fields-container">
                <div class="no-protocol">Select an organ system and protocol to begin.</div>
            </div>
        </div>

        <div class="preview-panel">
            <div class="panel-header">Synoptic Report Preview</div>
            <div id="previewContent" class="preview-content">Select a protocol and fill in the fields to generate a synoptic report.</div>
            <div class="button-row">
                <button class="btn-copy" onclick="copyReport()">Copy Report</button>
                <button class="btn-clear" onclick="clearForm()">Clear Form</button>
            </div>
        </div>
    </div>

    <div class="footer">
        CAP Cancer Synoptic Generator &mdash; University of Colorado Department of Pathology<br>
        Last updated January 2026
    </div>

    <script>
    // ========================================
    // PROTOCOL DATA
    // ========================================
    const protocolData = {
"Breast": [
    {
        name: "Breast DCIS, Resection",
        pdf: "https://documents.cap.org/protocols/Breast.DCIS.Bx_1.0.1.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Lumpectomy (partial mastectomy)", "Total mastectomy (simple mastectomy)", "Modified radical mastectomy", "Excisional biopsy", "Re-excision", "Other (specify)", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Upper outer quadrant", "Upper inner quadrant", "Lower outer quadrant", "Lower inner quadrant", "Central (subareolar)", "Nipple", "Clock position: 12 o'clock", "Clock position: 1 o'clock", "Clock position: 2 o'clock", "Clock position: 3 o'clock", "Clock position: 4 o'clock", "Clock position: 5 o'clock", "Clock position: 6 o'clock", "Clock position: 7 o'clock", "Clock position: 8 o'clock", "Clock position: 9 o'clock", "Clock position: 10 o'clock", "Clock position: 11 o'clock", "Overlapping quadrants", "Not specified"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Ductal carcinoma in situ (DCIS)", "DCIS with microinvasion", "Encapsulated papillary carcinoma", "Solid papillary carcinoma in situ", "Intraductal papillary carcinoma", "See Comment"] },
            { id: "nuclearGrade", label: "Nuclear Grade", type: "select", options: ["Low nuclear grade (Grade 1)", "Intermediate nuclear grade (Grade 2)", "High nuclear grade (Grade 3)", "See Comment"] },
            { id: "architecturePattern", label: "Architecture / Growth Pattern", type: "checkbox", options: ["Comedo", "Cribriform", "Micropapillary", "Papillary", "Solid", "Other (specify)"] },
            { id: "necrosis", label: "Necrosis", type: "select", options: ["Not identified", "Present (comedo-type / central necrosis)", "Present (punctate / focal necrosis)", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["Superior margin", "Inferior margin", "Medial margin", "Lateral margin", "Anterior (superficial) margin", "Posterior (deep) margin", "Nipple margin", "All margins negative", "Margin(s) positive", "Margin(s) cannot be assessed"] },
            { id: "closestMarginDistance", label: "Closest Margin Distance (mm)", type: "text" },
            { id: "pTisStaging", label: "Pathologic Stage (pTis)", type: "select", options: ["pTis (DCIS): Ductal carcinoma in situ", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Atypical ductal hyperplasia (ADH)", "Atypical lobular hyperplasia (ALH)", "Lobular carcinoma in situ (LCIS)", "Pleomorphic LCIS", "Flat epithelial atypia (FEA)", "Columnar cell change", "Columnar cell hyperplasia", "Usual ductal hyperplasia", "Fibrocystic changes", "Sclerosing adenosis", "Radial scar / complex sclerosing lesion", "Fibroadenoma", "Intraductal papilloma", "Fat necrosis", "Calcifications within DCIS", "Calcifications outside DCIS", "Paget disease of nipple", "None identified"] },
            { id: "additionalComments", label: "Additional Comments", type: "textarea" }
        ]
    },
    {
        name: "Breast DCIS, Biopsy",
        pdf: "https://documents.cap.org/protocols/Breast.DCIS.Bx_1.0.1.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Core needle biopsy", "Incisional biopsy", "Other (specify)", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Upper outer quadrant", "Upper inner quadrant", "Lower outer quadrant", "Lower inner quadrant", "Central (subareolar)", "Nipple", "Clock position: 12 o'clock", "Clock position: 1 o'clock", "Clock position: 2 o'clock", "Clock position: 3 o'clock", "Clock position: 4 o'clock", "Clock position: 5 o'clock", "Clock position: 6 o'clock", "Clock position: 7 o'clock", "Clock position: 8 o'clock", "Clock position: 9 o'clock", "Clock position: 10 o'clock", "Clock position: 11 o'clock", "Overlapping quadrants", "Not specified"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Ductal carcinoma in situ (DCIS)", "Encapsulated papillary carcinoma", "Solid papillary carcinoma in situ", "Intraductal papillary carcinoma", "See Comment"] },
            { id: "nuclearGrade", label: "Nuclear Grade", type: "select", options: ["Low nuclear grade (Grade 1)", "Intermediate nuclear grade (Grade 2)", "High nuclear grade (Grade 3)", "See Comment"] },
            { id: "architecturePattern", label: "Architecture / Growth Pattern", type: "checkbox", options: ["Comedo", "Cribriform", "Micropapillary", "Papillary", "Solid", "Other (specify)"] },
            { id: "necrosis", label: "Necrosis", type: "select", options: ["Not identified", "Present (comedo-type / central necrosis)", "Present (punctate / focal necrosis)", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Atypical ductal hyperplasia (ADH)", "Atypical lobular hyperplasia (ALH)", "Lobular carcinoma in situ (LCIS)", "Pleomorphic LCIS", "Flat epithelial atypia (FEA)", "Columnar cell change", "Columnar cell hyperplasia", "Usual ductal hyperplasia", "Fibrocystic changes", "Sclerosing adenosis", "Radial scar / complex sclerosing lesion", "Fibroadenoma", "Intraductal papilloma", "Calcifications within DCIS", "Calcifications outside DCIS", "None identified"] },
            { id: "additionalComments", label: "Additional Comments", type: "textarea" }
        ]
    },
    {
        name: "Breast Phyllodes Tumor",
        pdf: "https://documents.cap.org/protocols/Breast.Phyllodes_1.1.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Lumpectomy (partial mastectomy)", "Total mastectomy (simple mastectomy)", "Modified radical mastectomy", "Excisional biopsy", "Re-excision", "Other (specify)", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Upper outer quadrant", "Upper inner quadrant", "Lower outer quadrant", "Lower inner quadrant", "Central (subareolar)", "Nipple", "Clock position: 12 o'clock", "Clock position: 1 o'clock", "Clock position: 2 o'clock", "Clock position: 3 o'clock", "Clock position: 4 o'clock", "Clock position: 5 o'clock", "Clock position: 6 o'clock", "Clock position: 7 o'clock", "Clock position: 8 o'clock", "Clock position: 9 o'clock", "Clock position: 10 o'clock", "Clock position: 11 o'clock", "Overlapping quadrants", "Not specified"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Phyllodes tumor, benign", "Phyllodes tumor, borderline", "Phyllodes tumor, malignant", "Periductal stromal tumor", "See Comment"] },
            { id: "stromalCellularity", label: "Stromal Cellularity", type: "select", options: ["Mild", "Moderate", "Marked", "See Comment"] },
            { id: "stromalAtypia", label: "Stromal Atypia", type: "select", options: ["Mild", "Moderate", "Marked", "See Comment"] },
            { id: "stromalMitoses", label: "Stromal Mitoses (per 10 HPF)", type: "select", options: ["0-4 per 10 HPF", "5-9 per 10 HPF", ">=10 per 10 HPF", "See Comment"] },
            { id: "stromalOvergrowth", label: "Stromal Overgrowth", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "tumorBorder", label: "Tumor Border", type: "select", options: ["Well-circumscribed (pushing)", "Focally infiltrative", "Infiltrative", "See Comment"] },
            { id: "heterologousElements", label: "Heterologous Stromal Elements", type: "select", options: ["Not identified", "Liposarcomatous differentiation", "Chondrosarcomatous differentiation", "Osteosarcomatous differentiation", "Rhabdomyosarcomatous differentiation", "Other heterologous differentiation (specify)", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["Superior margin", "Inferior margin", "Medial margin", "Lateral margin", "Anterior (superficial) margin", "Posterior (deep) margin", "All margins negative (uninvolved)", "Margin(s) positive (involved by tumor)", "Margin(s) cannot be assessed"] },
            { id: "marginDistance", label: "Closest Margin Distance (mm)", type: "text" },
            { id: "pTStaging", label: "Pathologic Tumor Stage (pT)", type: "select", options: ["pTX: Primary tumor cannot be assessed", "pT1: Tumor 2 cm in greatest dimension", "pT2: Tumor >2 cm but 5 cm in greatest dimension", "pT3: Tumor >5 cm but 10 cm in greatest dimension", "pT4: Tumor >10 cm in greatest dimension", "See Comment"] },
            { id: "pNStaging", label: "Pathologic Node Stage (pN) (malignant phyllodes only)", type: "select", options: ["pNX: Regional lymph nodes cannot be assessed", "pN0: No regional lymph node metastasis", "pN1: Regional lymph node metastasis", "Not applicable (benign / borderline phyllodes)", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Ductal carcinoma in situ (DCIS)", "Lobular carcinoma in situ (LCIS)", "Fibrocystic changes", "Fibroadenomatous areas", "Calcifications", "Fat necrosis", "Necrosis within tumor", "None identified"] },
            { id: "additionalComments", label: "Additional Comments", type: "textarea" }
        ]
    },
    {
        name: "Breast Invasive, Resection",
        pdf: "https://documents.cap.org/protocols/Breast.Invasive_4.10.0.0.REL.CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Lumpectomy (partial mastectomy)", "Total mastectomy (simple mastectomy)", "Modified radical mastectomy", "Radical mastectomy", "Excisional biopsy", "Re-excision", "Other (specify)", "See Comment"] },
            { id: "specimenLaterality", label: "Specimen Laterality", type: "select", options: ["Right", "Left", "Not specified", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Upper outer quadrant", "Upper inner quadrant", "Lower outer quadrant", "Lower inner quadrant", "Central (subareolar)", "Nipple", "Clock position: 12 o'clock", "Clock position: 1 o'clock", "Clock position: 2 o'clock", "Clock position: 3 o'clock", "Clock position: 4 o'clock", "Clock position: 5 o'clock", "Clock position: 6 o'clock", "Clock position: 7 o'clock", "Clock position: 8 o'clock", "Clock position: 9 o'clock", "Clock position: 10 o'clock", "Clock position: 11 o'clock", "Overlapping quadrants", "Not specified"] },
            { id: "tumorSize", label: "Tumor Size - Invasive Component (cm)", type: "text" },
            { id: "tumorFocality", label: "Tumor Focality", type: "select", options: ["Unifocal", "Multifocal", "Cannot be determined", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Invasive carcinoma of no special type (ductal, NOS)", "Invasive lobular carcinoma", "Invasive lobular carcinoma - Classic type", "Invasive lobular carcinoma - Pleomorphic type", "Invasive lobular carcinoma - Solid type", "Invasive lobular carcinoma - Alveolar type", "Invasive lobular carcinoma - Tubulolobular type", "Tubular carcinoma", "Invasive cribriform carcinoma", "Mucinous (colloid) carcinoma", "Carcinoma with medullary features", "Invasive micropapillary carcinoma", "Carcinoma with apocrine differentiation", "Metaplastic carcinoma, NOS", "Metaplastic carcinoma - Squamous cell carcinoma", "Metaplastic carcinoma - Spindle cell carcinoma", "Metaplastic carcinoma - Carcinosarcoma", "Metaplastic carcinoma - Low-grade adenosquamous carcinoma", "Metaplastic carcinoma - Fibromatosis-like", "Metaplastic carcinoma - Mixed metaplastic", "Invasive papillary carcinoma", "Encapsulated papillary carcinoma with invasion", "Solid papillary carcinoma with invasion", "Secretory carcinoma", "Adenoid cystic carcinoma", "Acinic cell carcinoma", "Mucoepidermoid carcinoma", "Polymorphous adenocarcinoma", "Tall cell carcinoma with reversed polarity", "Neuroendocrine tumor (well-differentiated)", "Neuroendocrine carcinoma (poorly differentiated / small cell)", "Large cell neuroendocrine carcinoma", "Carcinoma with neuroendocrine differentiation", "Invasive carcinoma with mixed histologic features (specify)", "Other (specify)", "See Comment"] },
            { id: "nottinghamTubules", label: "Nottingham Grade - Tubule Formation", type: "select", options: ["Score 1: >75% of tumor forming tubules / glands", "Score 2: 10-75% of tumor forming tubules / glands", "Score 3: <10% of tumor forming tubules / glands", "See Comment"] },
            { id: "nottinghamNuclear", label: "Nottingham Grade - Nuclear Pleomorphism", type: "select", options: ["Score 1: Small, uniform nuclei with minimal variation", "Score 2: Moderate variation in nuclear size and shape", "Score 3: Marked nuclear variation, prominent nucleoli, vesicular chromatin", "See Comment"] },
            { id: "nottinghamMitoses", label: "Nottingham Grade - Mitotic Count", type: "select", options: ["Score 1: Low mitotic count (0-7 mitoses per 10 HPF, field diameter 0.5 mm)", "Score 2: Intermediate mitotic count (8-14 mitoses per 10 HPF)", "Score 3: High mitotic count (15 mitoses per 10 HPF)", "See Comment"] },
            { id: "nottinghamOverallGrade", label: "Nottingham Grade - Overall Grade", type: "select", options: ["Grade 1 (well differentiated): Total score 3-5", "Grade 2 (moderately differentiated): Total score 6-7", "Grade 3 (poorly differentiated): Total score 8-9", "See Comment"] },
            { id: "associatedDCIS", label: "Associated DCIS", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "dcisSize", label: "DCIS Size / Extent (cm)", type: "text" },
            { id: "dcisNuclearGrade", label: "DCIS Nuclear Grade (if DCIS present)", type: "select", options: ["Not applicable", "Low (Grade 1)", "Intermediate (Grade 2)", "High (Grade 3)", "See Comment"] },
            { id: "dcisArchPattern", label: "DCIS Architectural Pattern (if DCIS present)", type: "checkbox", options: ["Not applicable", "Solid", "Cribriform", "Micropapillary", "Papillary", "Comedo", "Flat/clinging"] },
            { id: "dcisNecrosis", label: "DCIS Necrosis (if DCIS present)", type: "select", options: ["Not applicable", "Not identified", "Present (comedo-type)", "Present (non-comedo type / punctate)", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["Superior margin", "Inferior margin", "Medial margin", "Lateral margin", "Anterior (superficial) margin", "Posterior (deep) margin", "Nipple margin", "Chest wall margin", "Skin margin", "All margins negative (uninvolved by invasive carcinoma)", "All margins negative (uninvolved by DCIS)", "Invasive carcinoma at margin(s)", "DCIS at margin(s)", "Cannot be assessed"] },
            { id: "closestInvasiveMarginDistance", label: "Closest Invasive Carcinoma Margin Distance (mm)", type: "text" },
            { id: "closestDCISMarginDistance", label: "Closest DCIS Margin Distance (mm)", type: "text" },
            { id: "lvi", label: "Lymphovascular Invasion (LVI)", type: "select", options: ["Not identified", "Present", "Indeterminate", "See Comment"] },
            { id: "pni", label: "Perineural Invasion (PNI)", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "dermalLymphaticInvasion", label: "Dermal Lymphatic Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "skinInvolvement", label: "Skin Involvement", type: "select", options: ["Not identified", "Present - ulceration", "Present - satellite skin nodules", "Present - dermal invasion without ulceration", "Present - peau d'orange (clinical)", "See Comment"] },
            { id: "nippleInvolvement", label: "Nipple Involvement", type: "select", options: ["Not identified", "Present - Paget disease", "Present - direct tumor invasion", "Not applicable", "See Comment"] },
            { id: "skeletalMuscleInvolvement", label: "Skeletal Muscle Involvement", type: "select", options: ["Not identified", "Present", "Not applicable", "See Comment"] },
            { id: "treatmentEffect", label: "Treatment Effect (Neoadjuvant Therapy)", type: "select", options: ["No known presurgical therapy", "No residual invasive carcinoma (complete pathologic response / ypT0)", "Residual invasive carcinoma present with probable / definite treatment effect", "Residual invasive carcinoma present with no definite treatment effect", "Cannot be determined", "See Comment"] },
            { id: "rcbScore", label: "Residual Cancer Burden (RCB) Score (if neoadjuvant)", type: "text", placeholder: "Enter RCB score (e.g., 1.35)" },
            { id: "rcbClass", label: "RCB Class (if neoadjuvant)", type: "select", options: ["Not applicable", "RCB-0: Complete pathologic response (pCR)", "RCB-I: Minimal residual disease", "RCB-II: Moderate residual disease", "RCB-III: Extensive residual disease", "See Comment"] },
            { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "sizeOfLargestMetastaticDeposit", label: "Size of Largest Metastatic Deposit (mm)", type: "text" },
            { id: "extranodalExtension", label: "Extranodal Extension", type: "select", options: ["Not identified", "Present", "Not applicable (no positive nodes)", "See Comment"] },
            { id: "pTStaging", label: "Pathologic Tumor Stage (pT) - AJCC 8th Edition", type: "select", options: ["pTX: Primary tumor cannot be assessed", "pTis: Carcinoma in situ (DCIS)", "pT1mi: Microinvasion 1 mm in greatest dimension", "pT1a: Tumor >1 mm but 5 mm in greatest dimension", "pT1b: Tumor >5 mm but 10 mm in greatest dimension", "pT1c: Tumor >10 mm but 20 mm in greatest dimension", "pT2: Tumor >20 mm but 50 mm in greatest dimension", "pT3: Tumor >50 mm in greatest dimension", "pT4a: Extension to chest wall (not including pectoralis muscle)", "pT4b: Ulceration and/or ipsilateral satellite nodules and/or edema (including peau d'orange) of the skin", "pT4c: Both pT4a and pT4b", "pT4d: Inflammatory carcinoma", "See Comment"] },
            { id: "pNStaging", label: "Pathologic Node Stage (pN) - AJCC 8th Edition", type: "select", options: ["pNX: Regional lymph nodes cannot be assessed (previously removed or not removed for pathologic study)", "pN0: No regional lymph node metastasis identified histologically", "pN0(i+): Isolated tumor cells 0.2 mm in regional lymph node(s)", "pN0(mol+): Positive molecular findings (RT-PCR); no isolated tumor cells detected by histology", "pN1mi: Micrometastasis >0.2 mm and/or >200 cells, but none >2.0 mm", "pN1a: Metastasis in 1-3 axillary lymph nodes, at least one metastasis >2.0 mm", "pN1b: Metastasis in ipsilateral internal mammary sentinel lymph nodes, excluding isolated tumor cells", "pN1c: pN1a and pN1b combined", "pN2a: Metastasis in 4-9 axillary lymph nodes, at least one metastasis >2.0 mm", "pN2b: Metastasis in clinically detected internal mammary lymph nodes with or without microscopic confirmation; with pathologically negative axillary nodes", "pN3a: Metastasis in 10 axillary lymph nodes (at least one >2.0 mm); or metastasis to ipsilateral infraclavicular (level III axillary) lymph nodes", "pN3b: pN1a or pN2a with cN2b (clinically detected internal mammary nodes); or pN2a with pN1b", "pN3c: Metastasis in ipsilateral supraclavicular lymph nodes", "See Comment"] },
            { id: "pMStaging", label: "Pathologic Distant Metastasis (pM) - AJCC 8th Edition", type: "select", options: ["Not applicable: No distant metastasis", "pM1: Distant metastasis confirmed by microscopic examination", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Atypical ductal hyperplasia (ADH)", "Atypical lobular hyperplasia (ALH)", "Lobular carcinoma in situ (LCIS)", "Pleomorphic LCIS", "Flat epithelial atypia (FEA)", "Columnar cell change", "Columnar cell hyperplasia", "Usual ductal hyperplasia", "Fibrocystic changes", "Sclerosing adenosis", "Radial scar / complex sclerosing lesion", "Fibroadenoma", "Intraductal papilloma", "Fat necrosis", "Calcifications within invasive carcinoma", "Calcifications within DCIS", "Calcifications in benign tissue", "Paget disease of nipple", "Chest wall invasion", "None identified"] },
            { id: "additionalComments", label: "Additional Comments", type: "textarea" }
        ]
    },
    {
        name: "Breast Invasive, Biopsy",
        pdf: "https://documents.cap.org/documents/Breast.Invasive.Bx_1.2.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Core needle biopsy", "Incisional biopsy", "Other (specify)", "See Comment"] },
            { id: "specimenLaterality", label: "Specimen Laterality", type: "select", options: ["Right", "Left", "Not specified", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Upper outer quadrant", "Upper inner quadrant", "Lower outer quadrant", "Lower inner quadrant", "Central (subareolar)", "Nipple", "Clock position: 12 o'clock", "Clock position: 1 o'clock", "Clock position: 2 o'clock", "Clock position: 3 o'clock", "Clock position: 4 o'clock", "Clock position: 5 o'clock", "Clock position: 6 o'clock", "Clock position: 7 o'clock", "Clock position: 8 o'clock", "Clock position: 9 o'clock", "Clock position: 10 o'clock", "Clock position: 11 o'clock", "Overlapping quadrants", "Not specified"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Invasive carcinoma of no special type (ductal, NOS)", "Invasive lobular carcinoma", "Invasive lobular carcinoma - Classic type", "Invasive lobular carcinoma - Pleomorphic type", "Invasive lobular carcinoma - Solid type", "Invasive lobular carcinoma - Alveolar type", "Invasive lobular carcinoma - Tubulolobular type", "Tubular carcinoma", "Invasive cribriform carcinoma", "Mucinous (colloid) carcinoma", "Carcinoma with medullary features", "Invasive micropapillary carcinoma", "Carcinoma with apocrine differentiation", "Metaplastic carcinoma, NOS", "Metaplastic carcinoma - Squamous cell carcinoma", "Metaplastic carcinoma - Spindle cell carcinoma", "Metaplastic carcinoma - Carcinosarcoma", "Metaplastic carcinoma - Low-grade adenosquamous carcinoma", "Metaplastic carcinoma - Fibromatosis-like", "Metaplastic carcinoma - Mixed metaplastic", "Invasive papillary carcinoma", "Encapsulated papillary carcinoma with invasion", "Solid papillary carcinoma with invasion", "Secretory carcinoma", "Adenoid cystic carcinoma", "Acinic cell carcinoma", "Mucoepidermoid carcinoma", "Polymorphous adenocarcinoma", "Tall cell carcinoma with reversed polarity", "Neuroendocrine tumor (well-differentiated)", "Neuroendocrine carcinoma (poorly differentiated / small cell)", "Large cell neuroendocrine carcinoma", "Carcinoma with neuroendocrine differentiation", "Invasive carcinoma with mixed histologic features (specify)", "Other (specify)", "See Comment"] },
            { id: "nottinghamTubules", label: "Nottingham Grade - Tubule Formation", type: "select", options: ["Score 1: >75% of tumor forming tubules / glands", "Score 2: 10-75% of tumor forming tubules / glands", "Score 3: <10% of tumor forming tubules / glands", "See Comment"] },
            { id: "nottinghamNuclear", label: "Nottingham Grade - Nuclear Pleomorphism", type: "select", options: ["Score 1: Small, uniform nuclei with minimal variation", "Score 2: Moderate variation in nuclear size and shape", "Score 3: Marked nuclear variation, prominent nucleoli, vesicular chromatin", "See Comment"] },
            { id: "nottinghamMitoses", label: "Nottingham Grade - Mitotic Count", type: "select", options: ["Score 1: Low mitotic count (0-7 mitoses per 10 HPF, field diameter 0.5 mm)", "Score 2: Intermediate mitotic count (8-14 mitoses per 10 HPF)", "Score 3: High mitotic count (15 mitoses per 10 HPF)", "See Comment"] },
            { id: "nottinghamOverallGrade", label: "Nottingham Grade - Overall Grade", type: "select", options: ["Grade 1 (well differentiated): Total score 3-5", "Grade 2 (moderately differentiated): Total score 6-7", "Grade 3 (poorly differentiated): Total score 8-9", "See Comment"] },
            { id: "associatedDCIS", label: "Associated DCIS", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion (LVI)", type: "select", options: ["Not identified", "Present", "Indeterminate", "See Comment"] },
            { id: "pni", label: "Perineural Invasion (PNI)", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Atypical ductal hyperplasia (ADH)", "Atypical lobular hyperplasia (ALH)", "Lobular carcinoma in situ (LCIS)", "Pleomorphic LCIS", "Flat epithelial atypia (FEA)", "Columnar cell change", "Columnar cell hyperplasia", "Usual ductal hyperplasia", "Fibrocystic changes", "Sclerosing adenosis", "Radial scar / complex sclerosing lesion", "Fibroadenoma", "Intraductal papilloma", "Calcifications within invasive carcinoma", "Calcifications within DCIS", "Calcifications in benign tissue", "None identified"] },
            { id: "additionalComments", label: "Additional Comments", type: "textarea" }
        ]
    },
    {
        name: "Breast Biomarker Reporting",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/Breast.Bmk_1.6.1.0.-REL_CAPCP.pdf",
        fields: [
            { id: "erStatus", label: "Estrogen Receptor (ER) Status", type: "select", options: ["Positive (10% nuclear staining)", "Low positive (1-10% nuclear staining)", "Negative (<1% nuclear staining)", "Cannot be determined", "See Comment"] },
            { id: "erPercentage", label: "ER Percentage of Cells Staining (%)", type: "text" },
            { id: "prStatus", label: "Progesterone Receptor (PR) Status", type: "select", options: ["Positive (10% nuclear staining)", "Low positive (1-10% nuclear staining)", "Negative (<1% nuclear staining)", "Cannot be determined", "See Comment"] },
            { id: "prPercentage", label: "PR Percentage of Cells Staining (%)", type: "text" },
            { id: "her2IHCResult", label: "HER2 IHC Result", type: "select", options: ["Negative (Score 0): No staining or incomplete, faint/barely perceptible membrane staining in 10% of invasive tumor cells", "Negative (Score 1+): Incomplete, faint/barely perceptible membrane staining in >10% of invasive tumor cells", "Equivocal (Score 2+): Weak to moderate complete membrane staining in >10% of invasive tumor cells or circumferential intense but incomplete staining in >10% or intense complete in 10%", "Positive (Score 3+): Circumferential complete, intense membrane staining in >10% of invasive tumor cells", "Cannot be determined", "Not performed", "See Comment"] },
            { id: "her2ISHResult", label: "HER2 ISH (FISH/CISH/SISH) Result", type: "select", options: ["Positive (HER2/CEP17 ratio 2.0 with average HER2 copy number 4.0 signals/cell)", "Positive (HER2/CEP17 ratio 2.0 with average HER2 copy number <4.0 signals/cell)", "Negative (HER2/CEP17 ratio <2.0 with average HER2 copy number <4.0 signals/cell)", "Equivocal (HER2/CEP17 ratio <2.0 with average HER2 copy number 4.0 and <6.0 signals/cell)", "Positive (HER2/CEP17 ratio <2.0 with average HER2 copy number 6.0 signals/cell)", "Cannot be determined", "Not performed", "See Comment"] },
            { id: "her2ISHRatio", label: "HER2/CEP17 Ratio", type: "text" },
            { id: "her2ISHAvgCopyNumber", label: "HER2 ISH Average HER2 Copy Number (signals/cell)", type: "text" },
            { id: "her2OverallResult", label: "HER2 Overall Result", type: "select", options: ["Positive", "Negative", "Equivocal", "Cannot be determined", "See Comment"] },
            { id: "ki67", label: "Ki-67 Proliferation Index (%)", type: "text" },
            { id: "additionalBiomarkerComments", label: "Additional Biomarker Comments", type: "textarea" }
        ]
    }
],
"Central Nervous System": [
    {
        name: "Central Nervous System",
        pdf: "https://documents.cap.org/protocols/CentralNervousSystem.Bx.Res_1.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Biopsy (stereotactic)", "Biopsy (open)", "Subtotal resection", "Gross total resection", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Cerebral hemisphere", "Cerebellum", "Brain stem", "Spinal cord", "Meninges", "Sellar region", "Pineal region", "Ventricles", "Other"] },
            { id: "laterality", label: "Laterality", type: "select", options: ["Right", "Left", "Midline", "Bilateral", "Not applicable", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Diffuse astrocytoma, IDH-mutant", "Oligodendroglioma, IDH-mutant and 1p/19q-codeleted", "Glioblastoma, IDH-wildtype", "Pilocytic astrocytoma", "Ependymoma", "Meningioma", "Medulloblastoma", "Schwannoma", "Hemangioblastoma", "CNS lymphoma", "Metastatic carcinoma", "Other (specify)", "See Comment"] },
            { id: "whoGrade", label: "WHO Grade", type: "select", options: ["Grade 1", "Grade 2", "Grade 3", "Grade 4", "Not applicable", "See Comment"] },
            { id: "idhStatus", label: "IDH Mutation Status", type: "select", options: ["IDH-wildtype", "IDH-mutant (IDH1 R132H)", "IDH-mutant (other variant)", "Not tested", "Cannot be determined", "See Comment"] },
            { id: "1p19qStatus", label: "1p/19q Codeletion Status", type: "select", options: ["Codeleted", "Non-codeleted", "Not tested", "Cannot be determined", "See Comment"] },
            { id: "mgmtStatus", label: "MGMT Promoter Methylation", type: "select", options: ["Methylated", "Unmethylated", "Not tested", "Cannot be determined", "See Comment"] },
            { id: "mitoticRate", label: "Mitotic Rate (per 10 HPF)", type: "text" },
            { id: "necrosis", label: "Necrosis", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "microvascularProliferation", label: "Microvascular Proliferation", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Cannot be assessed", "Uninvolved", "Involved", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Treatment effect present", "Calcifications", "Hemorrhage", "Cortical invasion (meningioma)", "Brain invasion (meningioma)", "Dural invasion", "Bone invasion", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    }
],

"Endocrine": [
    {
        name: "Adrenal Gland",
        pdf: "https://documents.cap.org/documents/Adrenal_4.3.1.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Adrenalectomy", "Partial adrenalectomy", "Other", "See Comment"] },
            { id: "laterality", label: "Laterality", type: "select", options: ["Right", "Left", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "tumorWeight", label: "Tumor Weight (g)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Adrenal cortical adenoma", "Adrenal cortical carcinoma", "Pheochromocytoma", "Metastatic carcinoma", "Other (specify)", "See Comment"] },
            { id: "weissScore", label: "Weiss Score (if cortical)", type: "select", options: ["0", "1", "2", "3", "4", "5", "6", "7", "8", "9", "Not applicable", "See Comment"] },
            { id: "mitoticRate", label: "Mitotic Rate (per 50 HPF)", type: "text" },
            { id: "atypicalMitoses", label: "Atypical Mitoses", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "necrosis", label: "Necrosis", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "capsularInvasion", label: "Capsular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "sinusoidalInvasion", label: "Sinusoidal Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "vascularInvasion", label: "Vascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "pT", label: "pT Stage", type: "select", options: ["pT1: Tumor \u22645 cm, no extra-adrenal invasion", "pT2: Tumor >5 cm, no extra-adrenal invasion", "pT3: Any size, local invasion but not adjacent organs", "pT4: Any size, invasion of adjacent organs (kidney, diaphragm, great vessels, pancreas, spleen, liver)", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "pN Stage", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Regional lymph node metastasis", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Adjacent organ involvement", "Extra-adrenal extension", "Tumor thrombus in adrenal vein", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Appendix NET",
        pdf: "https://documents.cap.org/protocols/Appendix.NET_5.0.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Appendectomy", "Right hemicolectomy", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Location", type: "select", options: ["Tip", "Body", "Base", "Diffuse", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Well-differentiated neuroendocrine tumor (NET)", "Neuroendocrine carcinoma (NEC), large cell", "Neuroendocrine carcinoma (NEC), small cell", "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "WHO Grade", type: "select", options: ["G1: Mitotic rate <2/10 HPF and Ki-67 <3%", "G2: Mitotic rate 2-20/10 HPF or Ki-67 3-20%", "G3: Mitotic rate >20/10 HPF or Ki-67 >20%", "See Comment"] },
            { id: "mitoticRate", label: "Mitotic Rate (per 10 HPF)", type: "text" },
            { id: "ki67", label: "Ki-67 Index (%)", type: "text" },
            { id: "mesoappendixInvasion", label: "Mesoappendix Invasion", type: "select", options: ["Not identified", "Present, <3 mm", "Present, \u22653 mm", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "pT Stage", type: "select", options: ["pT1: Tumor \u22642 cm", "pT2: Tumor >2 cm but \u22644 cm", "pT3: Tumor >4 cm or with subserosal invasion or invasion of mesoappendix", "pT4: Tumor perforates peritoneum or invades adjacent organs", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "pN Stage", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Regional lymph node metastasis", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Perforation", "Mesoappendiceal fat invasion", "Serosal involvement", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Colon NET",
        pdf: "https://documents.cap.org/protocols/ColoRectal.NET_5.0.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Polypectomy", "Segmental resection", "Hemicolectomy", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Cecum", "Ascending colon", "Transverse colon", "Descending colon", "Sigmoid colon", "Rectum", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Well-differentiated neuroendocrine tumor (NET)", "Neuroendocrine carcinoma (NEC), large cell", "Neuroendocrine carcinoma (NEC), small cell", "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "WHO Grade", type: "select", options: ["G1: Mitotic rate <2/10 HPF and Ki-67 <3%", "G2: Mitotic rate 2-20/10 HPF or Ki-67 3-20%", "G3: Mitotic rate >20/10 HPF or Ki-67 >20%", "See Comment"] },
            { id: "mitoticRate", label: "Mitotic Rate (per 10 HPF)", type: "text" },
            { id: "ki67", label: "Ki-67 Index (%)", type: "text" },
            { id: "depthOfInvasion", label: "Depth of Invasion", type: "select", options: ["Lamina propria", "Submucosa", "Muscularis propria", "Subserosa/pericolonic fat", "Serosa/visceral peritoneum", "Adjacent structures", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "pT Stage", type: "select", options: ["pT1: Invades lamina propria or submucosa, \u22642 cm", "pT2: Invades muscularis propria or >2 cm", "pT3: Invades subserosa or non-peritonealized pericolic tissues", "pT4: Perforates peritoneum or invades adjacent organs", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "pN Stage", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Regional lymph node metastasis", "pN2: Distant mesenteric lymph node metastasis", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Serosal involvement", "Mesenteric deposits", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Duodenum and Ampulla NET",
        pdf: "https://documents.cap.org/protocols/DuodAmp.NET_2.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Endoscopic resection", "Ampullectomy", "Pancreaticoduodenectomy (Whipple)", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Duodenum", "Ampulla of Vater", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Well-differentiated neuroendocrine tumor (NET)", "Neuroendocrine carcinoma (NEC), large cell", "Neuroendocrine carcinoma (NEC), small cell", "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)", "Gangliocytic paraganglioma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "WHO Grade", type: "select", options: ["G1: Mitotic rate <2/10 HPF and Ki-67 <3%", "G2: Mitotic rate 2-20/10 HPF or Ki-67 3-20%", "G3: Mitotic rate >20/10 HPF or Ki-67 >20%", "See Comment"] },
            { id: "mitoticRate", label: "Mitotic Rate (per 10 HPF)", type: "text" },
            { id: "ki67", label: "Ki-67 Index (%)", type: "text" },
            { id: "depthOfInvasion", label: "Depth of Invasion", type: "select", options: ["Mucosa", "Submucosa", "Muscularis propria", "Pancreas/peripancreatic adipose tissue", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "pT Stage", type: "select", options: ["pT1: Tumor \u22641 cm, limited to mucosa or submucosa", "pT2: Tumor >1 cm or invades muscularis propria", "pT3: Invades pancreas or peripancreatic adipose tissue", "pT4: Perforates peritoneum or invades adjacent organs", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "pN Stage", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Regional lymph node metastasis", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Ampullary involvement", "Pancreatic invasion", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Jejunum and Ileum NET",
        pdf: "https://documents.cap.org/protocols/Jejunum_Ileum.NET_2.0.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Segmental resection", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Jejunum", "Ileum", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "multifocality", label: "Multifocality", type: "select", options: ["Unifocal", "Multifocal", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Well-differentiated neuroendocrine tumor (NET)", "Neuroendocrine carcinoma (NEC), large cell", "Neuroendocrine carcinoma (NEC), small cell", "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "WHO Grade", type: "select", options: ["G1: Mitotic rate <2/10 HPF and Ki-67 <3%", "G2: Mitotic rate 2-20/10 HPF or Ki-67 3-20%", "G3: Mitotic rate >20/10 HPF or Ki-67 >20%", "See Comment"] },
            { id: "mitoticRate", label: "Mitotic Rate (per 10 HPF)", type: "text" },
            { id: "ki67", label: "Ki-67 Index (%)", type: "text" },
            { id: "depthOfInvasion", label: "Depth of Invasion", type: "select", options: ["Mucosa/submucosa", "Muscularis propria", "Subserosa", "Serosa/mesentery", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "pT Stage", type: "select", options: ["pT1: Invades lamina propria or submucosa, \u22641 cm", "pT2: Invades muscularis propria or >1 cm", "pT3: Invades subserosa", "pT4: Perforates peritoneum or invades adjacent structures", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "pN Stage", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Regional lymph node metastasis <12 nodes", "pN2: Large mesenteric masses (>2 cm) and/or extensive nodal deposits (\u226512 nodes)", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Mesenteric fibrosis/desmoplasia", "Serosal involvement", "Multiple primary tumors", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Pancreas (Endocrine)",
        pdf: "https://documents.cap.org/protocols/Panc.Endo_5.0.1.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Enucleation", "Distal pancreatectomy", "Pancreaticoduodenectomy (Whipple)", "Total pancreatectomy", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Head", "Body", "Tail", "Multiple", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Pancreatic neuroendocrine tumor (PanNET)", "Pancreatic neuroendocrine carcinoma (PanNEC), large cell", "Pancreatic neuroendocrine carcinoma (PanNEC), small cell", "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)", "Other (specify)", "See Comment"] },
            { id: "functionalStatus", label: "Functional Status", type: "select", options: ["Non-functional", "Insulinoma", "Gastrinoma", "Glucagonoma", "VIPoma", "Somatostatinoma", "Other functional", "See Comment"] },
            { id: "histologicGrade", label: "WHO Grade", type: "select", options: ["G1: Mitotic rate <2/10 HPF and Ki-67 <3%", "G2: Mitotic rate 2-20/10 HPF or Ki-67 3-20%", "G3: Mitotic rate >20/10 HPF or Ki-67 >20%", "See Comment"] },
            { id: "mitoticRate", label: "Mitotic Rate (per 10 HPF)", type: "text" },
            { id: "ki67", label: "Ki-67 Index (%)", type: "text" },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "pT Stage", type: "select", options: ["pT1: Tumor \u22642 cm, limited to pancreas", "pT2: Tumor >2 cm but \u22644 cm, limited to pancreas", "pT3: Tumor >4 cm, or invading duodenum or common bile duct", "pT4: Invades adjacent organs (stomach, spleen, colon, adrenal) or wall of large vessels (celiac axis, superior mesenteric artery)", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "pN Stage", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Regional lymph node metastasis", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Duodenal invasion", "Common bile duct invasion", "Vascular invasion (large vessel)", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Paraganglioma Pheochromocytoma",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-March-2025/Paragang_Pheochrom_1.0.0.0.REL.CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Adrenalectomy", "Resection of extra-adrenal paraganglioma", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Adrenal gland", "Head and neck", "Thorax", "Abdomen", "Pelvis", "Other", "See Comment"] },
            { id: "laterality", label: "Laterality", type: "select", options: ["Right", "Left", "Midline", "Not applicable", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "tumorWeight", label: "Tumor Weight (g)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Pheochromocytoma", "Paraganglioma", "See Comment"] },
            { id: "passScore", label: "PASS Score (if pheochromocytoma)", type: "text" },
            { id: "gappScore", label: "GAPP Score", type: "text" },
            { id: "mitoticRate", label: "Mitotic Rate (per 10 HPF)", type: "text" },
            { id: "ki67", label: "Ki-67 Index (%)", type: "text" },
            { id: "necrosis", label: "Necrosis", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "vascularInvasion", label: "Vascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "capsularInvasion", label: "Capsular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "sdhbIHC", label: "SDHB Immunohistochemistry", type: "select", options: ["Retained", "Lost", "Not performed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Extra-adrenal extension", "Composite tumor features", "Sustentacular cell loss (S-100)", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Pituitary Neuroendocrine Tumor (PitNET)",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-March-2025/Pituitary.NET_1.0.0.0.REL.CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Transsphenoidal resection", "Transcranial resection", "Biopsy", "Other", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Somatotroph tumor", "Lactotroph tumor", "Corticotroph tumor", "Thyrotroph tumor", "Gonadotroph tumor", "Null cell tumor", "Plurihormonal tumor", "Other (specify)", "See Comment"] },
            { id: "hormoneProduction", label: "Hormone Production", type: "checkbox", options: ["GH (growth hormone)", "PRL (prolactin)", "ACTH (adrenocorticotropic hormone)", "TSH (thyroid-stimulating hormone)", "FSH (follicle-stimulating hormone)", "LH (luteinizing hormone)", "Null cell (no hormone production)"] },
            { id: "transcriptionFactor", label: "Transcription Factor Lineage", type: "select", options: ["PIT1 lineage", "TPIT lineage", "SF1 lineage", "Null cell", "Cannot be determined", "See Comment"] },
            { id: "ki67", label: "Ki-67 Index (%)", type: "text" },
            { id: "mitoticRate", label: "Mitotic Rate (per 10 HPF)", type: "text" },
            { id: "p53", label: "p53 Status", type: "select", options: ["Wild-type pattern", "Abnormal pattern", "Not performed", "See Comment"] },
            { id: "invasion", label: "Invasion", type: "checkbox", options: ["Cavernous sinus", "Sphenoid sinus", "Suprasellar extension", "Infrasellar extension", "Bone invasion", "Dural invasion", "No invasion identified"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Apoplexy/hemorrhage", "Necrosis", "Fibrosis", "Calcification", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Stomach NET",
        pdf: "https://documents.cap.org/protocols/Stomach.NET_5.0.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Endoscopic resection", "Wedge resection", "Partial gastrectomy", "Total gastrectomy", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Cardia", "Fundus", "Body", "Antrum", "Pylorus", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "netType", label: "NET Type", type: "select", options: ["Type 1 (associated with atrophic gastritis)", "Type 2 (associated with MEN1/ZES)", "Type 3 (sporadic)", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Well-differentiated neuroendocrine tumor (NET)", "Neuroendocrine carcinoma (NEC), large cell", "Neuroendocrine carcinoma (NEC), small cell", "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "WHO Grade", type: "select", options: ["G1: Mitotic rate <2/10 HPF and Ki-67 <3%", "G2: Mitotic rate 2-20/10 HPF or Ki-67 3-20%", "G3: Mitotic rate >20/10 HPF or Ki-67 >20%", "See Comment"] },
            { id: "mitoticRate", label: "Mitotic Rate (per 10 HPF)", type: "text" },
            { id: "ki67", label: "Ki-67 Index (%)", type: "text" },
            { id: "depthOfInvasion", label: "Depth of Invasion", type: "select", options: ["Mucosa/submucosa", "Muscularis propria", "Subserosa", "Serosa/visceral peritoneum", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "pT Stage", type: "select", options: ["pT1: Invades mucosa or submucosa, \u22641 cm", "pT2: Invades muscularis propria or >1 cm", "pT3: Invades subserosa", "pT4: Perforates peritoneum or invades adjacent organs", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "pN Stage", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Regional lymph node metastasis", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Background atrophic gastritis", "ECL cell hyperplasia", "Serosal involvement", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Thyroid",
        pdf: "https://documents.cap.org/documents/Thyroid_4.4.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Lobectomy", "Total thyroidectomy", "Completion thyroidectomy", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Right lobe", "Left lobe", "Isthmus", "Multiple sites", "See Comment"] },
            { id: "tumorFocality", label: "Tumor Focality", type: "select", options: ["Unifocal", "Multifocal", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Papillary carcinoma, classic", "Papillary carcinoma, follicular variant", "Papillary carcinoma, tall cell variant", "Papillary carcinoma, other variant (specify)", "Follicular carcinoma, minimally invasive", "Follicular carcinoma, encapsulated angioinvasive", "Follicular carcinoma, widely invasive", "Hurthle (oncocytic) cell carcinoma", "Medullary carcinoma", "Poorly differentiated thyroid carcinoma", "Anaplastic (undifferentiated) thyroid carcinoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["Low grade", "High grade", "Not applicable", "See Comment"] },
            { id: "extrathyroidalExtension", label: "Extrathyroidal Extension", type: "select", options: ["Not identified", "Microscopic (minimal; strap muscle only)", "Gross (extensive)", "See Comment"] },
            { id: "vascularInvasion", label: "Vascular Invasion", type: "select", options: ["Not identified", "Present, <4 vessels", "Present, \u22654 vessels", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "pT Stage (Differentiated/Anaplastic)", type: "select", options: ["pT1a: Tumor \u22641 cm, limited to thyroid", "pT1b: Tumor >1 cm but \u22642 cm, limited to thyroid", "pT2: Tumor >2 cm but \u22644 cm, limited to thyroid", "pT3a: Tumor >4 cm, limited to thyroid", "pT3b: Gross extrathyroidal extension into strap muscles only", "pT4a: Gross extrathyroidal extension invading subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve", "pT4b: Gross extrathyroidal extension invading prevertebral fascia or encasing carotid artery or mediastinal vessels", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "pN Stage", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1a: Metastasis to Level VI or VII (pretracheal, paratracheal, prelaryngeal/Delphian, or upper mediastinal) lymph nodes", "pN1b: Metastasis to unilateral, bilateral, or contralateral lateral neck (Levels I-V) or retropharyngeal or superior mediastinal lymph nodes", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Hashimoto thyroiditis", "Multinodular goiter", "Graves disease", "Concurrent papillary microcarcinoma", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    }
],

"Head and Neck": [
    {
        name: "Larynx",
        pdf: "https://documents.cap.org/protocols/HN.Larynx_4.2.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Partial laryngectomy", "Total laryngectomy", "Supraglottic laryngectomy", "Biopsy", "Other", "See Comment"] },
            { id: "tumorSubsite", label: "Tumor Subsite", type: "select", options: ["Supraglottis", "Glottis", "Subglottis", "Transglottic", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Squamous cell carcinoma, conventional", "Squamous cell carcinoma, verrucous", "Squamous cell carcinoma, basaloid", "Squamous cell carcinoma, spindle cell (sarcomatoid)", "Adenocarcinoma", "Neuroendocrine carcinoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["G1: Well differentiated", "G2: Moderately differentiated", "G3: Poorly differentiated", "GX: Cannot be assessed", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved by invasive carcinoma", "Involved by carcinoma in situ", "Cannot be assessed", "See Comment"] },
            { id: "closestMargin", label: "Distance to Closest Margin (mm)", type: "text" },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "extranodalExtension", label: "Extranodal Extension", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "pT", label: "pT Stage (Glottis)", type: "select", options: ["pT1a: Limited to one vocal cord with normal mobility", "pT1b: Involves both vocal cords with normal mobility", "pT2: Extends to supraglottis and/or subglottis, and/or impaired vocal cord mobility", "pT3: Vocal cord fixation and/or invasion of paraglottic space and/or inner cortex of thyroid cartilage", "pT4a: Invades through thyroid cartilage or tissues beyond the larynx (trachea, cricoid, soft tissues of neck, deep extrinsic tongue muscles, strap muscles, thyroid, esophagus)", "pT4b: Invades prevertebral space, encases carotid artery, or invades mediastinal structures", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "pN Stage (HPV-Negative)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Single ipsilateral lymph node \u22643 cm, no ENE", "pN2a: Single ipsilateral lymph node >3 cm but \u22646 cm, no ENE", "pN2b: Multiple ipsilateral lymph nodes \u22646 cm, no ENE", "pN2c: Bilateral or contralateral lymph nodes \u22646 cm, no ENE", "pN3a: Lymph node >6 cm, no ENE", "pN3b: Any node(s) with clinical extranodal extension (ENE)", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Cartilage invasion", "Thyroid gland invasion", "Paraglottic space invasion", "Pre-epiglottic space invasion", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Oral Cavity",
        pdf: "https://documents.cap.org/protocols/HN.Oral_4.2.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Excision", "Glossectomy (partial/total)", "Mandibulectomy (marginal/segmental)", "Maxillectomy", "Floor of mouth resection", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Oral tongue", "Floor of mouth", "Buccal mucosa", "Upper gingiva/alveolar ridge", "Lower gingiva/alveolar ridge", "Hard palate", "Retromolar trigone", "Lip (mucosal)", "Other"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "depthOfInvasion", label: "Depth of Invasion (mm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Squamous cell carcinoma, conventional", "Squamous cell carcinoma, verrucous", "Squamous cell carcinoma, basaloid", "Squamous cell carcinoma, spindle cell", "Squamous cell carcinoma, adenosquamous", "Adenocarcinoma", "Mucoepidermoid carcinoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["G1: Well differentiated", "G2: Moderately differentiated", "G3: Poorly differentiated", "GX: Cannot be assessed", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "boneInvasion", label: "Bone Invasion", type: "select", options: ["Not identified", "Cortical bone invasion", "Medullary bone invasion", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["All margins uninvolved", "Mucosal margin involved", "Deep margin involved", "Bone margin involved", "Cannot be assessed"] },
            { id: "closestMargin", label: "Distance to Closest Margin (mm)", type: "text" },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "extranodalExtension", label: "Extranodal Extension", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "pT", label: "pT Stage", type: "select", options: ["pT1: Tumor \u22642 cm, DOI \u22645 mm", "pT2: Tumor \u22642 cm with DOI >5-10 mm; or >2-4 cm with DOI \u226410 mm", "pT3: Tumor >4 cm or any tumor with DOI >10 mm", "pT4a: Moderately advanced; invades through cortical bone, deep extrinsic tongue muscles, maxillary sinus, or skin of face", "pT4b: Very advanced; invades masticator space, pterygoid plates, skull base, or encases internal carotid artery", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "pN Stage (HPV-Negative)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Single ipsilateral lymph node \u22643 cm, no ENE", "pN2a: Single ipsilateral >3-6 cm, no ENE", "pN2b: Multiple ipsilateral \u22646 cm, no ENE", "pN2c: Bilateral or contralateral \u22646 cm, no ENE", "pN3a: Any node >6 cm, no ENE", "pN3b: Any node(s) with clinical ENE", "pNX: Cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Dysplasia at margin", "Bone invasion", "Skin invasion", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Major Salivary Glands",
        pdf: "https://documents.cap.org/protocols/HN.MajorSalivary_4.3.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Superficial parotidectomy", "Total parotidectomy", "Submandibular gland excision", "Sublingual gland excision", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Parotid gland", "Submandibular gland", "Sublingual gland", "See Comment"] },
            { id: "laterality", label: "Laterality", type: "select", options: ["Right", "Left", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Mucoepidermoid carcinoma", "Adenoid cystic carcinoma", "Acinic cell carcinoma", "Salivary duct carcinoma", "Secretory carcinoma", "Polymorphous adenocarcinoma", "Adenocarcinoma, NOS", "Myoepithelial carcinoma", "Epithelial-myoepithelial carcinoma", "Carcinoma ex pleomorphic adenoma", "Squamous cell carcinoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["Low grade", "Intermediate grade", "High grade", "Not applicable", "See Comment"] },
            { id: "extraparenchymalExtension", label: "Extraparenchymal Extension", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "facialNerveInvolvement", label: "Facial Nerve Involvement", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "closestMargin", label: "Distance to Closest Margin (mm)", type: "text" },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "pT Stage", type: "select", options: ["pT1: Tumor \u22642 cm, no extraparenchymal extension", "pT2: Tumor >2 cm but \u22644 cm, no extraparenchymal extension", "pT3: Tumor >4 cm and/or extraparenchymal extension", "pT4a: Invades skin, mandible, ear canal, and/or facial nerve", "pT4b: Invades skull base, pterygoid plates, or encases carotid artery", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "pN Stage", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Single ipsilateral \u22643 cm, no ENE", "pN2a: Single ipsilateral >3-6 cm, no ENE", "pN2b: Multiple ipsilateral \u22646 cm, no ENE", "pN2c: Bilateral/contralateral \u22646 cm, no ENE", "pN3a: Any node >6 cm, no ENE", "pN3b: Any node(s) with clinical ENE", "pNX: Cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Facial nerve sacrifice", "Skin involvement", "Mandible invasion", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Nasal Cavity and Paranasal Sinuses",
        pdf: "https://documents.cap.org/protocols/HN.Nasal_4.2.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Maxillectomy (partial/total)", "Endoscopic resection", "Craniofacial resection", "Lateral rhinotomy", "Biopsy", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Nasal cavity", "Maxillary sinus", "Ethmoid sinus", "Frontal sinus", "Sphenoid sinus", "Other"] },
            { id: "laterality", label: "Laterality", type: "select", options: ["Right", "Left", "Bilateral", "Midline", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Squamous cell carcinoma", "Intestinal-type adenocarcinoma", "Non-intestinal-type adenocarcinoma", "Adenoid cystic carcinoma", "Esthesioneuroblastoma (olfactory neuroblastoma)", "Sinonasal undifferentiated carcinoma (SNUC)", "NUT carcinoma", "Mucosal melanoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["G1: Well differentiated", "G2: Moderately differentiated", "G3: Poorly differentiated", "GX: Cannot be assessed", "Not applicable", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["All margins uninvolved", "Superior margin involved", "Inferior margin involved", "Medial margin involved", "Lateral margin involved", "Posterior margin involved", "Anterior margin involved", "Cannot be assessed"] },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "pT Stage (Maxillary Sinus)", type: "select", options: ["pT1: Limited to mucosa with no bone erosion or destruction", "pT2: Bone erosion/destruction including extension into hard palate and/or middle nasal meatus", "pT3: Invades posterior wall of maxillary sinus, subcutaneous tissues, floor/medial wall of orbit, pterygoid fossa, ethmoid sinuses", "pT4a: Invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid/frontal sinuses", "pT4b: Invades orbital apex, dura, brain, middle cranial fossa, cranial nerves other than V2, nasopharynx, clivus", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "pN Stage", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Single ipsilateral \u22643 cm, no ENE", "pN2a: Single ipsilateral >3-6 cm, no ENE", "pN2b: Multiple ipsilateral \u22646 cm, no ENE", "pN2c: Bilateral/contralateral \u22646 cm, no ENE", "pN3a: Any node >6 cm, no ENE", "pN3b: Any node(s) with clinical ENE", "pNX: Cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Orbital invasion", "Dural invasion", "Brain invasion", "Bone invasion", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Pharynx",
        pdf: "https://documents.cap.org/protocols/HN.Pharynx_5.0.0.0.REL.CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Transoral resection", "Pharyngectomy (partial/total)", "Laryngopharyngectomy", "Mandibulotomy with resection", "Biopsy", "Other", "See Comment"] },
            { id: "tumorSubsite", label: "Tumor Subsite", type: "select", options: ["Oropharynx (base of tongue)", "Oropharynx (tonsil)", "Oropharynx (soft palate)", "Oropharynx (posterior wall)", "Nasopharynx", "Hypopharynx (pyriform sinus)", "Hypopharynx (postcricoid)", "Hypopharynx (posterior wall)", "See Comment"] },
            { id: "laterality", label: "Laterality", type: "select", options: ["Right", "Left", "Midline", "Bilateral", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "hpvStatus", label: "HPV/p16 Status (Oropharynx)", type: "select", options: ["p16 positive (HPV-associated)", "p16 negative (HPV-independent)", "Not tested", "Not applicable", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Squamous cell carcinoma, conventional", "Squamous cell carcinoma, nonkeratinizing", "Squamous cell carcinoma, basaloid", "Nasopharyngeal carcinoma, nonkeratinizing", "Nasopharyngeal carcinoma, keratinizing", "Adenocarcinoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["G1: Well differentiated", "G2: Moderately differentiated", "G3: Poorly differentiated", "GX: Cannot be assessed", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved by invasive carcinoma", "Involved by in situ carcinoma", "Cannot be assessed", "See Comment"] },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "extranodalExtension", label: "Extranodal Extension", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "pT", label: "pT Stage (varies by subsite; select applicable)", type: "select", options: ["pT1", "pT2", "pT3", "pT4a", "pT4b", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "pN Stage", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Single ipsilateral \u22643 cm, no ENE", "pN2a: Single ipsilateral >3-6 cm, no ENE", "pN2b: Multiple ipsilateral \u22646 cm, no ENE", "pN2c: Bilateral/contralateral \u22646 cm, no ENE", "pN3a: Any node >6 cm, no ENE", "pN3b: Any node(s) with clinical ENE", "pNX: Cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Extrinsic tongue muscle invasion", "Pterygoid muscle invasion", "Prevertebral fascia invasion", "Mandible invasion", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Head and Neck Biomarker Reporting",
        pdf: "https://documents.cap.org/protocols/HN.Bmk_2.2.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "p16IHC", label: "p16 Immunohistochemistry", type: "select", options: ["Positive (diffuse, strong nuclear and cytoplasmic staining)", "Negative", "Equivocal", "Not performed", "See Comment"] },
            { id: "hpvTesting", label: "HPV Testing (ISH or PCR)", type: "select", options: ["HPV detected (high-risk type)", "HPV not detected", "Not performed", "See Comment"] },
            { id: "hpvType", label: "HPV Type (if detected)", type: "select", options: ["HPV 16", "HPV 18", "Other type (specify)", "Not applicable", "See Comment"] },
            { id: "pdl1CPS", label: "PD-L1 Combined Positive Score (CPS)", type: "text" },
            { id: "pdl1Interpretation", label: "PD-L1 Interpretation", type: "select", options: ["CPS \u22651", "CPS \u226520", "CPS <1", "Not performed", "See Comment"] },
            { id: "ebvStatus", label: "EBV Status (if nasopharyngeal)", type: "select", options: ["Positive", "Negative", "Not performed", "Not applicable", "See Comment"] },
            { id: "comments", label: "Additional Biomarker Comments", type: "textarea" }
        ]
    },
    {
        name: "Cutaneous Squamous Cell Carcinoma of the Head and Neck",
        pdf: "https://documents.cap.org/protocols/HN.SCC_1.1.0.0.REL.CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Excision", "Wide local excision", "Mohs excision", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Scalp", "Forehead", "Temple", "Ear", "Cheek", "Nose", "Lip (cutaneous)", "Periorbital", "Neck", "Other", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "tumorThickness", label: "Tumor Thickness/Depth of Invasion (mm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Squamous cell carcinoma, conventional", "Squamous cell carcinoma, desmoplastic", "Squamous cell carcinoma, adenosquamous", "Squamous cell carcinoma, spindle cell", "Squamous cell carcinoma, verrucous", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["G1: Well differentiated", "G2: Moderately differentiated", "G3: Poorly differentiated", "GX: Cannot be assessed", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present (nerve \u22650.1 mm caliber or named nerve)", "Present (nerve <0.1 mm caliber)", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["All margins uninvolved", "Peripheral margin involved", "Deep margin involved", "Cannot be assessed"] },
            { id: "closestMargin", label: "Distance to Closest Margin (mm)", type: "text" },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "pT Stage", type: "select", options: ["pT1: Tumor \u22642 cm", "pT2: Tumor >2 cm but \u22644 cm", "pT3: Tumor >4 cm, or minor bone erosion, or perineural invasion, or deep invasion >6 mm", "pT4a: Gross cortical bone and/or marrow invasion", "pT4b: Skull base invasion and/or skull base foramen involvement", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "pN Stage", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Single ipsilateral \u22643 cm, no ENE", "pN2a: Single ipsilateral >3-6 cm, no ENE", "pN2b: Multiple ipsilateral \u22646 cm, no ENE", "pN2c: Bilateral/contralateral \u22646 cm, no ENE", "pN3a: Any node >6 cm, no ENE", "pN3b: Any node(s) with clinical ENE", "pNX: Cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Immunosuppression-associated", "Prior radiation field", "Chronic wound/scar", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    }
],

"Hematologic": [
    {
        name: "Precursor and Mature Lymphoid Malignancies",
        pdf: "https://documents.cap.org/protocols/Heme.Lymphoid.Bx.Res_1.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "specimenType", label: "Specimen Type", type: "select", options: ["Lymph node excision", "Lymph node biopsy (core)", "Bone marrow biopsy", "Extranodal tissue biopsy", "Splenectomy", "Other", "See Comment"] },
            { id: "specimenSite", label: "Specimen Site", type: "text" },
            { id: "histologicType", label: "WHO Classification", type: "select", options: ["B-lymphoblastic leukemia/lymphoma", "T-lymphoblastic leukemia/lymphoma", "Chronic lymphocytic leukemia/small lymphocytic lymphoma", "Mantle cell lymphoma", "Follicular lymphoma", "Marginal zone lymphoma (extranodal/MALT)", "Marginal zone lymphoma (nodal)", "Marginal zone lymphoma (splenic)", "Diffuse large B-cell lymphoma, NOS", "Burkitt lymphoma", "Classical Hodgkin lymphoma", "Nodular lymphocyte-predominant Hodgkin lymphoma", "Peripheral T-cell lymphoma, NOS", "Anaplastic large cell lymphoma (ALK-positive)", "Anaplastic large cell lymphoma (ALK-negative)", "Angioimmunoblastic T-cell lymphoma", "Adult T-cell leukemia/lymphoma", "NK/T-cell lymphoma", "Other (specify)", "See Comment"] },
            { id: "grade", label: "Grade (if applicable)", type: "select", options: ["Grade 1-2 (low grade)", "Grade 3A", "Grade 3B", "Not applicable", "See Comment"] },
            { id: "annArborStage", label: "Ann Arbor Stage", type: "select", options: ["Stage I", "Stage II", "Stage III", "Stage IV", "Not applicable", "See Comment"] },
            { id: "cellLineage", label: "Cell Lineage", type: "select", options: ["B-cell", "T-cell", "NK-cell", "Cannot be determined", "See Comment"] },
            { id: "architecturalPattern", label: "Architectural Pattern", type: "select", options: ["Nodular", "Diffuse", "Mixed", "Not applicable", "See Comment"] },
            { id: "flowCytometry", label: "Flow Cytometry Findings", type: "textarea" },
            { id: "ihcResults", label: "Immunohistochemistry Results", type: "checkbox", options: ["CD20+", "CD3+", "CD5+", "CD10+", "CD23+", "BCL2+", "BCL6+", "MUM1+", "Cyclin D1+", "Ki-67 high (\u226550%)", "Ki-67 low (<50%)", "ALK+", "CD30+", "CD15+", "EBV+ (EBER)", "Other (specify in comments)"] },
            { id: "molecularFindings", label: "Molecular/Cytogenetic Findings", type: "textarea" },
            { id: "boneMarrowInvolvement", label: "Bone Marrow Involvement", type: "select", options: ["Not identified", "Present", "Not evaluated", "See Comment"] },
            { id: "ki67", label: "Ki-67 Proliferation Index (%)", type: "text" },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Myeloid and Mixed/Ambiguous Lineage Neoplasms",
        pdf: "https://documents.cap.org/protocols/Heme.Myeloid_Mixed_Amb.Bx.Res_1.1.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "specimenType", label: "Specimen Type", type: "select", options: ["Bone marrow biopsy", "Peripheral blood", "Tissue biopsy (myeloid sarcoma)", "Other", "See Comment"] },
            { id: "whoClassification", label: "WHO Classification", type: "select", options: ["Acute myeloid leukemia, NOS", "AML with recurrent genetic abnormalities", "AML with myelodysplasia-related changes", "Therapy-related myeloid neoplasm", "Myelodysplastic syndrome (MDS)", "Myeloproliferative neoplasm (MPN)", "MDS/MPN overlap", "Chronic myeloid leukemia, BCR-ABL1+", "Myeloid sarcoma", "Acute leukemia of ambiguous lineage", "Other (specify)", "See Comment"] },
            { id: "whoSubtype", label: "WHO Subtype (specify)", type: "text" },
            { id: "blastPercentage", label: "Blast Percentage (%)", type: "text" },
            { id: "cellularity", label: "Marrow Cellularity (%)", type: "text" },
            { id: "dysplasia", label: "Dysplasia", type: "select", options: ["Not identified", "Single lineage", "Multilineage", "See Comment"] },
            { id: "fibrosis", label: "Fibrosis Grade", type: "select", options: ["MF-0", "MF-1", "MF-2", "MF-3", "Not assessed", "See Comment"] },
            { id: "flowCytometry", label: "Flow Cytometry Findings", type: "textarea" },
            { id: "cytogenetics", label: "Cytogenetic Findings", type: "textarea" },
            { id: "molecularFindings", label: "Molecular Findings", type: "textarea" },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Plasma Cell Malignancies",
        pdf: "https://documents.cap.org/protocols/Heme.PlasmaCell_Immuno.Bx.Res_1.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "specimenType", label: "Specimen Type", type: "select", options: ["Bone marrow biopsy", "Soft tissue biopsy (plasmacytoma)", "Other", "See Comment"] },
            { id: "diagnosis", label: "Diagnosis", type: "select", options: ["Plasma cell myeloma", "Plasmacytoma, osseous", "Plasmacytoma, extraosseous", "Light chain deposition disease", "Primary amyloidosis (AL)", "Other (specify)", "See Comment"] },
            { id: "plasmaPercentage", label: "Plasma Cell Percentage (%)", type: "text" },
            { id: "immunoglobulinType", label: "Immunoglobulin Heavy Chain Type", type: "select", options: ["IgG", "IgA", "IgM", "IgD", "IgE", "None (light chain only)", "See Comment"] },
            { id: "lightChainType", label: "Light Chain Type", type: "select", options: ["Kappa", "Lambda", "See Comment"] },
            { id: "amyloid", label: "Amyloid", type: "select", options: ["Not identified", "Present", "Not evaluated", "See Comment"] },
            { id: "cellularity", label: "Marrow Cellularity (%)", type: "text" },
            { id: "cytogenetics", label: "Cytogenetics/FISH Findings", type: "textarea" },
            { id: "issStage", label: "ISS Stage", type: "select", options: ["Stage I: Serum \u03b22-microglobulin <3.5 mg/L and serum albumin \u22653.5 g/dL", "Stage II: Not stage I or III", "Stage III: Serum \u03b22-microglobulin \u22655.5 mg/L", "Not determined", "See Comment"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    }
],

"Ophthalmic": [
    {
        name: "Retinoblastoma",
        pdf: "https://documents.cap.org/protocols/Retinoblastoma_4.2.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Enucleation", "Biopsy", "Other", "See Comment"] },
            { id: "laterality", label: "Laterality", type: "select", options: ["Right", "Left", "Bilateral", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (mm)", type: "text" },
            { id: "differentiation", label: "Differentiation", type: "select", options: ["Well differentiated (Flexner-Wintersteiner rosettes)", "Moderately differentiated", "Poorly differentiated (undifferentiated)", "See Comment"] },
            { id: "growthPattern", label: "Growth Pattern", type: "select", options: ["Endophytic", "Exophytic", "Mixed", "Diffuse infiltrating", "See Comment"] },
            { id: "opticNerveInvasion", label: "Optic Nerve Invasion", type: "select", options: ["Not identified", "Prelaminar", "Laminar", "Postlaminar (retrolaminar)", "At surgical margin of optic nerve", "See Comment"] },
            { id: "choroidalInvasion", label: "Choroidal Invasion", type: "select", options: ["Not identified", "Focal (<3 mm)", "Massive (\u22653 mm)", "See Comment"] },
            { id: "scleralInvasion", label: "Scleral Invasion", type: "select", options: ["Not identified", "Intrascleral", "Extrascleral", "See Comment"] },
            { id: "extraocularExtension", label: "Extraocular Extension", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "anteriorSegmentInvasion", label: "Anterior Segment Invasion", type: "select", options: ["Not identified", "Iris invasion", "Ciliary body invasion", "Anterior chamber seeding", "See Comment"] },
            { id: "vitreousSeeding", label: "Vitreous Seeding", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "subretinalSeeding", label: "Subretinal Seeding", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "iircStage", label: "International Intraocular RB Classification", type: "select", options: ["Group A", "Group B", "Group C", "Group D", "Group E", "See Comment"] },
            { id: "pT", label: "pT Stage", type: "select", options: ["pT1: Intraocular tumor(s) with no optic nerve or choroidal invasion", "pT2: Intraocular tumor(s) with subretinal and/or vitreous seeding", "pT3: Advanced intraocular tumor(s)", "pT4: Extraocular tumor (extrascleral extension)", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Necrosis", "Calcification", "Retinal detachment", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Uveal Melanoma",
        pdf: "https://documents.cap.org/protocols/Uvea.Mel_4.2.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Enucleation", "Local resection (iridectomy/iridocyclectomy)", "Biopsy", "Other", "See Comment"] },
            { id: "laterality", label: "Laterality", type: "select", options: ["Right", "Left", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Iris", "Ciliary body", "Choroid", "Multiple sites", "See Comment"] },
            { id: "tumorBasalDiameter", label: "Largest Basal Diameter (mm)", type: "text" },
            { id: "tumorThickness", label: "Tumor Thickness (mm)", type: "text" },
            { id: "cellType", label: "Cell Type", type: "select", options: ["Spindle cell (type A)", "Spindle cell (type B)", "Epithelioid cell", "Mixed cell (spindle and epithelioid)", "See Comment"] },
            { id: "mitoticRate", label: "Mitotic Rate (per 40 HPF)", type: "text" },
            { id: "extraocularExtension", label: "Extraocular Extension", type: "select", options: ["Not identified", "Present, microscopic", "Present, macroscopic (specify mm)", "See Comment"] },
            { id: "opticNerveInvasion", label: "Optic Nerve Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "scleralInvasion", label: "Scleral Invasion", type: "select", options: ["Not identified", "Intrascleral", "Extrascleral", "See Comment"] },
            { id: "ciliarBodyInvolvement", label: "Ciliary Body Involvement", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Not applicable (enucleation)", "Uninvolved", "Involved", "See Comment"] },
            { id: "chromosome3Status", label: "Chromosome 3 Status", type: "select", options: ["Disomy 3 (favorable)", "Monosomy 3 (unfavorable)", "Not tested", "See Comment"] },
            { id: "chromosome8qStatus", label: "Chromosome 8q Status", type: "select", options: ["Normal", "Gain", "Not tested", "See Comment"] },
            { id: "geneExpressionClass", label: "Gene Expression Class", type: "select", options: ["Class 1A (low risk)", "Class 1B (intermediate risk)", "Class 2 (high risk)", "Not tested", "See Comment"] },
            { id: "bap1Status", label: "BAP1 Status", type: "select", options: ["Retained", "Lost", "Not tested", "See Comment"] },
            { id: "pT", label: "pT Stage (Iris)", type: "select", options: ["pT1: Limited to iris", "pT2: Confluence and/or extension into ciliary body, choroid, or both", "pT3: Extension into ciliary body and/or choroid with scleral extension", "pT4: Extrascleral extension", "pTX: Cannot be assessed", "See Comment"] },
            { id: "pTCB", label: "pT Stage (Ciliary Body/Choroid; size-based)", type: "select", options: ["pT1: Size category 1", "pT2: Size category 2", "pT3: Size category 3", "pT4: Size category 4 or extraocular extension", "pTX: Cannot be assessed", "Not applicable", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Necrosis", "Pigmentation (heavy)", "Retinal detachment", "Closed loops (PAS+)", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    }
],

"Pediatric": [
    {
        name: "Ewing Sarcoma, Resection",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/PNET_Ewing_5.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Excision/resection", "Amputation", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Long bone (femur)", "Long bone (tibia/fibula)", "Long bone (humerus)", "Long bone (other)", "Pelvis", "Rib/chest wall", "Spine", "Soft tissue", "Other", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Ewing sarcoma", "Ewing sarcoma with divergent differentiation", "Other (specify)", "See Comment"] },
            { id: "percentNecrosis", label: "Percent Necrosis (post-chemotherapy)", type: "text" },
            { id: "treatmentEffect", label: "Treatment Effect", type: "select", options: ["\u226590% necrosis (good response)", "<90% necrosis (poor response)", "No prior treatment", "Cannot be assessed", "See Comment"] },
            { id: "softTissueExtension", label: "Soft Tissue Extension", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["R0 (negative)", "R1 (microscopically positive)", "R2 (grossly positive)", "Cannot be assessed", "See Comment"] },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "molecularConfirmation", label: "Molecular Confirmation", type: "select", options: ["EWSR1 rearrangement confirmed", "FUS rearrangement confirmed", "Other translocation (specify)", "Not tested", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Skip metastasis", "Joint involvement", "Pathologic fracture", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Ewing Sarcoma, Biopsy",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/PNET_Ewing.Bx_5.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Core needle biopsy", "Incisional biopsy", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Long bone", "Pelvis", "Rib/chest wall", "Spine", "Soft tissue", "Other", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Ewing sarcoma", "Other (specify)", "See Comment"] },
            { id: "molecularConfirmation", label: "Molecular Confirmation", type: "select", options: ["EWSR1 rearrangement confirmed", "FUS rearrangement confirmed", "Other translocation (specify)", "Not tested", "See Comment"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Germ Cell Tumor, Resection",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/ExGonad.GCT_5.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Excision/resection", "Orchiectomy", "Oophorectomy", "Coccygectomy", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Testis", "Ovary", "Sacrococcygeal", "Mediastinum", "Retroperitoneum", "CNS (intracranial)", "Other", "See Comment"] },
            { id: "laterality", label: "Laterality", type: "select", options: ["Right", "Left", "Midline", "Not applicable", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Yolk sac tumor (endodermal sinus tumor)", "Embryonal carcinoma", "Choriocarcinoma", "Teratoma, mature", "Teratoma, immature", "Mixed germ cell tumor (specify components)", "Germinoma/Seminoma/Dysgerminoma", "Other (specify)", "See Comment"] },
            { id: "immatureTeratomaGrade", label: "Immature Teratoma Grade", type: "select", options: ["Grade 0 (mature only)", "Grade 1 (rare immature tissue)", "Grade 2 (moderate immature tissue)", "Grade 3 (abundant immature tissue)", "Not applicable", "See Comment"] },
            { id: "percentNecrosis", label: "Percent Necrosis (post-chemotherapy)", type: "text" },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Somatic-type malignancy arising in teratoma", "Capsular invasion", "Adjacent organ invasion", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Germ Cell Tumor, Biopsy",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/ExGonad.GCT.Bx_5.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Core needle biopsy", "Incisional biopsy", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Testis", "Ovary", "Sacrococcygeal", "Mediastinum", "Retroperitoneum", "CNS", "Other", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Yolk sac tumor", "Embryonal carcinoma", "Choriocarcinoma", "Teratoma", "Mixed germ cell tumor", "Germinoma/Seminoma/Dysgerminoma", "Other (specify)", "See Comment"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Hepatoblastoma, Resection",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/Liver.Hepatoblastoma_5.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Partial hepatectomy", "Lobectomy", "Trisegmentectomy", "Total hepatectomy (transplant)", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Right lobe", "Left lobe", "Caudate lobe", "Both lobes", "Other"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "tumorFocality", label: "Tumor Focality", type: "select", options: ["Unifocal", "Multifocal", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Hepatoblastoma, epithelial (fetal, well differentiated)", "Hepatoblastoma, epithelial (fetal, mitotically active)", "Hepatoblastoma, epithelial (embryonal)", "Hepatoblastoma, epithelial (small cell undifferentiated)", "Hepatoblastoma, epithelial (cholangioblastic)", "Hepatoblastoma, mixed epithelial and mesenchymal (without teratoid features)", "Hepatoblastoma, mixed epithelial and mesenchymal (with teratoid features)", "Other (specify)", "See Comment"] },
            { id: "percentNecrosis", label: "Percent Necrosis (post-chemotherapy)", type: "text" },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "closestMargin", label: "Distance to Closest Margin (mm)", type: "text" },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "pretextStage", label: "PRETEXT/POST-TEXT Stage", type: "select", options: ["PRETEXT I", "PRETEXT II", "PRETEXT III", "PRETEXT IV", "See Comment"] },
            { id: "cogStage", label: "COG Stage", type: "select", options: ["Stage I: Complete resection", "Stage II: Microscopic residual", "Stage III: Macroscopic residual or node positive", "Stage IV: Metastatic disease", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Portal vein involvement", "Hepatic vein involvement", "Extrahepatic extension", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Hepatoblastoma, Biopsy",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/Liver.Hepatoblastoma.Bx_5.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Core needle biopsy", "Incisional biopsy", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Right lobe", "Left lobe", "Both lobes", "Not specified", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Hepatoblastoma, epithelial (fetal)", "Hepatoblastoma, epithelial (embryonal)", "Hepatoblastoma, epithelial (small cell undifferentiated)", "Hepatoblastoma, mixed epithelial and mesenchymal", "Other (specify)", "See Comment"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Neuroblastoma, Resection",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/Neuroblastoma_5.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Excision/resection", "Adrenalectomy", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Adrenal gland", "Retroperitoneum (extra-adrenal)", "Mediastinum (posterior)", "Pelvis", "Neck", "Other", "See Comment"] },
            { id: "laterality", label: "Laterality", type: "select", options: ["Right", "Left", "Midline", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicCategory", label: "Histologic Category (INPC)", type: "select", options: ["Neuroblastoma (Schwannian stroma-poor)", "Ganglioneuroblastoma, intermixed (Schwannian stroma-rich)", "Ganglioneuroblastoma, nodular (composite)", "Ganglioneuroma (Schwannian stroma-dominant)", "See Comment"] },
            { id: "differentiationGrade", label: "Grade of Neuroblastic Differentiation", type: "select", options: ["Undifferentiated", "Poorly differentiated", "Differentiating", "See Comment"] },
            { id: "mki", label: "Mitosis-Karyorrhexis Index (MKI)", type: "select", options: ["Low (<100/5000 cells or <2%)", "Intermediate (100-200/5000 cells or 2-4%)", "High (>200/5000 cells or >4%)", "See Comment"] },
            { id: "inpcCategory", label: "INPC Prognostic Category", type: "select", options: ["Favorable histology", "Unfavorable histology", "See Comment"] },
            { id: "mycnAmplification", label: "MYCN Amplification", type: "select", options: ["Not amplified", "Amplified", "Not tested", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "inrgssStage", label: "INRGSS Stage", type: "select", options: ["L1: Localized, no image-defined risk factors", "L2: Localized, with image-defined risk factors", "M: Distant metastatic disease", "MS: Metastatic special (age <18 months with metastases confined to skin, liver, bone marrow)", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Calcification", "Hemorrhage", "Ganglion cell maturation", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Neuroblastoma, Biopsy",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/Neuroblastoma.Bx_5.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Core needle biopsy", "Incisional biopsy", "Bone marrow biopsy", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Adrenal gland", "Retroperitoneum", "Mediastinum", "Pelvis", "Neck", "Other", "See Comment"] },
            { id: "histologicCategory", label: "Histologic Category", type: "select", options: ["Neuroblastoma", "Ganglioneuroblastoma", "Ganglioneuroma", "See Comment"] },
            { id: "differentiationGrade", label: "Grade of Differentiation", type: "select", options: ["Undifferentiated", "Poorly differentiated", "Differentiating", "Cannot be assessed", "See Comment"] },
            { id: "mycnAmplification", label: "MYCN Amplification", type: "select", options: ["Not amplified", "Amplified", "Not tested", "See Comment"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Rhabdomyosarcoma, Resection",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/Rhabdomyosarcoma_5.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Excision/resection", "Wide excision", "Radical resection", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Orbit", "Head and neck (parameningeal)", "Head and neck (non-parameningeal)", "Genitourinary (bladder/prostate)", "Genitourinary (paratesticular)", "Genitourinary (other)", "Extremity", "Trunk/retroperitoneum", "Biliary tract", "Other", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Embryonal rhabdomyosarcoma", "Embryonal rhabdomyosarcoma, botryoid variant", "Embryonal rhabdomyosarcoma, spindle cell/sclerosing variant", "Alveolar rhabdomyosarcoma", "Pleomorphic rhabdomyosarcoma", "Other (specify)", "See Comment"] },
            { id: "foxo1Status", label: "FOXO1 Fusion Status", type: "select", options: ["Fusion negative", "PAX3-FOXO1 positive", "PAX7-FOXO1 positive", "Other fusion (specify)", "Not tested", "See Comment"] },
            { id: "percentNecrosis", label: "Percent Necrosis (post-chemotherapy)", type: "text" },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["R0 (negative)", "R1 (microscopically positive)", "R2 (grossly positive)", "Cannot be assessed", "See Comment"] },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "irsClinicalGroup", label: "IRS Clinical Group (Post-Surgical)", type: "select", options: ["Group I: Localized, completely resected", "Group II: Microscopic residual or regional disease", "Group III: Gross residual disease", "Group IV: Distant metastatic disease", "See Comment"] },
            { id: "tnmStage", label: "TNM Stage", type: "select", options: ["Stage 1: Favorable site", "Stage 2: Unfavorable site, \u22645 cm, N0", "Stage 3: Unfavorable site, >5 cm and/or N1", "Stage 4: Distant metastasis", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Bone invasion", "Meningeal involvement", "Adjacent organ invasion", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Rhabdomyosarcoma, Biopsy",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/Rhabdomyosarcoma.Bx_5.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Core needle biopsy", "Incisional biopsy", "Other", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Head and neck", "Genitourinary", "Extremity", "Trunk/retroperitoneum", "Other", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Embryonal rhabdomyosarcoma", "Alveolar rhabdomyosarcoma", "Pleomorphic rhabdomyosarcoma", "Other (specify)", "See Comment"] },
            { id: "foxo1Status", label: "FOXO1 Fusion Status", type: "select", options: ["Fusion negative", "PAX3-FOXO1 positive", "PAX7-FOXO1 positive", "Other fusion (specify)", "Not tested", "See Comment"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Wilms Tumor, Resection",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/ExGonad.GCT_5.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Radical nephrectomy", "Partial nephrectomy", "Other", "See Comment"] },
            { id: "laterality", label: "Laterality", type: "select", options: ["Right", "Left", "Bilateral", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
            { id: "tumorWeight", label: "Tumor Weight (g)", type: "text" },
            { id: "histologicType", label: "Histologic Classification", type: "select", options: ["Favorable histology (no anaplasia)", "Focal anaplasia", "Diffuse anaplasia", "See Comment"] },
            { id: "components", label: "Components Present", type: "checkbox", options: ["Blastemal", "Epithelial", "Stromal", "Rhabdomyomatous differentiation", "Other"] },
            { id: "percentNecrosis", label: "Percent Necrosis (post-chemotherapy)", type: "text" },
            { id: "blastemalViability", label: "Post-Chemotherapy Blastemal Viability", type: "select", options: ["Not applicable (no prior treatment)", "Low risk (completely necrotic/regressive)", "Intermediate risk (blastemal < predominant)", "High risk (blastemal predominant, viable \u226510%)", "See Comment"] },
            { id: "renalSinusInvasion", label: "Renal Sinus Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "perinephricFatInvasion", label: "Perinephric Fat/Capsular Invasion", type: "select", options: ["Not identified", "Present, contained within Gerota fascia", "Present, extends beyond Gerota fascia", "See Comment"] },
            { id: "renalVeinInvasion", label: "Renal Vein Invasion", type: "select", options: ["Not identified", "Present (intrarenal)", "Present (at renal hilum)", "See Comment"] },
            { id: "capsuleRupture", label: "Capsule Rupture", type: "select", options: ["Not identified", "Present (intraoperative, localized)", "Present (intraoperative, diffuse)", "Present (preoperative)", "See Comment"] },
            { id: "margins", label: "Margins", type: "select", options: ["Uninvolved", "Involved", "Cannot be assessed", "See Comment"] },
            { id: "lymphNodesExamined", label: "Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Lymph Nodes Positive", type: "text" },
            { id: "nephrogenicRests", label: "Nephrogenic Rests", type: "select", options: ["Not identified", "Perilobar nephrogenic rests", "Intralobar nephrogenic rests", "Both perilobar and intralobar", "See Comment"] },
            { id: "cogStage", label: "COG/NWTS Stage", type: "select", options: ["Stage I: Tumor limited to kidney, completely excised", "Stage II: Tumor extends beyond kidney but completely excised", "Stage III: Residual tumor confined to abdomen (positive margins, LN+, peritoneal contamination, tumor thrombus at margin)", "Stage IV: Hematogenous metastases (lung, liver, bone, brain)", "Stage V: Bilateral renal involvement at diagnosis", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Nephroblastomatosis", "Perilobar nephrogenic rests", "Intralobar nephrogenic rests", "None identified"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Wilms Tumor, Biopsy",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/ExGonad.GCT.Bx_5.0.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Core needle biopsy", "Incisional biopsy", "Other", "See Comment"] },
            { id: "laterality", label: "Laterality", type: "select", options: ["Right", "Left", "Bilateral", "See Comment"] },
            { id: "histologicType", label: "Histologic Classification", type: "select", options: ["Favorable histology (no anaplasia)", "Focal anaplasia", "Diffuse anaplasia", "Cannot be assessed on biopsy", "See Comment"] },
            { id: "components", label: "Components Present", type: "checkbox", options: ["Blastemal", "Epithelial", "Stromal", "Other"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    }
],
    "Gastrointestinal": [
{
    name: "Ampulla of Vater",
    pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/Ampulla_4.3.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Pancreaticoduodenectomy (Whipple resection)",
            "Local excision (ampullectomy)",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: [
            "Ampulla of Vater",
            "Sphincter of Oddi",
            "Periampullary duodenum",
            "Other (specify)"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Adenocarcinoma, NOS",
            "Adenocarcinoma, intestinal type",
            "Adenocarcinoma, pancreatobiliary type",
            "Adenocarcinoma, mixed type",
            "Mucinous adenocarcinoma",
            "Signet ring cell carcinoma",
            "Undifferentiated carcinoma",
            "Adenosquamous carcinoma",
            "Squamous cell carcinoma",
            "Neuroendocrine carcinoma, large cell",
            "Neuroendocrine carcinoma, small cell",
            "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)",
            "Other histologic type (specify)",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "GX: Cannot be assessed",
            "See Comment"
        ]},
        { id: "depthOfInvasion", label: "Depth of Invasion", type: "select", options: [
            "Tumor limited to ampulla of Vater or sphincter of Oddi",
            "Tumor invades beyond sphincter of Oddi into duodenal submucosa",
            "Tumor invades muscularis propria of duodenum",
            "Tumor invades pancreas (up to 0.5 cm)",
            "Tumor invades pancreas (>0.5 cm) or extends into peripancreatic/periduodenal tissue or duodenal serosa",
            "Tumor involves celiac axis, SMA, and/or common hepatic artery",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Proximal margin (duodenal)",
            "Distal margin (duodenal)",
            "Pancreatic parenchymal margin",
            "Common bile duct (hepatic) margin",
            "Uncinate process (retroperitoneal/SMA) margin",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by invasive carcinoma",
            "Margin(s) involved by invasive carcinoma",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pni", label: "Perineural Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
        { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
        { id: "pT", label: "Pathologic Tumor Stage (pT)", type: "select", options: [
            "pTis: High-grade dysplasia",
            "pT1a: Tumor limited to ampulla of Vater or sphincter of Oddi",
            "pT1b: Tumor invades beyond sphincter of Oddi into duodenal submucosa",
            "pT2: Tumor invades muscularis propria of duodenum",
            "pT3a: Tumor invades pancreas, up to 0.5 cm",
            "pT3b: Tumor invades >0.5 cm into pancreas or extends into peripancreatic/periduodenal tissue or duodenal serosa without involvement of celiac axis or SMA",
            "pT4: Tumor involves celiac axis, superior mesenteric artery (SMA), and/or common hepatic artery",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1: Metastasis in 1-3 regional lymph nodes",
            "pN2: Metastasis in 4 or more regional lymph nodes",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1: Distant metastasis",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "Adenoma (tubular, villous, or tubulovillous)",
            "Low-grade dysplasia",
            "High-grade dysplasia",
            "Chronic pancreatitis",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "Anus, Excision",
    pdf: "https://documents.cap.org/protocols/Anus.Bx.TDE_5.0.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Local excision",
            "Excisional biopsy",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: [
            "Anal canal",
            "Perianal skin",
            "Other (specify)"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Squamous cell carcinoma, NOS",
            "Squamous cell carcinoma, keratinizing",
            "Squamous cell carcinoma, nonkeratinizing",
            "Basaloid squamous cell carcinoma",
            "Verrucous carcinoma",
            "Adenocarcinoma, NOS",
            "Mucinous adenocarcinoma",
            "Paget disease",
            "Neuroendocrine carcinoma, large cell",
            "Neuroendocrine carcinoma, small cell",
            "Undifferentiated carcinoma",
            "Other histologic type (specify)",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "GX: Cannot be assessed",
            "See Comment"
        ]},
        { id: "depthOfInvasion", label: "Depth of Invasion", type: "select", options: [
            "Tumor limited to mucosa (intraepithelial)",
            "Tumor invades lamina propria",
            "Tumor invades muscularis mucosae",
            "Tumor invades submucosa",
            "Tumor invades sphincter muscle(s)",
            "Tumor invades adjacent structures",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Peripheral (mucosal) margin",
            "Deep margin",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by invasive carcinoma",
            "Margin(s) involved by invasive carcinoma",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pni", label: "Perineural Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pT", label: "Pathologic Tumor Stage (pT)", type: "select", options: [
            "pTis: High-grade squamous intraepithelial lesion (HSIL)",
            "pT1: Tumor 2 cm or less in greatest dimension",
            "pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension",
            "pT3: Tumor more than 5 cm in greatest dimension",
            "pT4: Tumor of any size invading adjacent organ(s) (e.g., vagina, urethra, bladder)",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1a: Metastasis in inguinal, mesorectal, or internal iliac nodes",
            "pN1b: Metastasis in external iliac nodes",
            "pN1c: Metastasis in external iliac with any N1a nodes",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1: Distant metastasis",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "High-grade squamous intraepithelial lesion (HSIL)",
            "Low-grade squamous intraepithelial lesion (LSIL)",
            "Condyloma",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "Anus, Resection",
    pdf: "https://documents.cap.org/protocols/Anus_5.0.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Abdominoperineal resection",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: [
            "Anal canal",
            "Perianal skin",
            "Other (specify)"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Squamous cell carcinoma, NOS",
            "Squamous cell carcinoma, keratinizing",
            "Squamous cell carcinoma, nonkeratinizing",
            "Basaloid squamous cell carcinoma",
            "Verrucous carcinoma",
            "Adenocarcinoma, NOS",
            "Mucinous adenocarcinoma",
            "Paget disease",
            "Neuroendocrine carcinoma, large cell",
            "Neuroendocrine carcinoma, small cell",
            "Undifferentiated carcinoma",
            "Other histologic type (specify)",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "GX: Cannot be assessed",
            "See Comment"
        ]},
        { id: "depthOfInvasion", label: "Depth of Invasion", type: "select", options: [
            "Tumor limited to mucosa (intraepithelial)",
            "Tumor invades lamina propria",
            "Tumor invades muscularis mucosae",
            "Tumor invades submucosa",
            "Tumor invades sphincter muscle(s)",
            "Tumor invades perirectal tissue",
            "Tumor invades adjacent structures",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Proximal margin",
            "Distal margin",
            "Radial (circumferential) margin",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by invasive carcinoma",
            "Margin(s) involved by invasive carcinoma",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pni", label: "Perineural Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
        { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
        { id: "treatmentEffect", label: "Treatment Effect (if neoadjuvant therapy)", type: "select", options: [
            "No prior treatment",
            "No residual tumor (complete response, score 0)",
            "Moderate response (minimal residual cancer, score 1)",
            "Mild response (score 2)",
            "Poor or no response (score 3)",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pT", label: "Pathologic Tumor Stage (pT)", type: "select", options: [
            "pTis: High-grade squamous intraepithelial lesion (HSIL)",
            "pT1: Tumor 2 cm or less in greatest dimension",
            "pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension",
            "pT3: Tumor more than 5 cm in greatest dimension",
            "pT4: Tumor of any size invading adjacent organ(s) (e.g., vagina, urethra, bladder)",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1a: Metastasis in inguinal, mesorectal, or internal iliac nodes",
            "pN1b: Metastasis in external iliac nodes",
            "pN1c: Metastasis in external iliac with any N1a nodes",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1: Distant metastasis",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "High-grade squamous intraepithelial lesion (HSIL)",
            "Low-grade squamous intraepithelial lesion (LSIL)",
            "Condyloma",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "Appendix",
    pdf: "https://documents.cap.org/protocols/Appendix_5.1.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Appendectomy",
            "Right hemicolectomy",
            "Ileocecectomy",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Low-grade appendiceal mucinous neoplasm (LAMN)",
            "High-grade appendiceal mucinous neoplasm (HAMN)",
            "Mucinous adenocarcinoma",
            "Adenocarcinoma, NOS",
            "Signet ring cell carcinoma",
            "Goblet cell adenocarcinoma",
            "Undifferentiated carcinoma",
            "Neuroendocrine carcinoma, large cell",
            "Neuroendocrine carcinoma, small cell",
            "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)",
            "Other histologic type (specify)",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "GX: Cannot be assessed",
            "Not applicable",
            "See Comment"
        ]},
        { id: "tumorExtension", label: "Tumor Extension", type: "select", options: [
            "Tumor limited to the appendix",
            "Tumor invades submucosa",
            "Tumor invades muscularis propria",
            "Tumor invades through muscularis propria into subserosa or mesoappendix",
            "Tumor penetrates visceral peritoneum (serosa)",
            "Tumor directly invades adjacent organs or structures",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Proximal (cecal) margin",
            "Mesoappendix margin",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by invasive carcinoma",
            "Margin(s) involved by invasive carcinoma",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "acellularMucinSerosa", label: "Acellular Mucin on Serosa", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pni", label: "Perineural Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
        { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
        { id: "pT", label: "Pathologic Tumor Stage (pT)", type: "select", options: [
            "pTis: Carcinoma in situ (intramucosal carcinoma; invasion of lamina propria or extension into but not through muscularis mucosae)",
            "pT1: Tumor invades submucosa (through muscularis mucosae but not into muscularis propria), tumor 2 cm or less",
            "pT2: Tumor invades muscularis propria and/or is 2 cm or less in greatest dimension",
            "pT3: Tumor invades through muscularis propria into subserosa or mesoappendix and/or is more than 2 cm",
            "pT4a: Tumor penetrates visceral peritoneum, including acellular mucinous peritoneal deposits",
            "pT4b: Tumor directly invades or adheres to adjacent organs or structures",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1: Metastasis in 1-3 regional lymph nodes",
            "pN2: Metastasis in 4 or more regional lymph nodes",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1a: Intraperitoneal acellular mucin only",
            "pM1b: Intraperitoneal metastasis only, including mucinous peritoneal deposits containing tumor cells",
            "pM1c: Metastasis to non-peritoneal sites",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "Adenoma (tubular, villous, or tubulovillous)",
            "Serrated lesion/polyp",
            "Diverticulum",
            "Endometriosis",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "Colon and Rectum, Biopsy",
    pdf: "https://documents.cap.org/protocols/ColoRectal.Bx_4.3.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Biopsy (endoscopic)",
            "Polypectomy",
            "Endoscopic mucosal resection (EMR)",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: [
            "Cecum",
            "Ascending colon",
            "Hepatic flexure",
            "Transverse colon",
            "Splenic flexure",
            "Descending colon",
            "Sigmoid colon",
            "Rectosigmoid junction",
            "Rectum",
            "Other (specify)"
        ]},
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Adenocarcinoma, NOS",
            "Mucinous adenocarcinoma",
            "Signet ring cell carcinoma",
            "Medullary carcinoma",
            "Adenosquamous carcinoma",
            "Micropapillary carcinoma",
            "Serrated adenocarcinoma",
            "Adenoma-like adenocarcinoma",
            "Squamous cell carcinoma",
            "Undifferentiated carcinoma",
            "Neuroendocrine carcinoma, large cell",
            "Neuroendocrine carcinoma, small cell",
            "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)",
            "Other histologic type (specify)",
            "Carcinoma, type cannot be determined",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "GX: Cannot be assessed",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "Adenoma (tubular)",
            "Adenoma (villous)",
            "Adenoma (tubulovillous)",
            "Sessile serrated lesion",
            "Traditional serrated adenoma",
            "Inflammatory bowel disease",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "Colon and Rectum, Resection",
    pdf: "https://documents.cap.org/protocols/ColoRectal_4.4.0.1.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Right hemicolectomy",
            "Transverse colectomy",
            "Left hemicolectomy",
            "Sigmoidectomy",
            "Low anterior resection",
            "Abdominoperineal resection",
            "Total colectomy",
            "Total proctocolectomy",
            "Subtotal colectomy",
            "Segmental resection",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "specimenType", label: "Specimen Type", type: "select", options: [
            "Segmental resection of colon",
            "Segmental resection of rectum",
            "Low anterior resection",
            "Abdominoperineal resection",
            "Total colectomy",
            "Total proctocolectomy",
            "Other (specify)",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: [
            "Cecum",
            "Ascending colon",
            "Hepatic flexure",
            "Transverse colon",
            "Splenic flexure",
            "Descending colon",
            "Sigmoid colon",
            "Rectosigmoid junction",
            "Rectum",
            "Other (specify)"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
        { id: "tumorConfiguration", label: "Tumor Configuration", type: "select", options: [
            "Polypoid/exophytic",
            "Ulcerative",
            "Infiltrative",
            "Annular",
            "Other (specify)",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Adenocarcinoma, NOS",
            "Mucinous adenocarcinoma",
            "Signet ring cell carcinoma",
            "Medullary carcinoma",
            "Adenosquamous carcinoma",
            "Micropapillary carcinoma",
            "Serrated adenocarcinoma",
            "Adenoma-like adenocarcinoma",
            "Squamous cell carcinoma",
            "Undifferentiated carcinoma",
            "Neuroendocrine carcinoma, large cell",
            "Neuroendocrine carcinoma, small cell",
            "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)",
            "Other histologic type (specify)",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "GX: Cannot be assessed",
            "See Comment"
        ]},
        { id: "tumorExtension", label: "Tumor Extension / Depth of Invasion", type: "select", options: [
            "Tumor invades lamina propria",
            "Tumor invades muscularis mucosae",
            "Tumor invades submucosa",
            "Tumor invades muscularis propria",
            "Tumor invades through muscularis propria into pericolorectal tissues",
            "Tumor penetrates to the surface of the visceral peritoneum",
            "Tumor directly invades or is adherent to other organs or structures",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Proximal margin",
            "Distal margin",
            "Radial (circumferential/mesenteric) margin",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginDistance", label: "Distance of Invasive Carcinoma from Closest Margin (cm)", type: "text" },
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by invasive carcinoma",
            "Margin(s) involved by invasive carcinoma",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "mesorectalIntegrity", label: "Mesorectal Integrity (rectal specimens only)", type: "select", options: [
            "Not applicable (colon specimen)",
            "Complete: Intact mesorectum with smooth surface, no defects >5 mm",
            "Nearly complete: Moderate bulk of mesorectum with irregularity, no visible muscularis propria",
            "Incomplete: Little bulk to mesorectum with defects down to muscularis propria",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "tumorDeposits", label: "Tumor Deposits", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "tumorDepositsNumber", label: "Number of Tumor Deposits", type: "text" },
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pni", label: "Perineural Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "tumorBudding", label: "Tumor Budding (ITBCC)", type: "select", options: [
            "Bd1: Low (0-4 buds per 0.785 mm)",
            "Bd2: Intermediate (5-9 buds per 0.785 mm)",
            "Bd3: High (>=10 buds per 0.785 mm)",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "msiStatus", label: "Microsatellite Instability (MSI)", type: "select", options: [
            "Not performed",
            "MSI-High (MSI-H)",
            "MSI-Low (MSI-L)",
            "Microsatellite stable (MSS)",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "treatmentEffect", label: "Treatment Effect (if neoadjuvant therapy)", type: "select", options: [
            "No prior treatment",
            "No residual tumor cells (complete response, score 0)",
            "Single cells or rare small groups of cancer cells (near-complete response, score 1)",
            "Residual cancer with evident tumor regression, but more than single cells or rare small groups (partial response, score 2)",
            "Extensive residual cancer with no evident tumor regression (poor or no response, score 3)",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
        { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
        { id: "pT", label: "Pathologic Tumor Stage (pT)", type: "select", options: [
            "pTis: Carcinoma in situ, intramucosal carcinoma (involvement of lamina propria with no extension through muscularis mucosae)",
            "pT1: Tumor invades submucosa (through muscularis mucosae but not into muscularis propria)",
            "pT2: Tumor invades muscularis propria",
            "pT3: Tumor invades through muscularis propria into pericolorectal tissues",
            "pT4a: Tumor penetrates to the surface of the visceral peritoneum",
            "pT4b: Tumor directly invades or is adherent to other organs or structures",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1a: Metastasis in 1 regional lymph node",
            "pN1b: Metastasis in 2-3 regional lymph nodes",
            "pN1c: Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional nodal metastasis",
            "pN2a: Metastasis in 4-6 regional lymph nodes",
            "pN2b: Metastasis in 7 or more regional lymph nodes",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1a: Metastasis to one site or organ without peritoneal metastasis",
            "pM1b: Metastasis to two or more sites or organs without peritoneal metastasis",
            "pM1c: Metastasis to the peritoneal surface alone or with other site or organ metastases",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "Adenoma (tubular)",
            "Adenoma (villous)",
            "Adenoma (tubulovillous)",
            "Sessile serrated lesion",
            "Traditional serrated adenoma",
            "Inflammatory bowel disease-associated dysplasia",
            "Perforation",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "Colorectal Biomarker Reporting",
    pdf: "https://documents.cap.org/protocols/ColoRectal.Bmk_1.3.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "mmrStatus", label: "Mismatch Repair (MMR) / MSI Status", type: "select", options: [
            "No loss of nuclear expression of MMR proteins (intact/proficient)",
            "Loss of MLH1 and PMS2 expression",
            "Loss of MSH2 and MSH6 expression",
            "Loss of PMS2 expression (retained MLH1)",
            "Loss of MSH6 expression (retained MSH2)",
            "Loss of MLH1 expression only",
            "Loss of MSH2 expression only",
            "MSI-High (MSI-H)",
            "Microsatellite stable (MSS)",
            "MSI-Low (MSI-L)",
            "Indeterminate / equivocal",
            "Not performed",
            "See Comment"
        ]},
        { id: "krasMutation", label: "KRAS Mutation Status", type: "select", options: [
            "No mutation detected (wild type)",
            "Mutation detected in exon 2 (codons 12/13)",
            "Mutation detected in exon 3 (codons 59/61)",
            "Mutation detected in exon 4 (codons 117/146)",
            "KRAS G12C mutation detected",
            "Other KRAS mutation detected (specify)",
            "Not performed",
            "See Comment"
        ]},
        { id: "nrasMutation", label: "NRAS Mutation Status", type: "select", options: [
            "No mutation detected (wild type)",
            "Mutation detected in exon 2 (codons 12/13)",
            "Mutation detected in exon 3 (codons 59/61)",
            "Mutation detected in exon 4 (codons 117/146)",
            "Other NRAS mutation detected (specify)",
            "Not performed",
            "See Comment"
        ]},
        { id: "brafV600e", label: "BRAF V600E Mutation Status", type: "select", options: [
            "No BRAF V600E mutation detected (wild type)",
            "BRAF V600E mutation detected",
            "Other BRAF mutation detected (specify)",
            "Not performed",
            "See Comment"
        ]},
        { id: "her2Status", label: "HER2 Status", type: "select", options: [
            "Negative (IHC 0 or 1+)",
            "Equivocal (IHC 2+) - reflex ISH recommended",
            "Positive (IHC 3+)",
            "Positive by ISH (amplified)",
            "Negative by ISH (not amplified)",
            "Not performed",
            "See Comment"
        ]},
        { id: "ntrkFusion", label: "NTRK Fusion Status", type: "select", options: [
            "No NTRK fusion detected",
            "NTRK fusion detected (specify gene partner)",
            "Not performed",
            "See Comment"
        ]},
        { id: "tmb", label: "Tumor Mutational Burden (TMB)", type: "select", options: [
            "TMB-Low (< 10 mutations/megabase)",
            "TMB-High (>= 10 mutations/megabase)",
            "Not performed",
            "See Comment"
        ]},
        { id: "comments", label: "Additional Biomarker Comments", type: "textarea" }
    ]
},
{
    name: "Distal Extrahepatic Bile Ducts",
    pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/BileDuctDE_4.3.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Pancreaticoduodenectomy (Whipple resection)",
            "Bile duct excision",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "select", options: [
            "Distal extrahepatic bile duct (common bile duct)",
            "Other (specify)",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Adenocarcinoma, NOS",
            "Adenocarcinoma, biliary type",
            "Adenocarcinoma, intestinal type",
            "Adenocarcinoma, gastric foveolar type",
            "Mucinous adenocarcinoma",
            "Signet ring cell carcinoma",
            "Clear cell adenocarcinoma",
            "Adenosquamous carcinoma",
            "Squamous cell carcinoma",
            "Undifferentiated carcinoma",
            "Neuroendocrine carcinoma, large cell",
            "Neuroendocrine carcinoma, small cell",
            "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)",
            "Other histologic type (specify)",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "GX: Cannot be assessed",
            "See Comment"
        ]},
        { id: "tumorExtension", label: "Tumor Extension", type: "select", options: [
            "Tumor confined to bile duct wall",
            "Tumor invades beyond bile duct wall",
            "Tumor invades adjacent structures",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Proximal bile duct margin",
            "Distal bile duct margin",
            "Pancreatic parenchymal margin",
            "Uncinate process (retroperitoneal/SMA) margin",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by invasive carcinoma",
            "Margin(s) involved by invasive carcinoma",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pni", label: "Perineural Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
        { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
        { id: "pT", label: "Pathologic Tumor Stage (pT)", type: "select", options: [
            "pTis: Carcinoma in situ / high-grade dysplasia",
            "pT1: Tumor invades bile duct wall with depth less than 5 mm",
            "pT2: Tumor invades bile duct wall with depth of 5-12 mm",
            "pT3: Tumor invades bile duct wall with depth greater than 12 mm",
            "pT4: Tumor involves celiac axis, superior mesenteric artery, and/or common hepatic artery",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1: Metastasis in 1-3 regional lymph nodes",
            "pN2: Metastasis in 4 or more regional lymph nodes",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1: Distant metastasis",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "Biliary intraepithelial neoplasia (BilIN), low grade",
            "Biliary intraepithelial neoplasia (BilIN), high grade",
            "Primary sclerosing cholangitis",
            "Choledocholithiasis",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "Esophagus",
    pdf: "https://documents.cap.org/protocols/Esophagus_4.2.0.1.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Esophagectomy, partial",
            "Esophagectomy, total",
            "Esophagogastrectomy",
            "Endoscopic mucosal resection (EMR)",
            "Endoscopic submucosal dissection (ESD)",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: [
            "Upper thoracic esophagus",
            "Middle thoracic esophagus",
            "Lower thoracic esophagus",
            "Esophagogastric junction (EGJ)/cardia",
            "Other (specify)"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Adenocarcinoma, NOS",
            "Squamous cell carcinoma, NOS",
            "Squamous cell carcinoma, keratinizing",
            "Squamous cell carcinoma, nonkeratinizing",
            "Squamous cell carcinoma, basaloid",
            "Squamous cell carcinoma, verrucous",
            "Squamous cell carcinoma, spindle cell (sarcomatoid)",
            "Adenosquamous carcinoma",
            "Mucinous adenocarcinoma",
            "Signet ring cell carcinoma",
            "Undifferentiated carcinoma",
            "Neuroendocrine carcinoma, large cell",
            "Neuroendocrine carcinoma, small cell",
            "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)",
            "Other histologic type (specify)",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "GX: Cannot be assessed",
            "See Comment"
        ]},
        { id: "tumorExtension", label: "Depth of Invasion", type: "select", options: [
            "Tumor limited to mucosa (epithelium or lamina propria)",
            "Tumor invades muscularis mucosae",
            "Tumor invades submucosa",
            "Tumor invades muscularis propria",
            "Tumor invades adventitia",
            "Tumor invades adjacent structures",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Proximal margin",
            "Distal margin",
            "Radial (circumferential) margin",
            "Deep margin (EMR/ESD)",
            "Lateral/peripheral margin (EMR/ESD)",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by invasive carcinoma",
            "Margin(s) involved by invasive carcinoma",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pni", label: "Perineural Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "treatmentEffect", label: "Treatment Effect (if neoadjuvant therapy)", type: "select", options: [
            "No prior treatment",
            "No residual tumor (complete response, score 0)",
            "Marked response (minimal residual cancer, score 1)",
            "Moderate response (score 2)",
            "Poor or no response (extensive residual cancer, score 3)",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
        { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
        { id: "pT", label: "Pathologic Tumor Stage (pT)", type: "select", options: [
            "pTis: High-grade dysplasia (includes all noninvasive neoplastic epithelia formerly called carcinoma in situ)",
            "pT1a: Tumor invades lamina propria or muscularis mucosae",
            "pT1b: Tumor invades submucosa",
            "pT2: Tumor invades muscularis propria",
            "pT3: Tumor invades adventitia",
            "pT4a: Tumor invades pleura, pericardium, azygos vein, diaphragm, or peritoneum",
            "pT4b: Tumor invades other adjacent structures such as aorta, vertebral body, or trachea",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1: Metastasis in 1-2 regional lymph nodes",
            "pN2: Metastasis in 3-6 regional lymph nodes",
            "pN3: Metastasis in 7 or more regional lymph nodes",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1: Distant metastasis",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "Barrett esophagus/columnar mucosa with intestinal metaplasia",
            "Low-grade dysplasia in Barrett esophagus",
            "High-grade dysplasia in Barrett esophagus",
            "Squamous dysplasia, low grade",
            "Squamous dysplasia, high grade",
            "Eosinophilic esophagitis",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "Gallbladder",
    pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/Gallbladder_4.3.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Simple cholecystectomy",
            "Radical (extended) cholecystectomy",
            "Cholecystectomy with liver bed resection",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: [
            "Fundus",
            "Body",
            "Neck",
            "Cystic duct",
            "Other (specify)"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Adenocarcinoma, NOS",
            "Adenocarcinoma, biliary type",
            "Adenocarcinoma, intestinal type",
            "Adenocarcinoma, gastric foveolar type",
            "Mucinous adenocarcinoma",
            "Signet ring cell carcinoma",
            "Clear cell adenocarcinoma",
            "Papillary adenocarcinoma",
            "Adenosquamous carcinoma",
            "Squamous cell carcinoma",
            "Undifferentiated carcinoma",
            "Neuroendocrine carcinoma, large cell",
            "Neuroendocrine carcinoma, small cell",
            "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)",
            "Sarcomatoid carcinoma",
            "Other histologic type (specify)",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "GX: Cannot be assessed",
            "See Comment"
        ]},
        { id: "tumorExtension", label: "Tumor Extension", type: "select", options: [
            "Tumor confined to gallbladder mucosa (lamina propria)",
            "Tumor invades muscular layer",
            "Tumor invades perimuscular connective tissue, peritoneal side",
            "Tumor invades perimuscular connective tissue, hepatic side",
            "Tumor invades serosa and/or directly invades liver and/or one adjacent organ or structure",
            "Tumor invades main portal vein or hepatic artery or two or more extrahepatic organs or structures",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Cystic duct margin",
            "Liver bed margin (if applicable)",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by invasive carcinoma",
            "Margin(s) involved by invasive carcinoma",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pni", label: "Perineural Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
        { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
        { id: "pT", label: "Pathologic Tumor Stage (pT)", type: "select", options: [
            "pTis: Carcinoma in situ (high-grade dysplasia)",
            "pT1a: Tumor invades lamina propria",
            "pT1b: Tumor invades muscular layer",
            "pT2a: Tumor invades perimuscular connective tissue on the peritoneal side, without involvement of serosa",
            "pT2b: Tumor invades perimuscular connective tissue on the hepatic side, without extension into liver",
            "pT3: Tumor perforates serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure",
            "pT4: Tumor invades main portal vein or hepatic artery or invades two or more extrahepatic organs or structures",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1: Metastasis in 1-3 regional lymph nodes",
            "pN2: Metastasis in 4 or more regional lymph nodes",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1: Distant metastasis",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "Biliary intraepithelial neoplasia (BilIN), low grade",
            "Biliary intraepithelial neoplasia (BilIN), high grade",
            "Intracholecystic papillary-tubular neoplasm (ICPN)",
            "Chronic cholecystitis",
            "Cholelithiasis",
            "Porcelain gallbladder",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "GIST, Biopsy",
    pdf: "https://documents.cap.org/protocols/Stomach.GIST.Bx_4.3.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "tumorSite", label: "Tumor Site", type: "select", options: [
            "Esophagus",
            "Stomach",
            "Small intestine (duodenum)",
            "Small intestine (jejunum)",
            "Small intestine (ileum)",
            "Colon",
            "Rectum",
            "Omentum/mesentery",
            "Retroperitoneum",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Gastrointestinal stromal tumor, spindle cell type",
            "Gastrointestinal stromal tumor, epithelioid cell type",
            "Gastrointestinal stromal tumor, mixed spindle and epithelioid cell type",
            "See Comment"
        ]},
        { id: "mitoticRate", label: "Mitotic Rate (per 5 mm\u00b2)", type: "text" },
        { id: "kitIHC", label: "KIT (CD117) by Immunohistochemistry", type: "select", options: [
            "Positive",
            "Negative",
            "Not performed",
            "See Comment"
        ]},
        { id: "dog1IHC", label: "DOG1 by Immunohistochemistry", type: "select", options: [
            "Positive",
            "Negative",
            "Not performed",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "Necrosis",
            "Mucosal ulceration",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "GIST, Resection",
    pdf: "https://documents.cap.org/protocols/Stomach.GIST_4.3.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Wedge/segmental resection",
            "Subtotal gastrectomy",
            "Total gastrectomy",
            "Small bowel resection",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "select", options: [
            "Esophagus",
            "Stomach",
            "Small intestine (duodenum)",
            "Small intestine (jejunum)",
            "Small intestine (ileum)",
            "Small intestine, NOS",
            "Colon",
            "Rectum",
            "Omentum/mesentery",
            "Retroperitoneum",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Gastrointestinal stromal tumor, spindle cell type",
            "Gastrointestinal stromal tumor, epithelioid cell type",
            "Gastrointestinal stromal tumor, mixed spindle and epithelioid cell type",
            "See Comment"
        ]},
        { id: "mitoticRate", label: "Mitotic Rate (per 5 mm\u00b2)", type: "text" },
        { id: "tumorRupture", label: "Tumor Rupture", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Proximal margin",
            "Distal margin",
            "Serosal/soft tissue margin",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by tumor",
            "Margin(s) involved by tumor",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "kitIHC", label: "KIT (CD117) by Immunohistochemistry", type: "select", options: [
            "Positive",
            "Negative",
            "Not performed",
            "See Comment"
        ]},
        { id: "dog1IHC", label: "DOG1 by Immunohistochemistry", type: "select", options: [
            "Positive",
            "Negative",
            "Not performed",
            "See Comment"
        ]},
        { id: "riskAssessment", label: "Risk Assessment", type: "select", options: [
            "Very low risk",
            "Low risk",
            "Moderate risk",
            "High risk",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
        { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
        { id: "pT_gastric", label: "Pathologic Tumor Stage (pT) - Gastric GIST", type: "select", options: [
            "pT1: Tumor 2 cm or less in greatest dimension",
            "pT2: Tumor more than 2 cm but not more than 5 cm",
            "pT3: Tumor more than 5 cm but not more than 10 cm",
            "pT4: Tumor more than 10 cm in greatest dimension",
            "See Comment"
        ]},
        { id: "pT_smallIntestine", label: "Pathologic Tumor Stage (pT) - Small Intestinal GIST", type: "select", options: [
            "pT1: Tumor 2 cm or less in greatest dimension",
            "pT2: Tumor more than 2 cm but not more than 5 cm",
            "pT3: Tumor more than 5 cm but not more than 10 cm",
            "pT4: Tumor more than 10 cm in greatest dimension",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1: Regional lymph node metastasis",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1: Distant metastasis",
            "See Comment"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "GIST Biomarker Reporting",
    pdf: "https://documents.cap.org/protocols/Stomach.GIST.Bmk_1.1.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "kitMutation", label: "KIT Mutation Status", type: "select", options: [
            "No KIT mutation detected",
            "KIT exon 9 mutation detected",
            "KIT exon 11 mutation detected",
            "KIT exon 13 mutation detected",
            "KIT exon 17 mutation detected",
            "Other KIT mutation detected (specify)",
            "Not performed",
            "See Comment"
        ]},
        { id: "pdgfraMutation", label: "PDGFRA Mutation Status", type: "select", options: [
            "No PDGFRA mutation detected",
            "PDGFRA exon 12 mutation detected",
            "PDGFRA exon 14 mutation detected",
            "PDGFRA exon 18 mutation detected (D842V)",
            "PDGFRA exon 18 mutation detected (non-D842V)",
            "Other PDGFRA mutation detected (specify)",
            "Not performed",
            "See Comment"
        ]},
        { id: "sdhStatus", label: "SDH Status", type: "select", options: [
            "Intact SDHA and SDHB expression by IHC",
            "Loss of SDHB expression by IHC",
            "Loss of SDHA and SDHB expression by IHC",
            "SDH germline mutation detected (specify)",
            "Not performed",
            "See Comment"
        ]},
        { id: "brafMutation", label: "BRAF Mutation Status", type: "select", options: [
            "No BRAF mutation detected",
            "BRAF V600E mutation detected",
            "Other BRAF mutation detected (specify)",
            "Not performed",
            "See Comment"
        ]},
        { id: "nf1Status", label: "NF1 Status", type: "select", options: [
            "No NF1 alteration detected",
            "NF1 alteration detected (specify)",
            "Clinical history of neurofibromatosis type 1",
            "Not performed",
            "See Comment"
        ]},
        { id: "comments", label: "Additional Biomarker Comments", type: "textarea" }
    ]
},
{
    name: "Hepatocellular Carcinoma",
    pdf: "https://documents.cap.org/protocols/Liver.HCC_4.3.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Partial hepatectomy (segmentectomy, lobectomy)",
            "Total hepatectomy (explant)",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: [
            "Right lobe",
            "Left lobe",
            "Caudate lobe",
            "Quadrate lobe",
            "Other (specify)"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm, largest nodule)", type: "text" },
        { id: "tumorFocality", label: "Tumor Focality", type: "select", options: [
            "Solitary",
            "Multifocal (specify number of nodules)",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Hepatocellular carcinoma, NOS",
            "Hepatocellular carcinoma, fibrolamellar",
            "Hepatocellular carcinoma, scirrhous",
            "Hepatocellular carcinoma, steatohepatitic",
            "Hepatocellular carcinoma, clear cell",
            "Hepatocellular carcinoma, macrotrabecular-massive",
            "Hepatocellular carcinoma, chromophobe",
            "Hepatocellular carcinoma, neutrophil-rich",
            "Hepatocellular carcinoma, lymphocyte-rich",
            "Combined hepatocellular-cholangiocarcinoma",
            "Other histologic type (specify)",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade (Edmondson-Steiner)", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "G4: Undifferentiated",
            "GX: Cannot be assessed",
            "See Comment"
        ]},
        { id: "vascularInvasion", label: "Vascular Invasion", type: "select", options: [
            "Not identified",
            "Present, microvascular (microscopic) only",
            "Present, macrovascular (gross involvement of major branch of portal or hepatic vein)",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Parenchymal margin",
            "Capsular margin (if applicable)",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by invasive carcinoma",
            "Margin(s) involved by invasive carcinoma",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "marginDistance", label: "Distance of Tumor from Closest Margin (cm)", type: "text" },
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pni", label: "Perineural Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
        { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
        { id: "backgroundLiver", label: "Background Liver", type: "select", options: [
            "No significant abnormality",
            "Chronic hepatitis (specify etiology if known)",
            "Cirrhosis",
            "Steatosis / steatohepatitis",
            "Fibrosis (specify stage)",
            "Other (specify)",
            "See Comment"
        ]},
        { id: "pT", label: "Pathologic Tumor Stage (pT)", type: "select", options: [
            "pT1a: Solitary tumor 2 cm or less in greatest dimension, with or without vascular invasion",
            "pT1b: Solitary tumor more than 2 cm without vascular invasion",
            "pT2: Solitary tumor more than 2 cm with vascular invasion, or multifocal tumors, none more than 5 cm",
            "pT3: Multifocal tumors, at least one of which is more than 5 cm",
            "pT4: Tumor(s) involving a major branch of the portal vein or hepatic vein, or direct invasion of adjacent organs other than the gallbladder, or perforation of visceral peritoneum",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1: Regional lymph node metastasis",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1: Distant metastasis",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "Cirrhosis",
            "Chronic hepatitis B",
            "Chronic hepatitis C",
            "Steatosis",
            "Steatohepatitis",
            "Iron overload",
            "Dysplastic nodule (low grade)",
            "Dysplastic nodule (high grade)",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "Intrahepatic Bile Ducts",
    pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/BileDuctIH_4.3.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Partial hepatectomy (segmentectomy, lobectomy)",
            "Total hepatectomy (explant)",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: [
            "Right lobe",
            "Left lobe",
            "Caudate lobe",
            "Other (specify)"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
        { id: "tumorFocality", label: "Tumor Focality", type: "select", options: [
            "Solitary",
            "Multifocal (specify number)",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Cholangiocarcinoma (intrahepatic), large duct type",
            "Cholangiocarcinoma (intrahepatic), small duct type",
            "Cholangiocarcinoma, NOS",
            "Mucinous adenocarcinoma",
            "Signet ring cell carcinoma",
            "Adenosquamous carcinoma",
            "Squamous cell carcinoma",
            "Undifferentiated carcinoma",
            "Neuroendocrine carcinoma, large cell",
            "Neuroendocrine carcinoma, small cell",
            "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)",
            "Combined hepatocellular-cholangiocarcinoma",
            "Other histologic type (specify)",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "GX: Cannot be assessed",
            "See Comment"
        ]},
        { id: "tumorExtension", label: "Tumor Extension", type: "select", options: [
            "Tumor confined to liver",
            "Tumor with intrahepatic vascular invasion",
            "Tumor perforating visceral peritoneum",
            "Tumor directly invading local extrahepatic structures",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Parenchymal margin",
            "Bile duct margin",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by invasive carcinoma",
            "Margin(s) involved by invasive carcinoma",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "marginDistance", label: "Distance of Tumor from Closest Margin (cm)", type: "text" },
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pni", label: "Perineural Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
        { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
        { id: "pT", label: "Pathologic Tumor Stage (pT)", type: "select", options: [
            "pTis: Carcinoma in situ (intraductal tumor)",
            "pT1a: Solitary tumor 5 cm or less without vascular invasion",
            "pT1b: Solitary tumor more than 5 cm without vascular invasion",
            "pT2: Solitary tumor with intrahepatic vascular invasion, or multiple tumors, with or without vascular invasion",
            "pT3: Tumor perforating the visceral peritoneum",
            "pT4: Tumor involving local extrahepatic structures by direct invasion",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1: Regional lymph node metastasis",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1: Distant metastasis",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "Biliary intraepithelial neoplasia (BilIN), low grade",
            "Biliary intraepithelial neoplasia (BilIN), high grade",
            "Intraductal papillary neoplasm of bile duct (IPN-B)",
            "Primary sclerosing cholangitis",
            "Cirrhosis",
            "Hepatolithiasis",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "Pancreas (Exocrine)",
    pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/Panc.Exo_4.3.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Pancreaticoduodenectomy (Whipple resection)",
            "Distal pancreatectomy",
            "Total pancreatectomy",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: [
            "Pancreatic head",
            "Pancreatic body",
            "Pancreatic tail",
            "Uncinate process",
            "Other (specify)"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Ductal adenocarcinoma",
            "Mucinous noncystic (colloid) adenocarcinoma",
            "Signet ring cell carcinoma",
            "Adenosquamous carcinoma",
            "Undifferentiated (anaplastic) carcinoma",
            "Undifferentiated carcinoma with osteoclast-like giant cells",
            "Hepatoid carcinoma",
            "Medullary carcinoma",
            "Acinar cell carcinoma",
            "Acinar cell cystadenocarcinoma",
            "Intraductal papillary mucinous neoplasm (IPMN) with associated invasive carcinoma",
            "Mucinous cystic neoplasm (MCN) with associated invasive carcinoma",
            "Pancreatoblastoma",
            "Neuroendocrine carcinoma, large cell",
            "Neuroendocrine carcinoma, small cell",
            "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)",
            "Solid pseudopapillary neoplasm with invasive carcinoma",
            "Other histologic type (specify)",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "GX: Cannot be assessed",
            "See Comment"
        ]},
        { id: "tumorExtension", label: "Tumor Extension", type: "select", options: [
            "Tumor limited to the pancreas",
            "Tumor extends beyond the pancreas but without involvement of celiac axis, SMA, or common hepatic artery",
            "Tumor involves celiac axis, SMA, and/or common hepatic artery",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Pancreatic neck/body margin",
            "Bile duct (common hepatic duct) margin",
            "Uncinate process (SMA/retroperitoneal) margin",
            "Anterior surface",
            "Posterior surface",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by invasive carcinoma",
            "Margin(s) involved by invasive carcinoma",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pni", label: "Perineural Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "treatmentEffect", label: "Treatment Effect (if neoadjuvant therapy)", type: "select", options: [
            "No prior treatment",
            "No residual tumor (complete response, score 0)",
            "Marked response (minimal residual cancer, score 1)",
            "Moderate response (score 2)",
            "Poor or no response (extensive residual cancer, score 3)",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
        { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
        { id: "pT", label: "Pathologic Tumor Stage (pT)", type: "select", options: [
            "pTis: Carcinoma in situ (includes high-grade pancreatic intraepithelial neoplasia [PanIN-3], IPMN with high-grade dysplasia, ITPN with high-grade dysplasia, MCN with high-grade dysplasia)",
            "pT1a: Tumor 0.5 cm or less in greatest dimension",
            "pT1b: Tumor greater than 0.5 cm and less than 1 cm in greatest dimension",
            "pT1c: Tumor 1-2 cm in greatest dimension",
            "pT2: Tumor greater than 2 cm and not more than 4 cm in greatest dimension",
            "pT3: Tumor greater than 4 cm in greatest dimension",
            "pT4: Tumor involves the celiac axis, the superior mesenteric artery, and/or the common hepatic artery, regardless of size",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1: Metastasis in 1-3 regional lymph nodes",
            "pN2: Metastasis in 4 or more regional lymph nodes",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1: Distant metastasis",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "Pancreatic intraepithelial neoplasia (PanIN), low grade",
            "Pancreatic intraepithelial neoplasia (PanIN), high grade",
            "Intraductal papillary mucinous neoplasm (IPMN)",
            "Mucinous cystic neoplasm (MCN)",
            "Chronic pancreatitis",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "Perihilar Bile Ducts",
    pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/BileDuctPH_4.3.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Hepatectomy with bile duct excision",
            "Bile duct excision alone",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: [
            "Right hepatic duct",
            "Left hepatic duct",
            "Confluence of right and left hepatic ducts",
            "Common hepatic duct",
            "Other (specify)"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Adenocarcinoma, NOS",
            "Adenocarcinoma, biliary type",
            "Adenocarcinoma, intestinal type",
            "Adenocarcinoma, gastric foveolar type",
            "Mucinous adenocarcinoma",
            "Signet ring cell carcinoma",
            "Clear cell adenocarcinoma",
            "Papillary adenocarcinoma",
            "Adenosquamous carcinoma",
            "Squamous cell carcinoma",
            "Undifferentiated carcinoma",
            "Neuroendocrine carcinoma, large cell",
            "Neuroendocrine carcinoma, small cell",
            "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)",
            "Other histologic type (specify)",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "GX: Cannot be assessed",
            "See Comment"
        ]},
        { id: "tumorExtension", label: "Tumor Extension", type: "select", options: [
            "Tumor confined to bile duct, with extension up to muscle layer or fibrous tissue",
            "Tumor invades beyond bile duct wall to surrounding adipose tissue",
            "Tumor invades adjacent hepatic parenchyma",
            "Tumor invades unilateral branches of portal vein or hepatic artery",
            "Tumor invades main portal vein or bilateral branches; or common hepatic artery; or unilateral second-order biliary radicals with contralateral portal vein or hepatic artery",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Proximal bile duct margin",
            "Distal bile duct margin",
            "Hepatic parenchymal margin",
            "Periductal soft tissue margin",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by invasive carcinoma",
            "Margin(s) involved by invasive carcinoma",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pni", label: "Perineural Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
        { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
        { id: "pT", label: "Pathologic Tumor Stage (pT)", type: "select", options: [
            "pTis: Carcinoma in situ / high-grade dysplasia",
            "pT1: Tumor confined to the bile duct, with extension up to the muscle layer or fibrous tissue",
            "pT2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue",
            "pT2b: Tumor invades adjacent hepatic parenchyma",
            "pT3: Tumor invades unilateral branches of the portal vein or hepatic artery",
            "pT4: Tumor invades the main portal vein or its branches bilaterally; or the common hepatic artery; or unilateral second-order biliary radicals with contralateral portal vein or hepatic artery involvement",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1: Metastasis in 1-3 regional lymph nodes",
            "pN2: Metastasis in 4 or more regional lymph nodes",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1: Distant metastasis",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "Biliary intraepithelial neoplasia (BilIN), low grade",
            "Biliary intraepithelial neoplasia (BilIN), high grade",
            "Intraductal papillary neoplasm of bile duct (IPN-B)",
            "Primary sclerosing cholangitis",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "Small Intestine",
    pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/Small_Int_4.3.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Segmental resection",
            "Pancreaticoduodenectomy (Whipple resection)",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: [
            "Duodenum",
            "Jejunum",
            "Ileum",
            "Other (specify)"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Adenocarcinoma, NOS",
            "Mucinous adenocarcinoma",
            "Signet ring cell carcinoma",
            "Medullary carcinoma",
            "Adenosquamous carcinoma",
            "Squamous cell carcinoma",
            "Undifferentiated carcinoma",
            "Neuroendocrine carcinoma, large cell",
            "Neuroendocrine carcinoma, small cell",
            "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)",
            "Other histologic type (specify)",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "GX: Cannot be assessed",
            "See Comment"
        ]},
        { id: "tumorExtension", label: "Tumor Extension / Depth of Invasion", type: "select", options: [
            "Tumor limited to mucosa (lamina propria)",
            "Tumor invades submucosa",
            "Tumor invades muscularis propria",
            "Tumor invades subserosa or nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension 2 cm or less",
            "Tumor perforates visceral peritoneum or directly invades other organs or structures",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Proximal margin",
            "Distal margin",
            "Radial (mesenteric) margin",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by invasive carcinoma",
            "Margin(s) involved by invasive carcinoma",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pni", label: "Perineural Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
        { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
        { id: "pT", label: "Pathologic Tumor Stage (pT)", type: "select", options: [
            "pTis: Carcinoma in situ",
            "pT1a: Tumor invades lamina propria",
            "pT1b: Tumor invades submucosa",
            "pT2: Tumor invades muscularis propria",
            "pT3: Tumor invades through muscularis propria into subserosa, or into nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension of 2 cm or less",
            "pT4: Tumor perforates the visceral peritoneum or directly invades other organs or structures (includes other loops of small intestine, mesentery, or retroperitoneum)",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1: Metastasis in 1-2 regional lymph nodes",
            "pN2: Metastasis in 3 or more regional lymph nodes",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1: Distant metastasis",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "Adenoma (tubular, villous, or tubulovillous)",
            "Celiac disease",
            "Crohn disease",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
},
{
    name: "Stomach",
    pdf: "https://documents.cap.org/documents/Stomach_4.4.0.0.REL_CAPCP.pdf",
    fields: [
        { id: "procedure", label: "Procedure", type: "select", options: [
            "Subtotal/partial gastrectomy",
            "Total gastrectomy",
            "Endoscopic mucosal resection (EMR)",
            "Endoscopic submucosal dissection (ESD)",
            "Wedge/segmental resection",
            "Other (specify)",
            "Not specified",
            "See Comment"
        ]},
        { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: [
            "Cardia/EGJ",
            "Fundus",
            "Body",
            "Antrum",
            "Pylorus",
            "Lesser curvature, NOS",
            "Greater curvature, NOS",
            "Overlapping/multifocal",
            "Other (specify)"
        ]},
        { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
        { id: "tumorConfiguration", label: "Tumor Configuration", type: "select", options: [
            "Polypoid/fungating",
            "Ulcerating",
            "Infiltrating (linitis plastica)",
            "Flat/depressed",
            "Other (specify)",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "histologicType", label: "Histologic Type", type: "select", options: [
            "Adenocarcinoma, NOS",
            "Tubular adenocarcinoma",
            "Papillary adenocarcinoma",
            "Mucinous adenocarcinoma",
            "Poorly cohesive carcinoma (including signet ring cell carcinoma)",
            "Mixed adenocarcinoma",
            "Hepatoid adenocarcinoma",
            "Micropapillary adenocarcinoma",
            "Medullary carcinoma with lymphoid stroma",
            "Adenosquamous carcinoma",
            "Squamous cell carcinoma",
            "Undifferentiated carcinoma",
            "Neuroendocrine carcinoma, large cell",
            "Neuroendocrine carcinoma, small cell",
            "Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)",
            "Paneth cell carcinoma",
            "Carcinoma with lymphoid stroma (EBV-associated)",
            "Other histologic type (specify)",
            "See Comment"
        ]},
        { id: "histologicGrade", label: "Histologic Grade", type: "select", options: [
            "G1: Well differentiated",
            "G2: Moderately differentiated",
            "G3: Poorly differentiated",
            "GX: Cannot be assessed",
            "See Comment"
        ]},
        { id: "tumorExtension", label: "Depth of Invasion", type: "select", options: [
            "Tumor invades lamina propria or muscularis mucosae",
            "Tumor invades submucosa",
            "Tumor invades muscularis propria",
            "Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures",
            "Tumor perforates visceral peritoneum (serosa)",
            "Tumor invades adjacent structures/organs",
            "See Comment"
        ]},
        { id: "margins", label: "Margins", type: "checkbox", options: [
            "Proximal margin",
            "Distal margin",
            "Radial/omental margin",
            "Deep margin (EMR/ESD)",
            "Lateral/peripheral margin (EMR/ESD)",
            "Other margin(s) (specify)",
            "Cannot be assessed"
        ]},
        { id: "marginStatus", label: "Margin Status", type: "select", options: [
            "All margins uninvolved by invasive carcinoma",
            "Margin(s) involved by invasive carcinoma",
            "Cannot be assessed",
            "See Comment"
        ]},
        { id: "marginDistance", label: "Distance of Invasive Carcinoma from Closest Margin (cm)", type: "text" },
        { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "pni", label: "Perineural Invasion", type: "select", options: [
            "Not identified",
            "Present",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "treatmentEffect", label: "Treatment Effect (if neoadjuvant therapy)", type: "select", options: [
            "No prior treatment",
            "No residual tumor (complete response, score 0)",
            "Marked response (minimal residual cancer, score 1)",
            "Moderate response (score 2)",
            "Poor or no response (extensive residual cancer, score 3)",
            "Cannot be determined",
            "See Comment"
        ]},
        { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
        { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
        { id: "pT", label: "Pathologic Tumor Stage (pT)", type: "select", options: [
            "pTis: Carcinoma in situ (intraepithelial tumor without invasion of the lamina propria), high-grade dysplasia",
            "pT1a: Tumor invades lamina propria or muscularis mucosae",
            "pT1b: Tumor invades submucosa",
            "pT2: Tumor invades muscularis propria",
            "pT3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures",
            "pT4a: Tumor perforates (invades) visceral peritoneum (serosa)",
            "pT4b: Tumor invades adjacent structures/organs",
            "See Comment"
        ]},
        { id: "pN", label: "Pathologic Node Stage (pN)", type: "select", options: [
            "pN0: No regional lymph node metastasis",
            "pN1: Metastasis in 1-2 regional lymph nodes",
            "pN2: Metastasis in 3-6 regional lymph nodes",
            "pN3a: Metastasis in 7-15 regional lymph nodes",
            "pN3b: Metastasis in 16 or more regional lymph nodes",
            "pNX: Regional lymph nodes cannot be assessed",
            "See Comment"
        ]},
        { id: "pM", label: "Pathologic Metastasis Stage (pM)", type: "select", options: [
            "Not applicable - pM cannot be determined from the submitted specimen(s)",
            "pM1: Distant metastasis",
            "See Comment"
        ]},
        { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: [
            "None identified",
            "Intestinal metaplasia",
            "Helicobacter pylori organisms",
            "Chronic gastritis",
            "Atrophic gastritis",
            "Dysplasia, low grade",
            "Dysplasia, high grade",
            "Autoimmune gastritis",
            "Other (specify)"
        ]},
        { id: "comments", label: "Comments", type: "textarea" }
    ]
}
    ],
    "Genitourinary": [
    {
        name: "Kidney, Biopsy",
        pdf: "https://documents.cap.org/protocols/Kidney.Bx_4.2.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Core needle biopsy", "Incisional biopsy", "Other (specify)", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Clear cell renal cell carcinoma", "Papillary renal cell carcinoma, type 1", "Papillary renal cell carcinoma, type 2", "Chromophobe renal cell carcinoma", "Collecting duct carcinoma", "Medullary carcinoma", "Translocation-associated renal cell carcinoma", "Acquired cystic disease-associated renal cell carcinoma", "Clear cell papillary renal cell tumor", "Mucinous tubular and spindle cell carcinoma", "Tubulocystic renal cell carcinoma", "Succinate dehydrogenase-deficient renal cell carcinoma", "Eosinophilic solid and cystic renal cell carcinoma", "Unclassified renal cell carcinoma", "Oncocytoma", "Other (specify)", "See Comment"] },
            { id: "whoIsupGrade", label: "WHO/ISUP Grade", type: "select", options: ["Grade 1: Nucleoli absent or inconspicuous and basophilic at 400x", "Grade 2: Nucleoli conspicuous and eosinophilic at 400x, visible but not prominent at 100x", "Grade 3: Nucleoli conspicuous and eosinophilic at 100x", "Grade 4: Marked nuclear pleomorphism and/or multinucleate giant cells and/or rhabdoid and/or sarcomatoid differentiation", "Not applicable", "See Comment"] },
            { id: "sarcomatoidFeatures", label: "Sarcomatoid Features", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "rhabdoidFeatures", label: "Rhabdoid Features", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "tumorNecrosis", label: "Tumor Necrosis", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Inflammation", "Fibrosis", "Cystic change", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Kidney, Resection",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/Kidney_4.2.1.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Partial nephrectomy", "Simple (total) nephrectomy", "Radical nephrectomy", "Radical nephrectomy with adrenalectomy", "Other (specify)", "See Comment"] },
            { id: "specimenLaterality", label: "Specimen Laterality", type: "select", options: ["Right", "Left", "Not specified", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Upper pole", "Mid pole", "Lower pole", "Renal pelvis", "Hilar", "Multifocal", "Not specified"] },
            { id: "tumorSize", label: "Tumor Size (cm, greatest dimension)", type: "text" },
            { id: "tumorFocality", label: "Tumor Focality", type: "select", options: ["Unifocal", "Multifocal", "Cannot be determined", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Clear cell renal cell carcinoma", "Papillary renal cell carcinoma, type 1", "Papillary renal cell carcinoma, type 2", "Chromophobe renal cell carcinoma", "Collecting duct carcinoma", "Medullary carcinoma", "Translocation-associated renal cell carcinoma", "Acquired cystic disease-associated renal cell carcinoma", "Clear cell papillary renal cell tumor", "Mucinous tubular and spindle cell carcinoma", "Tubulocystic renal cell carcinoma", "Succinate dehydrogenase-deficient renal cell carcinoma", "Eosinophilic solid and cystic renal cell carcinoma", "Unclassified renal cell carcinoma", "Oncocytoma", "Other (specify)", "See Comment"] },
            { id: "whoIsupGrade", label: "WHO/ISUP Grade", type: "select", options: ["Grade 1: Nucleoli absent or inconspicuous and basophilic at 400x", "Grade 2: Nucleoli conspicuous and eosinophilic at 400x, visible but not prominent at 100x", "Grade 3: Nucleoli conspicuous and eosinophilic at 100x", "Grade 4: Marked nuclear pleomorphism and/or multinucleate giant cells and/or rhabdoid and/or sarcomatoid differentiation", "Not applicable", "See Comment"] },
            { id: "sarcomatoidFeatures", label: "Sarcomatoid Features", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "rhabdoidFeatures", label: "Rhabdoid Features", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "tumorNecrosis", label: "Tumor Necrosis", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["Uninvolved by invasive carcinoma", "Involved by invasive carcinoma", "Renal parenchymal margin uninvolved", "Renal parenchymal margin involved", "Perinephric fat margin uninvolved", "Perinephric fat margin involved", "Renal vein margin uninvolved", "Renal vein margin involved", "Ureteral margin uninvolved", "Ureteral margin involved", "Cannot be assessed"] },
            { id: "renalVeinInvasion", label: "Renal Vein Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "venaCavaInvasion", label: "Vena Cava Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "adrenalGlandInvolvement", label: "Adrenal Gland Involvement", type: "select", options: ["No adrenal gland submitted", "Adrenal gland not involved", "Adrenal gland involved by direct extension", "Adrenal gland involved by metastasis", "See Comment"] },
            { id: "gerotaFasciaInvolvement", label: "Gerota Fascia Involvement", type: "select", options: ["Not identified", "Present (tumor extends beyond Gerota fascia)", "Cannot be determined", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "Pathologic Stage (pT)", type: "select", options: ["pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney", "pT1b: Tumor more than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney", "pT2a: Tumor more than 7 cm but not more than 10 cm in greatest dimension, limited to the kidney", "pT2b: Tumor more than 10 cm in greatest dimension, limited to the kidney", "pT3a: Tumor extends into the renal vein or its segmental branches, or invades the pelvicalyceal system, or invades perirenal and/or renal sinus fat but not beyond Gerota fascia", "pT3b: Tumor extends into the vena cava below the diaphragm", "pT3c: Tumor extends into the vena cava above the diaphragm or invades the wall of the vena cava", "pT4: Tumor invades beyond Gerota fascia (including contiguous extension into the ipsilateral adrenal gland)", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "Pathologic Stage (pN)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Metastasis in regional lymph node(s)", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "pM", label: "Pathologic Stage (pM)", type: "select", options: ["Not applicable", "pM1: Distant metastasis", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Cystic change", "Calcification", "Osseous metaplasia", "Chronic pyelonephritis", "Nephrosclerosis", "Diabetic nephropathy", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Penis",
        pdf: "https://documents.cap.org/protocols/Penis_4.2.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Circumcision", "Partial penectomy", "Total penectomy", "Excision/biopsy", "Other (specify)", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Glans", "Coronal sulcus", "Foreskin/prepuce", "Shaft skin", "Penile urethra", "Overlapping", "Not specified"] },
            { id: "tumorSize", label: "Tumor Size (cm, greatest dimension)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Squamous cell carcinoma, usual type", "Squamous cell carcinoma, basaloid", "Squamous cell carcinoma, warty (condylomatous)", "Squamous cell carcinoma, verrucous", "Squamous cell carcinoma, papillary", "Squamous cell carcinoma, sarcomatoid", "Squamous cell carcinoma, mixed", "Squamous cell carcinoma, pseudohyperplastic", "Squamous cell carcinoma, pseudoglandular", "Squamous cell carcinoma, carcinoma cuniculatum", "Squamous cell carcinoma, medullary", "Squamous cell carcinoma, lymphoepithelioma-like", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["G1: Well differentiated", "G2: Moderately differentiated", "G3: Poorly differentiated", "GX: Grade cannot be assessed", "See Comment"] },
            { id: "tumorThickness", label: "Tumor Thickness (mm)", type: "text" },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["Uninvolved by invasive carcinoma", "Involved by invasive carcinoma", "Proximal (urethral) margin uninvolved", "Proximal (urethral) margin involved", "Deep soft tissue margin uninvolved", "Deep soft tissue margin involved", "Skin/mucosal margin uninvolved", "Skin/mucosal margin involved", "Cannot be assessed"] },
            { id: "hpvStatus", label: "HPV Status", type: "select", options: ["Positive (HPV-associated)", "Negative (non-HPV-associated)", "Not performed", "See Comment"] },
            { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "Pathologic Stage (pT)", type: "select", options: ["pTis: Carcinoma in situ (penile intraepithelial neoplasia)", "pTa: Noninvasive localized squamous cell carcinoma", "pT1a: Tumor invades subepithelial connective tissue without lymphovascular invasion and is not poorly differentiated (i.e., grade 3)", "pT1b: Tumor invades subepithelial connective tissue with lymphovascular invasion or is poorly differentiated", "pT2: Tumor invades corpus spongiosum with or without urethral invasion", "pT3: Tumor invades corpus cavernosum (including tunica albuginea) with or without urethral invasion", "pT4: Tumor invades other adjacent structures (e.g., scrotum, prostate, pubic bone)", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "Pathologic Stage (pN)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Metastasis in up to 2 unilateral inguinal lymph nodes, no extranodal extension (ENE)", "pN2: Metastasis in 3 or more unilateral inguinal lymph nodes or bilateral inguinal lymph nodes", "pN3: Extranodal extension (ENE) of lymph node metastasis or pelvic lymph node metastasis", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "pM", label: "Pathologic Stage (pM)", type: "select", options: ["Not applicable", "pM1: Distant metastasis", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Lichen sclerosus", "Squamous hyperplasia", "Differentiated penile intraepithelial neoplasia (PeIN)", "Undifferentiated PeIN (basaloid)", "Undifferentiated PeIN (warty)", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Prostate Needle Biopsy, Case Level",
        pdf: "https://documents.cap.org/protocols/Prostate.Needle.Case.Bx_1.1.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Acinar adenocarcinoma", "Ductal adenocarcinoma", "Intraductal carcinoma", "Mixed acinar and ductal adenocarcinoma", "Adenosquamous carcinoma", "Squamous cell carcinoma", "Small cell neuroendocrine carcinoma", "Large cell neuroendocrine carcinoma", "Basal cell carcinoma", "Urothelial carcinoma", "Other (specify)", "See Comment"] },
            { id: "gradeGroup", label: "Grade Group", type: "select", options: ["Grade Group 1: Gleason score 3+3=6 (only individual discrete well-formed glands)", "Grade Group 2: Gleason score 3+4=7 (predominantly well-formed glands with lesser component of poorly formed/fused/cribriform glands)", "Grade Group 3: Gleason score 4+3=7 (predominantly poorly formed/fused/cribriform glands with lesser component of well-formed glands)", "Grade Group 4: Gleason score 4+4=8, 3+5=8, or 5+3=8 (only poorly formed/fused/cribriform glands; or predominantly well-formed glands with lesser component lacking glands; or predominantly lacking glands with lesser component of well-formed glands)", "Grade Group 5: Gleason score 9-10 (4+5=9, 5+4=9, or 5+5=10) (lack gland formation or necrosis with or without poorly formed/fused/cribriform glands)", "See Comment"] },
            { id: "primaryGleasonPattern", label: "Primary (Predominant) Gleason Pattern", type: "select", options: ["Pattern 3: Discrete glandular units", "Pattern 4: Poorly formed/fused/cribriform glands", "Pattern 5: Sheets, cords, single cells, solid nests, comedonecrosis", "See Comment"] },
            { id: "secondaryGleasonPattern", label: "Secondary Gleason Pattern", type: "select", options: ["Pattern 3: Discrete glandular units", "Pattern 4: Poorly formed/fused/cribriform glands", "Pattern 5: Sheets, cords, single cells, solid nests, comedonecrosis", "See Comment"] },
            { id: "tertiaryPattern", label: "Tertiary Gleason Pattern", type: "select", options: ["Not identified", "Pattern 5 present as tertiary pattern", "See Comment"] },
            { id: "percentPattern45", label: "Percentage of Pattern 4/5 (%)", type: "text" },
            { id: "numberOfPositiveCores", label: "Number of Positive Cores", type: "text" },
            { id: "totalCores", label: "Total Number of Cores Examined", type: "text" },
            { id: "percentageCoresPositive", label: "Percentage of Cores Positive (%)", type: "text" },
            { id: "greatestPercentCancerInCore", label: "Greatest Percentage of Cancer in a Single Core (%)", type: "text" },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "extraprostaticExtension", label: "Extraprostatic Extension", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "seminalVesicleInvasion", label: "Seminal Vesicle Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "intraductalCarcinoma", label: "Intraductal Carcinoma", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "High-grade prostatic intraepithelial neoplasia (HGPIN)", "Acute inflammation", "Chronic inflammation", "Granulomatous inflammation", "Atrophy", "Adenosis (atypical adenomatous hyperplasia)", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Prostate Needle Biopsy, Specimen Level",
        pdf: "https://documents.cap.org/protocols/Prostate.Needle.Case.Bx_1.1.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "specimenSite", label: "Specimen Site/Label", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Acinar adenocarcinoma", "Ductal adenocarcinoma", "Intraductal carcinoma", "Mixed acinar and ductal adenocarcinoma", "Small cell neuroendocrine carcinoma", "Large cell neuroendocrine carcinoma", "Other (specify)", "See Comment"] },
            { id: "gradeGroup", label: "Grade Group", type: "select", options: ["Grade Group 1: Gleason score 3+3=6 (only individual discrete well-formed glands)", "Grade Group 2: Gleason score 3+4=7 (predominantly well-formed glands with lesser component of poorly formed/fused/cribriform glands)", "Grade Group 3: Gleason score 4+3=7 (predominantly poorly formed/fused/cribriform glands with lesser component of well-formed glands)", "Grade Group 4: Gleason score 4+4=8, 3+5=8, or 5+3=8", "Grade Group 5: Gleason score 9-10 (4+5=9, 5+4=9, or 5+5=10)", "See Comment"] },
            { id: "primaryGleasonPattern", label: "Primary (Predominant) Gleason Pattern", type: "select", options: ["Pattern 3: Discrete glandular units", "Pattern 4: Poorly formed/fused/cribriform glands", "Pattern 5: Sheets, cords, single cells, solid nests, comedonecrosis", "See Comment"] },
            { id: "secondaryGleasonPattern", label: "Secondary Gleason Pattern", type: "select", options: ["Pattern 3: Discrete glandular units", "Pattern 4: Poorly formed/fused/cribriform glands", "Pattern 5: Sheets, cords, single cells, solid nests, comedonecrosis", "See Comment"] },
            { id: "tertiaryPattern", label: "Tertiary Gleason Pattern", type: "select", options: ["Not identified", "Pattern 5 present as tertiary pattern", "See Comment"] },
            { id: "percentPattern45", label: "Percentage of Pattern 4/5 (%)", type: "text" },
            { id: "numberOfCoresWithCarcinoma", label: "Number of Cores with Carcinoma", type: "text" },
            { id: "totalCoresInSpecimen", label: "Total Cores in This Specimen", type: "text" },
            { id: "linearMmCarcinoma", label: "Linear mm of Carcinoma", type: "text" },
            { id: "linearMmTotalTissue", label: "Linear mm of Total Tissue", type: "text" },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "extraprostaticExtension", label: "Extraprostatic Extension", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "seminalVesicleInvasion", label: "Seminal Vesicle Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "intraductalCarcinoma", label: "Intraductal Carcinoma", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "High-grade prostatic intraepithelial neoplasia (HGPIN)", "Acute inflammation", "Chronic inflammation", "Granulomatous inflammation", "Atrophy", "Adenosis (atypical adenomatous hyperplasia)", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Prostate, Resection",
        pdf: "https://documents.cap.org/protocols/Prostate_4.3.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Radical prostatectomy (retropubic)", "Radical prostatectomy (perineal)", "Radical prostatectomy (robotic-assisted)", "Radical prostatectomy (laparoscopic)", "Other (specify)", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Acinar adenocarcinoma", "Ductal adenocarcinoma", "Intraductal carcinoma", "Mixed acinar and ductal adenocarcinoma", "Adenosquamous carcinoma", "Squamous cell carcinoma", "Small cell neuroendocrine carcinoma", "Large cell neuroendocrine carcinoma", "Other (specify)", "See Comment"] },
            { id: "gradeGroup", label: "Grade Group", type: "select", options: ["Grade Group 1: Gleason score 3+3=6", "Grade Group 2: Gleason score 3+4=7", "Grade Group 3: Gleason score 4+3=7", "Grade Group 4: Gleason score 4+4=8, 3+5=8, or 5+3=8", "Grade Group 5: Gleason score 9-10 (4+5=9, 5+4=9, 5+5=10)", "See Comment"] },
            { id: "primaryGleasonPattern", label: "Primary Gleason Pattern", type: "select", options: ["Pattern 3", "Pattern 4", "Pattern 5", "See Comment"] },
            { id: "secondaryGleasonPattern", label: "Secondary Gleason Pattern", type: "select", options: ["Pattern 3", "Pattern 4", "Pattern 5", "See Comment"] },
            { id: "tertiaryPattern", label: "Tertiary Pattern", type: "select", options: ["Not identified", "Pattern 5 present as tertiary pattern", "See Comment"] },
            { id: "percentPattern45", label: "Percentage Pattern 4/5 (%)", type: "text" },
            { id: "tumorQuantitation", label: "Tumor Quantitation (%)", type: "text" },
            { id: "tumorLocation", label: "Tumor Location", type: "checkbox", options: ["Right apex", "Right mid", "Right base", "Left apex", "Left mid", "Left base", "Anterior", "Posterior", "Transition zone"] },
            { id: "extraprostaticExtension", label: "Extraprostatic Extension (EPE)", type: "select", options: ["Not identified", "Present, focal (few glands outside prostate)", "Present, nonfocal/established", "See Comment"] },
            { id: "epeLocation", label: "EPE Location", type: "checkbox", options: ["Right apex", "Right mid", "Right base", "Left apex", "Left mid", "Left base", "Anterior", "Posterior", "Bladder neck"] },
            { id: "seminalVesicleInvasion", label: "Seminal Vesicle Invasion", type: "select", options: ["Not identified", "Present, right", "Present, left", "Present, bilateral", "See Comment"] },
            { id: "bladderNeckInvasion", label: "Bladder Neck Invasion", type: "select", options: ["Not identified", "Present (microscopic)", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["Uninvolved by invasive carcinoma", "Involved by invasive carcinoma", "Right apex margin involved", "Left apex margin involved", "Right posterolateral margin involved", "Left posterolateral margin involved", "Bladder neck margin involved", "Anterior margin involved", "Cannot be assessed"] },
            { id: "marginExtent", label: "Margin Involvement Extent", type: "select", options: ["Focal (single site, 3 mm)", "Nonfocal/extensive (multiple sites or >3 mm)", "Not applicable", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "treatmentEffect", label: "Treatment Effect", type: "select", options: ["No prior treatment", "No definite treatment effect identified", "Treatment effect present (specify)", "See Comment"] },
            { id: "pT", label: "Pathologic Stage (pT)", type: "select", options: ["pT2: Organ confined", "pT3a: Extraprostatic extension (unilateral or bilateral) or microscopic invasion of bladder neck", "pT3b: Tumor invades seminal vesicle(s)", "pT4: Tumor is fixed or invades adjacent structures other than seminal vesicles (external sphincter, rectum, bladder, levator muscles, and/or pelvic wall)", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "Pathologic Stage (pN)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Metastasis in regional lymph node(s)", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "pM", label: "Pathologic Stage (pM)", type: "select", options: ["Not applicable", "pM1: Distant metastasis", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "High-grade prostatic intraepithelial neoplasia (HGPIN)", "Intraductal carcinoma of the prostate", "Acute inflammation", "Chronic inflammation", "Granulomatous inflammation", "Benign prostatic hyperplasia (BPH)", "Atrophy", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Prostate, TURP",
        pdf: "https://documents.cap.org/protocols/Prostate.TURP_4.2.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Transurethral resection of prostate (TURP)", "Suprapubic (transvesical) prostatectomy", "Enucleation", "Other (specify)", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Acinar adenocarcinoma", "Ductal adenocarcinoma", "Intraductal carcinoma", "Small cell neuroendocrine carcinoma", "Large cell neuroendocrine carcinoma", "Other (specify)", "See Comment"] },
            { id: "gradeGroup", label: "Grade Group", type: "select", options: ["Grade Group 1: Gleason score 3+3=6", "Grade Group 2: Gleason score 3+4=7", "Grade Group 3: Gleason score 4+3=7", "Grade Group 4: Gleason score 4+4=8, 3+5=8, or 5+3=8", "Grade Group 5: Gleason score 9-10 (4+5=9, 5+4=9, 5+5=10)", "See Comment"] },
            { id: "percentTissueInvolved", label: "Percentage of Tissue Involved by Carcinoma (%)", type: "text" },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "High-grade prostatic intraepithelial neoplasia (HGPIN)", "Intraductal carcinoma", "Acute inflammation", "Chronic inflammation", "Granulomatous inflammation", "Benign prostatic hyperplasia (BPH)", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Testis, Orchiectomy",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-March-2025/Testis_4.3.0.0.REL.CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Radical (inguinal) orchiectomy", "Simple orchiectomy", "Partial orchiectomy", "Other (specify)", "See Comment"] },
            { id: "specimenLaterality", label: "Specimen Laterality", type: "select", options: ["Right", "Left", "Not specified", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Testis", "Rete testis", "Epididymis", "Spermatic cord", "Tunica vaginalis", "Not specified"] },
            { id: "tumorSize", label: "Tumor Size (cm, greatest dimension)", type: "text" },
            { id: "tumorFocality", label: "Tumor Focality", type: "select", options: ["Unifocal", "Multifocal", "Cannot be determined", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "checkbox", options: ["Seminoma", "Embryonal carcinoma", "Yolk sac tumor, post-pubertal type", "Yolk sac tumor, prepubertal type", "Choriocarcinoma", "Teratoma, post-pubertal type", "Teratoma, prepubertal type", "Teratoma with somatic-type malignancy", "Mixed germ cell tumor (specify components and percentages)", "Spermatocytic tumor", "Sex cord-stromal tumor: Leydig cell tumor", "Sex cord-stromal tumor: Sertoli cell tumor", "Sex cord-stromal tumor: Granulosa cell tumor", "Sex cord-stromal tumor: Fibroma/thecoma", "Sex cord-stromal tumor: Mixed", "Other (specify)"] },
            { id: "gcnis", label: "Germ Cell Neoplasia In Situ (GCNIS)", type: "select", options: ["Not identified", "Present", "Cannot be assessed", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "reteTestisInvasion", label: "Rete Testis Invasion", type: "select", options: ["Not identified", "Pagetoid involvement only", "Stromal invasion present", "Cannot be determined", "See Comment"] },
            { id: "hilarSoftTissueInvasion", label: "Hilar Soft Tissue Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "epididymisInvasion", label: "Epididymis Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "spermaticCordInvasion", label: "Spermatic Cord Invasion", type: "select", options: ["Not identified", "Present (direct extension)", "Present (discontinuous involvement)", "Cannot be determined", "See Comment"] },
            { id: "tunicaVaginalisInvasion", label: "Tunica Vaginalis Invasion", type: "select", options: ["Not identified", "Present (penetrates visceral mesothelial layer)", "Cannot be determined", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["Uninvolved by invasive tumor", "Involved by invasive tumor", "Spermatic cord margin uninvolved", "Spermatic cord margin involved", "Tunica vaginalis margin uninvolved", "Tunica vaginalis margin involved", "Cannot be assessed"] },
            { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "Pathologic Stage (pT)", type: "select", options: ["pTis: Germ cell neoplasia in situ (GCNIS)", "pT1a: Tumor limited to the testis (including rete testis invasion) without lymphovascular invasion; tumor may invade into hilar soft tissue or epididymis or penetrate visceral mesothelial layer covering outer surface of tunica albuginea without invasion of tunica vaginalis; tumor size 3 cm or less", "pT1b: Tumor limited to the testis (including rete testis invasion) without lymphovascular invasion; tumor may invade into hilar soft tissue or epididymis or penetrate visceral mesothelial layer covering outer surface of tunica albuginea without invasion of tunica vaginalis; tumor size more than 3 cm", "pT2: Tumor limited to the testis (including rete testis invasion) with lymphovascular invasion; or tumor invading hilar soft tissue or epididymis or penetrating visceral mesothelial layer covering the outer surface of the tunica albuginea with involvement of the tunica vaginalis", "pT3: Tumor invades spermatic cord with or without lymphovascular invasion", "pT4: Tumor invades scrotum with or without lymphovascular invasion", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "Pathologic Stage (pN)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or up to 5 nodes positive, none more than 2 cm in greatest dimension", "pN2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or more than 5 nodes positive, none more than 5 cm; or evidence of extranodal extension of tumor", "pN3: Metastasis with a lymph node mass more than 5 cm in greatest dimension", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "pM", label: "Pathologic Stage (pM)", type: "select", options: ["Not applicable", "pM1a: Non-retroperitoneal nodal or pulmonary metastases", "pM1b: Non-pulmonary visceral metastases", "See Comment"] },
            { id: "serumTumorMarkers", label: "Serum Tumor Markers (S)", type: "select", options: ["SX: Marker studies not available or not performed", "S0: Marker study levels within normal limits", "S1: LDH <1.5x N and hCG <5,000 and AFP <1,000", "S2: LDH 1.5-10x N or hCG 5,000-50,000 or AFP 1,000-10,000", "S3: LDH >10x N or hCG >50,000 or AFP >10,000", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Atrophy", "Sertoli cell only syndrome", "Microlithiasis", "Intratubular germ cell neoplasia, unclassified (IGCNU)", "Fibrosis", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Testis, Lymphadenectomy",
        pdf: "https://documents.cap.org/protocols/Testis.RPL_4.2.1.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Retroperitoneal lymph node dissection (RPLND)", "Unilateral template dissection", "Bilateral template dissection", "Other (specify)", "See Comment"] },
            { id: "numberOfNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "numberOfNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "sizeOfLargestMetastasis", label: "Size of Largest Metastatic Deposit (cm)", type: "text" },
            { id: "extranodalExtension", label: "Extranodal Extension", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "histologicTypeOfMetastasis", label: "Histologic Type of Metastasis", type: "checkbox", options: ["Seminoma", "Embryonal carcinoma", "Yolk sac tumor", "Choriocarcinoma", "Teratoma (mature)", "Teratoma (immature)", "Teratoma with somatic-type malignancy", "Mixed (specify components)", "Other (specify)", "No viable tumor (fibrosis/necrosis only)"] },
            { id: "treatmentEffect", label: "Treatment Effect", type: "select", options: ["No prior chemotherapy", "No viable tumor identified (complete response)", "Viable tumor present (specify percentage)", "Cannot be assessed", "See Comment"] },
            { id: "pN", label: "Pathologic Stage (pN)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or up to 5 nodes positive, none more than 2 cm", "pN2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm; or more than 5 nodes positive, none more than 5 cm; or evidence of extranodal extension", "pN3: Metastasis with a lymph node mass more than 5 cm in greatest dimension", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Ureter/Renal Pelvis, Biopsy",
        pdf: "https://documents.cap.org/documents/UreterRenalPelvis.Bx_2.4.0.0.REL.CAPCP.pdf",
        fields: [
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Renal pelvis", "Ureter, proximal", "Ureter, mid", "Ureter, distal", "Ureteropelvic junction", "Not specified", "See Comment"] },
            { id: "specimenLaterality", label: "Specimen Laterality", type: "select", options: ["Right", "Left", "Not specified", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Urothelial (transitional cell) carcinoma", "Urothelial carcinoma with squamous differentiation", "Urothelial carcinoma with glandular differentiation", "Urothelial carcinoma with trophoblastic differentiation", "Urothelial carcinoma, nested variant", "Urothelial carcinoma, microcystic variant", "Urothelial carcinoma, micropapillary variant", "Urothelial carcinoma, lymphoepithelioma-like variant", "Urothelial carcinoma, plasmacytoid variant", "Urothelial carcinoma, sarcomatoid variant", "Squamous cell carcinoma", "Adenocarcinoma", "Small cell neuroendocrine carcinoma", "Large cell neuroendocrine carcinoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["Low grade", "High grade", "Cannot be assessed", "See Comment"] },
            { id: "associatedCIS", label: "Associated Carcinoma In Situ (CIS)", type: "select", options: ["Not identified", "Present", "Cannot be assessed", "See Comment"] },
            { id: "muscularisPropria", label: "Muscularis Propria in Specimen", type: "select", options: ["Not identified (absent)", "Present", "Cannot be determined", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Dysplasia/urothelial atypia", "Inflammation", "Polyp", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Ureter/Renal Pelvis, Resection",
        pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-March-2025/UreterRenalPelvis.Res_2.4.0.0.REL.CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Nephroureterectomy", "Segmental ureterectomy", "Segmental resection of renal pelvis", "Other (specify)", "See Comment"] },
            { id: "specimenLaterality", label: "Specimen Laterality", type: "select", options: ["Right", "Left", "Not specified", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Renal pelvis", "Ureter, proximal", "Ureter, mid", "Ureter, distal", "Ureteropelvic junction", "Multiple/multifocal", "Not specified"] },
            { id: "tumorSize", label: "Tumor Size (cm, greatest dimension)", type: "text" },
            { id: "tumorFocality", label: "Tumor Focality", type: "select", options: ["Unifocal", "Multifocal", "Cannot be determined", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Urothelial (transitional cell) carcinoma", "Urothelial carcinoma with squamous differentiation", "Urothelial carcinoma with glandular differentiation", "Urothelial carcinoma, micropapillary variant", "Urothelial carcinoma, nested variant", "Urothelial carcinoma, plasmacytoid variant", "Urothelial carcinoma, sarcomatoid variant", "Squamous cell carcinoma", "Adenocarcinoma", "Small cell neuroendocrine carcinoma", "Large cell neuroendocrine carcinoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["Low grade", "High grade", "Cannot be assessed", "See Comment"] },
            { id: "associatedCIS", label: "Associated Carcinoma In Situ (CIS)", type: "select", options: ["Not identified", "Present", "Cannot be assessed", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["Uninvolved by invasive carcinoma", "Involved by invasive carcinoma", "Ureteral margin uninvolved", "Ureteral margin involved", "Bladder cuff margin uninvolved", "Bladder cuff margin involved", "Renal parenchymal margin uninvolved", "Renal parenchymal margin involved", "Soft tissue/adventitial margin uninvolved", "Soft tissue/adventitial margin involved", "Cannot be assessed"] },
            { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "Pathologic Stage (pT)", type: "select", options: ["pTa: Papillary noninvasive carcinoma", "pTis: Carcinoma in situ (flat)", "pT1: Tumor invades subepithelial connective tissue", "pT2: Tumor invades muscularis", "pT3 (Renal Pelvis): Tumor invades beyond muscularis into peripelvic fat or renal parenchyma", "pT3 (Ureter): Tumor invades beyond muscularis into periureteric fat", "pT4: Tumor invades adjacent organs, or through the kidney into perinephric fat", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "Pathologic Stage (pN)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Metastasis in a single lymph node, 2 cm or less in greatest dimension", "pN2: Metastasis in a single lymph node, more than 2 cm; or multiple lymph nodes", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "pM", label: "Pathologic Stage (pM)", type: "select", options: ["Not applicable", "pM1: Distant metastasis", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Urothelial dysplasia", "Chronic inflammation", "Nephrolithiasis", "Hydronephrosis", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Urethra, Biopsy",
        pdf: "https://documents.cap.org/protocols/Urethra.Bx_4.3.0.0.REL.CAPCP.pdf",
        fields: [
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Prostatic urethra", "Membranous urethra", "Bulbar urethra", "Penile (pendulous) urethra", "Fossa navicularis", "Urethral meatus", "Female urethra, proximal", "Female urethra, distal", "Not specified", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Urothelial (transitional cell) carcinoma", "Squamous cell carcinoma", "Adenocarcinoma, not otherwise specified", "Adenocarcinoma, clear cell type", "Adenocarcinoma, enteric type", "Adenocarcinoma, villous type", "Small cell neuroendocrine carcinoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["Low grade", "High grade", "Well differentiated (G1)", "Moderately differentiated (G2)", "Poorly differentiated (G3)", "Cannot be assessed", "See Comment"] },
            { id: "associatedCIS", label: "Associated Carcinoma In Situ", type: "select", options: ["Not identified", "Present", "Cannot be assessed", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Inflammation", "Stricture", "Condyloma", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Urethra, Resection",
        pdf: "https://documents.cap.org/protocols/Urethra_4.3.0.0.REL.CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Urethrectomy", "Cystourethrectomy", "Anterior exenteration (female)", "Penectomy (partial or total) with urethrectomy", "Other (specify)", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Prostatic urethra", "Membranous urethra", "Bulbar urethra", "Penile (pendulous) urethra", "Fossa navicularis", "Female urethra, proximal", "Female urethra, distal", "Not specified"] },
            { id: "tumorSize", label: "Tumor Size (cm, greatest dimension)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Urothelial (transitional cell) carcinoma", "Squamous cell carcinoma", "Adenocarcinoma, not otherwise specified", "Adenocarcinoma, clear cell type", "Small cell neuroendocrine carcinoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["Low grade", "High grade", "Well differentiated (G1)", "Moderately differentiated (G2)", "Poorly differentiated (G3)", "Cannot be assessed", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["Uninvolved by invasive carcinoma", "Involved by invasive carcinoma", "Proximal urethral margin uninvolved", "Proximal urethral margin involved", "Distal urethral margin uninvolved", "Distal urethral margin involved", "Deep soft tissue margin uninvolved", "Deep soft tissue margin involved", "Cannot be assessed"] },
            { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "Pathologic Stage (pT)", type: "select", options: ["pTa: Noninvasive papillary carcinoma", "pTis: Carcinoma in situ", "pT1: Tumor invades subepithelial connective tissue", "pT2: Tumor invades corpus spongiosum, periurethral muscle, or prostate", "pT3: Tumor invades corpus cavernosum, beyond prostatic capsule, or anterior vaginal wall, or bladder neck", "pT4: Tumor invades other adjacent organs (e.g., invasion of the bladder)", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "Pathologic Stage (pN)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Single inguinal lymph node metastasis", "pN2: Single pelvic lymph node metastasis or multiple inguinal lymph node metastases", "pN3: Bilateral or multiple pelvic lymph node metastases", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "pM", label: "Pathologic Stage (pM)", type: "select", options: ["Not applicable", "pM1: Distant metastasis", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Urethral stricture", "Inflammation", "Condyloma", "Squamous metaplasia", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Urinary Bladder, Resection",
        pdf: "https://documents.cap.org/protocols/Bladder_4.2.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Partial cystectomy", "Simple (total) cystectomy", "Radical cystectomy", "Radical cystoprostatectomy", "Anterior exenteration (female)", "Other (specify)", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Dome", "Anterior wall", "Posterior wall", "Right lateral wall", "Left lateral wall", "Trigone", "Bladder neck", "Ureteral orifice, right", "Ureteral orifice, left", "Urethra (prostatic, in males)", "Multifocal", "Not specified"] },
            { id: "tumorSize", label: "Tumor Size (cm, greatest dimension)", type: "text" },
            { id: "tumorFocality", label: "Tumor Focality", type: "select", options: ["Unifocal", "Multifocal", "Cannot be determined", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Urothelial (transitional cell) carcinoma", "Urothelial carcinoma with squamous differentiation", "Urothelial carcinoma with glandular differentiation", "Urothelial carcinoma with trophoblastic differentiation", "Urothelial carcinoma, nested variant", "Urothelial carcinoma, microcystic variant", "Urothelial carcinoma, micropapillary variant", "Urothelial carcinoma, lymphoepithelioma-like variant", "Urothelial carcinoma, plasmacytoid/signet ring/diffuse variant", "Urothelial carcinoma, sarcomatoid variant", "Urothelial carcinoma, giant cell variant", "Urothelial carcinoma, poorly differentiated variant", "Squamous cell carcinoma", "Adenocarcinoma, not otherwise specified", "Adenocarcinoma, enteric type", "Adenocarcinoma, mucinous type", "Urachal carcinoma", "Small cell neuroendocrine carcinoma", "Large cell neuroendocrine carcinoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["Low grade", "High grade", "Cannot be assessed", "See Comment"] },
            { id: "associatedCIS", label: "Associated Carcinoma In Situ (CIS)", type: "select", options: ["Not identified", "Present", "Cannot be assessed", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["Uninvolved by invasive carcinoma", "Involved by invasive carcinoma", "Right ureteral margin uninvolved", "Right ureteral margin involved", "Left ureteral margin uninvolved", "Left ureteral margin involved", "Urethral margin uninvolved", "Urethral margin involved", "Radial/soft tissue margin uninvolved", "Radial/soft tissue margin involved", "Cannot be assessed"] },
            { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "Pathologic Stage (pT)", type: "select", options: ["pTa: Noninvasive papillary carcinoma", "pTis: Carcinoma in situ (flat tumor)", "pT1: Tumor invades subepithelial connective tissue (lamina propria)", "pT2a: Tumor invades superficial muscularis propria (inner half)", "pT2b: Tumor invades deep muscularis propria (outer half)", "pT3a: Microscopically invades perivesical tissue", "pT3b: Macroscopically invades perivesical tissue (extravesical mass)", "pT4a: Tumor invades prostatic stroma, uterus, vagina", "pT4b: Tumor invades pelvic wall, abdominal wall", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "Pathologic Stage (pN)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac, or presacral lymph node)", "pN2: Multiple regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac, or presacral lymph nodes)", "pN3: Lymph node metastasis to the common iliac lymph nodes", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "pM", label: "Pathologic Stage (pM)", type: "select", options: ["Not applicable", "pM1a: Nonregional lymph node metastasis", "pM1b: Other distant metastasis", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Urothelial dysplasia", "Squamous metaplasia", "Cystitis cystica", "Cystitis glandularis", "Intestinal metaplasia", "Chronic cystitis", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Urinary Bladder, Biopsy/TURBT",
        pdf: "https://documents.cap.org/protocols/Bladder_4.2.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Transurethral resection of bladder tumor (TURBT)", "Cold cup biopsy", "Other (specify)", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Dome", "Anterior wall", "Posterior wall", "Right lateral wall", "Left lateral wall", "Trigone", "Bladder neck", "Ureteral orifice", "Multifocal", "Not specified", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Urothelial (transitional cell) carcinoma", "Urothelial carcinoma with squamous differentiation", "Urothelial carcinoma with glandular differentiation", "Urothelial carcinoma, nested variant", "Urothelial carcinoma, micropapillary variant", "Urothelial carcinoma, plasmacytoid variant", "Urothelial carcinoma, sarcomatoid variant", "Squamous cell carcinoma", "Adenocarcinoma", "Small cell neuroendocrine carcinoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["Low grade", "High grade", "Cannot be assessed", "See Comment"] },
            { id: "muscularisPropria", label: "Muscularis Propria (Detrusor Muscle) Present", type: "select", options: ["Not identified (absent)", "Present, uninvolved by carcinoma", "Present, involved by carcinoma", "Cannot be determined", "See Comment"] },
            { id: "depthOfInvasion", label: "Depth of Invasion", type: "select", options: ["Noninvasive (papillary or flat)", "Invades lamina propria (subepithelial connective tissue)", "Invades muscularis mucosae", "Invades muscularis propria (detrusor muscle)", "Cannot be determined", "See Comment"] },
            { id: "associatedCIS", label: "Associated Carcinoma In Situ (CIS)", type: "select", options: ["Not identified", "Present", "Cannot be assessed", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Urothelial dysplasia", "Squamous metaplasia", "Cystitis cystica/glandularis", "von Brunn nests", "Chronic cystitis", "Cautery artifact", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    }
],
    "Gynecologic": [
    {
        name: "Endometrium Uterus",
        pdf: "https://documents.cap.org/protocols/Uterus_5.1.0.0.REL.CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Total hysterectomy", "Radical hysterectomy", "Supracervical hysterectomy", "Total hysterectomy with bilateral salpingo-oophorectomy", "Radical hysterectomy with bilateral salpingo-oophorectomy", "Other (specify)", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Fundus", "Body", "Lower uterine segment", "Isthmus", "Endocervix", "Not specified"] },
            { id: "tumorSize", label: "Tumor Size (cm, greatest dimension)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Endometrioid carcinoma", "Serous carcinoma", "Clear cell carcinoma", "Mixed cell carcinoma (specify components)", "Undifferentiated/dedifferentiated carcinoma", "Carcinosarcoma (malignant mixed Mullerian tumor/MMMT)", "Mucinous carcinoma", "Mesonephric-like carcinoma", "Gastric-type mucinous carcinoma", "Neuroendocrine carcinoma, small cell type", "Neuroendocrine carcinoma, large cell type", "Other (specify)", "See Comment"] },
            { id: "figoGrade", label: "FIGO Grade (for endometrioid)", type: "select", options: ["Grade 1: 5% or less solid growth pattern", "Grade 2: 6% to 50% solid growth pattern", "Grade 3: More than 50% solid growth pattern", "Not applicable (non-endometrioid type)", "See Comment"] },
            { id: "myometrialInvasion", label: "Myometrial Invasion", type: "select", options: ["None identified (tumor confined to endometrium/adenomyosis)", "Present, invades less than half of the myometrium", "Present, invades one half or more of the myometrium", "Cannot be determined", "See Comment"] },
            { id: "depthOfMyometrialInvasion", label: "Depth of Myometrial Invasion (mm)", type: "text" },
            { id: "myometrialThickness", label: "Myometrial Thickness (mm)", type: "text" },
            { id: "cervicalStromalInvasion", label: "Cervical Stromal Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "uterineSerosaInvolvement", label: "Uterine Serosa Involvement", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "adnexalInvolvement", label: "Adnexal Involvement", type: "select", options: ["Not identified", "Right ovary involved", "Left ovary involved", "Right fallopian tube involved", "Left fallopian tube involved", "Bilateral ovarian involvement", "Bilateral tubal involvement", "Cannot be determined", "See Comment"] },
            { id: "vaginalInvolvement", label: "Vaginal Involvement", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "parametrialInvolvement", label: "Parametrial Involvement", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["Uninvolved by invasive carcinoma", "Involved by invasive carcinoma", "Vaginal cuff margin uninvolved", "Vaginal cuff margin involved", "Parametrial margin uninvolved", "Parametrial margin involved", "Cannot be assessed"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "sentinelLymphNode", label: "Sentinel Lymph Node Findings", type: "select", options: ["Not performed", "Negative (H&E and IHC)", "Isolated tumor cells (ITC, 0.2 mm)", "Micrometastasis (>0.2 mm but 2.0 mm)", "Macrometastasis (>2.0 mm)", "See Comment"] },
            { id: "pT", label: "Pathologic Stage (pT)", type: "select", options: ["pT1a: Tumor limited to the endometrium or invades less than half of the myometrium", "pT1b: Tumor invades one half or more of the myometrium", "pT2: Tumor invades cervical stroma but does not extend beyond the uterus", "pT3a: Tumor invades the serosa of the corpus uteri and/or adnexa (direct extension or metastasis)", "pT3b: Vaginal and/or parametrial involvement (direct extension or metastasis)", "pT4: Tumor invades bladder and/or bowel mucosa", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "Pathologic Stage (pN)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN0(i+): Isolated tumor cells in regional lymph node(s) no greater than 0.2 mm", "pN1mi: Regional lymph node metastasis (micrometastasis, greater than 0.2 mm but not greater than 2.0 mm)", "pN1a: Regional lymph node metastasis to pelvic lymph nodes", "pN2: Para-aortic lymph node metastasis with or without positive pelvic lymph nodes", "pN2mi: Para-aortic micrometastasis (greater than 0.2 mm but not greater than 2.0 mm) with or without positive pelvic lymph nodes", "pN2a: Para-aortic macrometastasis (greater than 2.0 mm) with or without positive pelvic lymph nodes", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "pM", label: "Pathologic Stage (pM)", type: "select", options: ["Not applicable", "pM1: Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, bone; excludes metastasis to pelvic or para-aortic lymph nodes, vagina, uterine serosa, adnexa)", "See Comment"] },
            { id: "figoStage", label: "FIGO Stage", type: "select", options: ["Stage I: Tumor confined to the corpus uteri", "Stage IA: Tumor limited to endometrium or invades less than half of the myometrium", "Stage IB: Tumor invades one half or more of the myometrium", "Stage II: Tumor invades cervical stroma but does not extend beyond the uterus", "Stage IIIA: Tumor invades serosa of corpus uteri and/or adnexa", "Stage IIIB: Vaginal and/or parametrial involvement", "Stage IIIC1: Metastasis to pelvic lymph nodes", "Stage IIIC2: Metastasis to para-aortic lymph nodes with or without pelvic lymph node metastasis", "Stage IVA: Tumor invades bladder and/or bowel mucosa", "Stage IVB: Distant metastasis", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Endometrial polyp", "Leiomyoma(s)", "Adenomyosis", "Endometriosis", "Atypical hyperplasia/EIN", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Gynecologic, Biomarkers",
        pdf: "https://documents.cap.org/protocols/Gynecologic.Bmk_1.3.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "erStatus", label: "Estrogen Receptor (ER) Status", type: "select", options: ["Positive", "Negative", "Cannot be determined", "Not performed", "See Comment"] },
            { id: "erPercentPositive", label: "ER Percent Positive (%)", type: "text" },
            { id: "erIntensity", label: "ER Staining Intensity", type: "select", options: ["Weak", "Moderate", "Strong", "Not applicable", "See Comment"] },
            { id: "prStatus", label: "Progesterone Receptor (PR) Status", type: "select", options: ["Positive", "Negative", "Cannot be determined", "Not performed", "See Comment"] },
            { id: "prPercentPositive", label: "PR Percent Positive (%)", type: "text" },
            { id: "prIntensity", label: "PR Staining Intensity", type: "select", options: ["Weak", "Moderate", "Strong", "Not applicable", "See Comment"] },
            { id: "p53IHC", label: "p53 Immunohistochemistry", type: "select", options: ["Wild-type (normal) staining pattern", "Abnormal (overexpression/diffuse strong nuclear staining)", "Abnormal (complete absence of staining)", "Abnormal (cytoplasmic staining)", "Cannot be determined", "Not performed", "See Comment"] },
            { id: "mlh1", label: "MLH1", type: "select", options: ["Intact (retained) nuclear expression", "Loss of nuclear expression", "Cannot be determined", "Not performed", "See Comment"] },
            { id: "pms2", label: "PMS2", type: "select", options: ["Intact (retained) nuclear expression", "Loss of nuclear expression", "Cannot be determined", "Not performed", "See Comment"] },
            { id: "msh2", label: "MSH2", type: "select", options: ["Intact (retained) nuclear expression", "Loss of nuclear expression", "Cannot be determined", "Not performed", "See Comment"] },
            { id: "msh6", label: "MSH6", type: "select", options: ["Intact (retained) nuclear expression", "Loss of nuclear expression", "Cannot be determined", "Not performed", "See Comment"] },
            { id: "mmrInterpretation", label: "MMR/MSI Interpretation", type: "select", options: ["No loss of MMR protein expression (mismatch repair proficient)", "Loss of MLH1 and PMS2 expression (consider MLH1 promoter methylation testing)", "Loss of MSH2 and MSH6 expression (mismatch repair deficient)", "Loss of PMS2 expression with retained MLH1 expression", "Loss of MSH6 expression with retained MSH2 expression", "Indeterminate", "See Comment"] },
            { id: "l1cam", label: "L1CAM", type: "select", options: ["Negative (less than 10% staining)", "Positive (10% or more staining)", "Cannot be determined", "Not performed", "See Comment"] },
            { id: "her2", label: "HER2 Status", type: "select", options: ["Negative (0 or 1+)", "Equivocal (2+)", "Positive (3+)", "Cannot be determined", "Not performed", "See Comment"] },
            { id: "her2ISH", label: "HER2 ISH (if IHC equivocal)", type: "select", options: ["Amplified", "Not amplified", "Equivocal", "Not performed", "See Comment"] },
            { id: "poleMutationStatus", label: "POLE Mutation Status", type: "select", options: ["Pathogenic mutation identified (POLE ultramutated/POLEmut)", "No pathogenic POLE mutation identified", "Not performed", "See Comment"] },
            { id: "molecularClassification", label: "Molecular Classification (if performed)", type: "select", options: ["POLE ultramutated (POLEmut)", "Mismatch repair deficient (MMRd)", "No specific molecular profile (NSMP) / p53 wild-type", "p53 abnormal (p53abn)", "Multiple classifiers present (specify)", "Not performed", "See Comment"] },
            { id: "additionalBiomarkerComments", label: "Additional Biomarker Comments", type: "textarea" }
        ]
    },
    {
        name: "Ovary, Fallopian Tube, or Peritoneum",
        pdf: "https://documents.cap.org/protocols/Ovary_FT_Perit_1.5.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Total hysterectomy with bilateral salpingo-oophorectomy", "Unilateral salpingo-oophorectomy", "Bilateral salpingo-oophorectomy", "Oophorectomy only", "Debulking/cytoreduction", "Other (specify)", "See Comment"] },
            { id: "specimenLaterality", label: "Specimen Laterality", type: "select", options: ["Right", "Left", "Bilateral", "Not specified", "See Comment"] },
            { id: "primaryTumorSite", label: "Primary Tumor Site", type: "select", options: ["Ovary", "Fallopian tube", "Peritoneum", "Ovary and fallopian tube", "Cannot be determined", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm, greatest dimension)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["High-grade serous carcinoma", "Low-grade serous carcinoma", "Endometrioid carcinoma", "Clear cell carcinoma", "Mucinous carcinoma", "Seromucinous carcinoma", "Malignant Brenner tumor", "Mixed carcinoma (specify components)", "Undifferentiated carcinoma", "Carcinosarcoma (malignant mixed Mullerian tumor)", "Immature teratoma", "Dysgerminoma", "Yolk sac tumor", "Embryonal carcinoma", "Choriocarcinoma", "Adult granulosa cell tumor", "Juvenile granulosa cell tumor", "Sertoli-Leydig cell tumor", "Sex cord-stromal tumor, other", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["Low grade (Grade 1)", "High grade (Grade 2-3)", "Not applicable (e.g., high-grade serous)", "Cannot be assessed", "See Comment"] },
            { id: "tumorRupture", label: "Tumor Rupture", type: "select", options: ["Not identified", "Present (intraoperative surgical spill)", "Present (preoperative capsule rupture)", "Cannot be determined", "See Comment"] },
            { id: "ovarianSurfaceInvolvement", label: "Ovarian/Tubal Surface Involvement", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "ascites", label: "Ascites/Peritoneal Washings", type: "select", options: ["Negative for malignant cells", "Positive for malignant cells", "Not performed", "Cannot be determined", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "omentumInvolvement", label: "Omentum Involvement", type: "select", options: ["Not submitted", "Uninvolved by tumor", "Involved by tumor", "See Comment"] },
            { id: "peritonealImplants", label: "Peritoneal/Omental Implants", type: "select", options: ["Not identified", "Present, within pelvis", "Present, beyond pelvis, 2 cm", "Present, beyond pelvis, >2 cm", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["Cannot be assessed", "Uninvolved by invasive carcinoma", "Involved by invasive carcinoma", "Vaginal cuff margin uninvolved", "Vaginal cuff margin involved"] },
            { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "sticPresent", label: "Serous Tubal Intraepithelial Carcinoma (STIC)", type: "select", options: ["Not identified", "Present", "Cannot be determined", "Not applicable", "See Comment"] },
            { id: "pT", label: "Pathologic Stage (pT)", type: "select", options: ["pT1a: Tumor limited to one ovary (capsule intact) or fallopian tube; no tumor on ovarian or fallopian tube surface; no malignant cells in ascites or peritoneal washings", "pT1b: Tumor limited to both ovaries (capsules intact) or fallopian tubes; no tumor on ovarian or fallopian tube surface; no malignant cells in ascites or peritoneal washings", "pT1c1: Surgical spill", "pT1c2: Capsule ruptured before surgery or tumor on ovarian or fallopian tube surface", "pT1c3: Malignant cells in ascites or peritoneal washings", "pT2a: Extension and/or implants on uterus and/or fallopian tubes and/or ovaries", "pT2b: Extension to other pelvic intraperitoneal tissues", "pT3a: Microscopic extrapelvic (above pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes", "pT3b: Macroscopic peritoneal metastasis beyond the pelvis 2 cm or less in greatest dimension, with or without metastasis to the retroperitoneal lymph nodes", "pT3c: Macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension, with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ)", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "Pathologic Stage (pN)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Positive retroperitoneal lymph nodes only (histologically confirmed)", "pN1a: Metastasis up to 10 mm in greatest dimension", "pN1b: Metastasis more than 10 mm in greatest dimension", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "pM", label: "Pathologic Stage (pM)", type: "select", options: ["Not applicable", "pM1a: Pleural effusion with positive cytology", "pM1b: Parenchymal metastases and metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity)", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Endometriosis", "Serous tubal intraepithelial carcinoma (STIC)", "Fallopian tube dysplasia", "Borderline tumor component", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Trophoblastic Tumors",
        pdf: "https://documents.cap.org/protocols/Trophoblast_4.1.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Suction curettage/evacuation", "Hysterectomy", "Excision/resection", "Other (specify)", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Uterus", "Fallopian tube", "Ovary", "Other (specify)", "Not specified", "See Comment"] },
            { id: "tumorSize", label: "Tumor Size (cm, greatest dimension)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Complete hydatidiform mole", "Partial hydatidiform mole", "Invasive hydatidiform mole", "Choriocarcinoma", "Placental site trophoblastic tumor (PSTT)", "Epithelioid trophoblastic tumor (ETT)", "Mixed trophoblastic tumor", "Atypical placental site nodule", "Other (specify)", "See Comment"] },
            { id: "myometrialInvasion", label: "Myometrial Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "Not applicable", "See Comment"] },
            { id: "mitoses", label: "Mitotic Count (per 10 HPF)", type: "text" },
            { id: "necrosis", label: "Necrosis", type: "select", options: ["Not identified", "Present", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "serumHCG", label: "Serum hCG Level", type: "text" },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Decidua", "Products of conception/chorionic villi", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Uterine Cervix, Excision",
        pdf: "https://documents.cap.org/documents/Cervix.Bx_4.4.2.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["LEEP/LLETZ (loop electrosurgical excision procedure)", "Cold knife cone biopsy", "Laser cone biopsy", "Other (specify)", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Squamous cell carcinoma, keratinizing", "Squamous cell carcinoma, nonkeratinizing", "Squamous cell carcinoma, papillary", "Squamous cell carcinoma, basaloid", "Squamous cell carcinoma, warty", "Squamous cell carcinoma, verrucous", "Squamous cell carcinoma, lymphoepithelioma-like", "Adenocarcinoma, usual type (endocervical)", "Adenocarcinoma, mucinous type, gastric", "Adenocarcinoma, mucinous type, intestinal", "Adenocarcinoma, mucinous type, signet ring", "Adenocarcinoma, villoglandular", "Adenocarcinoma, endometrioid", "Adenocarcinoma, clear cell", "Adenocarcinoma, serous", "Adenocarcinoma, mesonephric", "Adenosquamous carcinoma", "Neuroendocrine carcinoma, small cell", "Neuroendocrine carcinoma, large cell", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["Well differentiated (G1)", "Moderately differentiated (G2)", "Poorly differentiated (G3)", "Not applicable", "See Comment"] },
            { id: "horizontalExtent", label: "Horizontal Extent (mm)", type: "text" },
            { id: "depthOfInvasion", label: "Depth of Stromal Invasion (mm)", type: "text" },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["All margins uninvolved by invasive carcinoma and HSIL", "Ectocervical margin uninvolved", "Ectocervical margin involved by invasive carcinoma", "Ectocervical margin involved by HSIL (CIN 2/3)", "Endocervical margin uninvolved", "Endocervical margin involved by invasive carcinoma", "Endocervical margin involved by HSIL (CIN 2/3)", "Deep/stromal margin uninvolved", "Deep/stromal margin involved by invasive carcinoma", "Cannot be assessed"] },
            { id: "associatedFindings", label: "Associated Epithelial Abnormality", type: "select", options: ["None identified", "HSIL (CIN 2)", "HSIL (CIN 3)", "AIS (adenocarcinoma in situ)", "HSIL (CIN 2/3) and AIS", "See Comment"] },
            { id: "hpvAssociation", label: "HPV Association", type: "select", options: ["HPV-associated", "HPV-independent", "Not determined", "See Comment"] },
            { id: "pT", label: "Pathologic Stage (pT)", type: "select", options: ["pT1a1: Measured stromal invasion 3.0 mm or less in depth", "pT1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm in depth", "pT1b1: Invasive carcinoma 5 mm or more depth of stromal invasion and 2 cm or less in greatest dimension", "pT1b2: Invasive carcinoma more than 2 cm but not more than 4 cm in greatest dimension", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Uterine Cervix, Resection",
        pdf: "https://documents.cap.org/documents/Cervix_5.1.1.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Simple hysterectomy", "Modified radical hysterectomy", "Radical hysterectomy", "Radical trachelectomy", "Other (specify)", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Exocervix/ectocervix", "Endocervix", "Both exocervix and endocervix", "Not specified"] },
            { id: "tumorSize", label: "Tumor Size (cm, greatest dimension)", type: "text" },
            { id: "tumorFocality", label: "Tumor Focality", type: "select", options: ["Unifocal", "Multifocal", "Cannot be determined", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Squamous cell carcinoma, keratinizing", "Squamous cell carcinoma, nonkeratinizing", "Squamous cell carcinoma, basaloid", "Squamous cell carcinoma, warty", "Squamous cell carcinoma, verrucous", "Squamous cell carcinoma, papillary", "Adenocarcinoma, usual type (endocervical)", "Adenocarcinoma, mucinous type, gastric", "Adenocarcinoma, mucinous type, intestinal", "Adenocarcinoma, villoglandular", "Adenocarcinoma, endometrioid", "Adenocarcinoma, clear cell", "Adenocarcinoma, serous", "Adenocarcinoma, mesonephric", "Adenosquamous carcinoma", "Neuroendocrine carcinoma, small cell", "Neuroendocrine carcinoma, large cell", "Undifferentiated carcinoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["Well differentiated (G1)", "Moderately differentiated (G2)", "Poorly differentiated (G3)", "Not applicable", "See Comment"] },
            { id: "depthOfInvasion", label: "Depth of Stromal Invasion (mm)", type: "text" },
            { id: "horizontalExtent", label: "Horizontal Extent (mm)", type: "text" },
            { id: "parametrialInvolvement", label: "Parametrial Involvement", type: "select", options: ["Not identified", "Present, right", "Present, left", "Present, bilateral", "Cannot be determined", "See Comment"] },
            { id: "vaginalInvolvement", label: "Vaginal Involvement", type: "select", options: ["Not identified", "Present, upper two-thirds", "Present, lower one-third", "Cannot be determined", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["All margins uninvolved", "Vaginal cuff margin uninvolved", "Vaginal cuff margin involved", "Parametrial margin uninvolved", "Parametrial margin involved", "Ectocervical margin uninvolved", "Ectocervical margin involved", "Endocervical margin uninvolved", "Endocervical margin involved", "Deep stromal margin uninvolved", "Deep stromal margin involved", "Cannot be assessed"] },
            { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "sentinelLymphNode", label: "Sentinel Lymph Node Findings", type: "select", options: ["Not performed", "Negative", "Isolated tumor cells (ITC, 0.2 mm)", "Micrometastasis (>0.2 mm but 2.0 mm)", "Macrometastasis (>2.0 mm)", "See Comment"] },
            { id: "pT", label: "Pathologic Stage (pT)", type: "select", options: ["pT1a1: Measured stromal invasion 3.0 mm or less in depth", "pT1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm in depth", "pT1b1: Invasive carcinoma 5 mm or more depth of stromal invasion, 2 cm or less in greatest dimension", "pT1b2: Invasive carcinoma more than 2 cm but not more than 4 cm in greatest dimension", "pT1b3: Invasive carcinoma more than 4 cm in greatest dimension", "pT2a1: Tumor invades beyond the uterus but not to the pelvic wall or to the lower third of vagina, without parametrial invasion, 4 cm or less in greatest dimension", "pT2a2: Tumor invades beyond the uterus but not to the pelvic wall or to the lower third of vagina, without parametrial invasion, more than 4 cm in greatest dimension", "pT2b: Tumor with parametrial invasion", "pT3a: Tumor involves the lower third of the vagina, no extension to the pelvic wall", "pT3b: Tumor extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney", "pT4: Tumor invades mucosa of the bladder or rectum and/or extends beyond the true pelvis", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "Pathologic Stage (pN)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN0(i+): Isolated tumor cells in regional lymph node(s) no greater than 0.2 mm", "pN1mi: Regional lymph node metastasis, micrometastasis (greater than 0.2 mm but not greater than 2.0 mm)", "pN1: Regional lymph node metastasis (macrometastasis, greater than 2.0 mm)", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "pM", label: "Pathologic Stage (pM)", type: "select", options: ["Not applicable", "pM1: Distant metastasis (includes peritoneal spread, involvement of supraclavicular, mediastinal, or para-aortic lymph nodes, lung, liver, bone)", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "HSIL (CIN 2/3)", "Adenocarcinoma in situ (AIS)", "Endometriosis", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Uterine Sarcoma",
        pdf: "https://documents.cap.org/protocols/Uterus.Sarc_4.4.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Total hysterectomy", "Total hysterectomy with bilateral salpingo-oophorectomy", "Radical hysterectomy", "Supracervical hysterectomy", "Myomectomy", "Other (specify)", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Fundus", "Body", "Lower uterine segment", "Cervix", "Broad ligament", "Not specified"] },
            { id: "tumorSize", label: "Tumor Size (cm, greatest dimension)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Leiomyosarcoma", "Low-grade endometrial stromal sarcoma", "High-grade endometrial stromal sarcoma", "Undifferentiated uterine sarcoma", "Adenosarcoma", "Adenosarcoma with sarcomatous overgrowth", "PEComa, malignant", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade (FNCLCC)", type: "select", options: ["Grade 1: Total differentiation, mitotic count, and necrosis score of 2-3", "Grade 2: Total differentiation, mitotic count, and necrosis score of 4-5", "Grade 3: Total differentiation, mitotic count, and necrosis score of 6-8", "Not applicable (low-grade ESS)", "See Comment"] },
            { id: "mitoticCount", label: "Mitotic Count (per 10 HPF)", type: "text" },
            { id: "tumorNecrosis", label: "Tumor Necrosis", type: "select", options: ["Not identified", "Present, 50% of tumor", "Present, >50% of tumor", "See Comment"] },
            { id: "myometrialInvasion", label: "Myometrial Invasion/Extent", type: "select", options: ["Confined to endometrium/endometrial polyp", "Invades less than half of the myometrium", "Invades one half or more of the myometrium", "Invades through myometrium to serosa", "See Comment"] },
            { id: "cervicalInvolvement", label: "Cervical Involvement", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "extrauterineSpread", label: "Extrauterine Spread", type: "select", options: ["Not identified", "Adnexal involvement", "Serosal involvement", "Vaginal involvement", "Parametrial involvement", "Other pelvic tissues", "See Comment"] },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["Uninvolved by tumor", "Involved by tumor", "Vaginal cuff margin uninvolved", "Vaginal cuff margin involved", "Parametrial margin uninvolved", "Parametrial margin involved", "Cannot be assessed"] },
            { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "pT_leiomyosarcoma", label: "pT Stage (Leiomyosarcoma/ESS)", type: "select", options: ["pT1a: Tumor limited to the uterus, 5 cm or less in greatest dimension", "pT1b: Tumor limited to the uterus, more than 5 cm", "pT2a: Tumor extends to the adnexa", "pT2b: Tumor extends to other pelvic tissues", "pT3a: Tumor invades abdominal tissues, one site", "pT3b: Tumor invades abdominal tissues, more than one site", "pT4: Tumor invades bladder and/or rectum", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pT_adenosarcoma", label: "pT Stage (Adenosarcoma)", type: "select", options: ["pT1a: Tumor limited to the endometrium/endocervix", "pT1b: Tumor invades less than half of the myometrium", "pT1c: Tumor invades one half or more of the myometrium", "pT2a: Tumor extends to the adnexa", "pT2b: Tumor extends to other pelvic tissues", "pT3a: Tumor invades abdominal tissues, one site", "pT3b: Tumor invades abdominal tissues, more than one site", "pT4: Tumor invades bladder and/or rectum", "Not applicable", "See Comment"] },
            { id: "pN", label: "Pathologic Stage (pN)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Regional lymph node metastasis", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "pM", label: "Pathologic Stage (pM)", type: "select", options: ["Not applicable", "pM1: Distant metastasis", "See Comment"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Vagina, Biopsy",
        pdf: "https://documents.cap.org/protocols/Vagina.Bx_4.3.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Upper third", "Middle third", "Lower third", "Not specified", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Squamous cell carcinoma", "Squamous cell carcinoma, keratinizing", "Squamous cell carcinoma, nonkeratinizing", "Squamous cell carcinoma, basaloid", "Squamous cell carcinoma, verrucous", "Squamous cell carcinoma, warty", "Adenocarcinoma, not otherwise specified", "Adenocarcinoma, clear cell", "Adenocarcinoma, endometrioid", "Adenocarcinoma, mucinous", "Adenosquamous carcinoma", "Melanoma", "Small cell neuroendocrine carcinoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["Well differentiated (G1)", "Moderately differentiated (G2)", "Poorly differentiated (G3)", "Cannot be assessed", "See Comment"] },
            { id: "associatedEpithelialAbnormality", label: "Associated Epithelial Abnormality", type: "select", options: ["None identified", "VAIN I (low-grade SIL)", "VAIN II/III (high-grade SIL)", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Vaginal adenosis", "Inflammation", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Vagina, Resection",
        pdf: "https://documents.cap.org/protocols/Vagina_4.3.0.1.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Partial vaginectomy", "Total vaginectomy", "Radical vaginectomy", "Vaginectomy with hysterectomy", "Pelvic exenteration", "Other (specify)", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Upper third", "Middle third", "Lower third", "Anterior wall", "Posterior wall", "Lateral wall, right", "Lateral wall, left", "Not specified"] },
            { id: "tumorSize", label: "Tumor Size (cm, greatest dimension)", type: "text" },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Squamous cell carcinoma", "Squamous cell carcinoma, keratinizing", "Squamous cell carcinoma, nonkeratinizing", "Squamous cell carcinoma, basaloid", "Squamous cell carcinoma, verrucous", "Squamous cell carcinoma, warty", "Adenocarcinoma, not otherwise specified", "Adenocarcinoma, clear cell", "Adenocarcinoma, endometrioid", "Adenosquamous carcinoma", "Melanoma", "Small cell neuroendocrine carcinoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["Well differentiated (G1)", "Moderately differentiated (G2)", "Poorly differentiated (G3)", "Cannot be assessed", "See Comment"] },
            { id: "depthOfInvasion", label: "Depth of Invasion (mm)", type: "text" },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["All margins uninvolved by invasive carcinoma", "Involved by invasive carcinoma", "Vaginal mucosal margin uninvolved", "Vaginal mucosal margin involved", "Deep soft tissue margin uninvolved", "Deep soft tissue margin involved", "Cannot be assessed"] },
            { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "pT", label: "Pathologic Stage (pT)", type: "select", options: ["pTis: Carcinoma in situ (VAIN III)", "pT1a: Tumor 2 cm or less in greatest dimension and with subepithelial invasion not more than 0.5 mm", "pT1b: Tumor more than 2 cm in greatest dimension or with subepithelial invasion more than 0.5 mm", "pT2a: Tumor invades paravaginal tissues but not to pelvic wall, 4 cm or less in greatest dimension", "pT2b: Tumor invades paravaginal tissues but not to pelvic wall, more than 4 cm in greatest dimension", "pT3: Tumor extends to the pelvic wall", "pT4: Tumor invades mucosa of the bladder or rectum, and/or extends beyond the true pelvis (bullous edema is not sufficient to classify as T4)", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "Pathologic Stage (pN)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Pelvic or inguinal lymph node metastasis", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "pM", label: "Pathologic Stage (pM)", type: "select", options: ["Not applicable", "pM1: Distant metastasis", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Vaginal adenosis", "VAIN (vaginal intraepithelial neoplasia)", "Endometriosis", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    },
    {
        name: "Vulva",
        pdf: "https://documents.cap.org/protocols/Vulva_5.1.0.0.REL_CAPCP.pdf",
        fields: [
            { id: "procedure", label: "Procedure", type: "select", options: ["Wide local excision", "Partial vulvectomy (simple)", "Partial vulvectomy (radical)", "Total vulvectomy (simple)", "Total vulvectomy (radical)", "Other (specify)", "See Comment"] },
            { id: "specimenLaterality", label: "Specimen Laterality", type: "select", options: ["Right", "Left", "Bilateral/midline", "Not specified", "See Comment"] },
            { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Labium majus", "Labium minus", "Clitoris", "Perineum", "Mons pubis", "Posterior fourchette", "Bartholin gland", "Overlapping/multifocal", "Not specified"] },
            { id: "tumorSize", label: "Tumor Size (cm, greatest dimension)", type: "text" },
            { id: "tumorFocality", label: "Tumor Focality", type: "select", options: ["Unifocal", "Multifocal", "Cannot be determined", "See Comment"] },
            { id: "histologicType", label: "Histologic Type", type: "select", options: ["Squamous cell carcinoma, usual type", "Squamous cell carcinoma, keratinizing", "Squamous cell carcinoma, nonkeratinizing", "Squamous cell carcinoma, basaloid", "Squamous cell carcinoma, warty", "Squamous cell carcinoma, verrucous", "Basal cell carcinoma", "Bartholin gland carcinoma, adenocarcinoma", "Bartholin gland carcinoma, squamous", "Bartholin gland carcinoma, adenoid cystic", "Adenocarcinoma of mammary gland type", "Paget disease of the vulva", "Melanoma", "Other (specify)", "See Comment"] },
            { id: "histologicGrade", label: "Histologic Grade", type: "select", options: ["Well differentiated (G1)", "Moderately differentiated (G2)", "Poorly differentiated (G3)", "Cannot be assessed", "See Comment"] },
            { id: "depthOfInvasion", label: "Depth of Stromal Invasion (mm)", type: "text" },
            { id: "tumorThickness", label: "Tumor Thickness (mm)", type: "text" },
            { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "Cannot be determined", "See Comment"] },
            { id: "margins", label: "Margins", type: "checkbox", options: ["All margins uninvolved by invasive carcinoma", "Involved by invasive carcinoma (specify margin)", "Peripheral/mucosal margin uninvolved", "Peripheral/mucosal margin involved", "Deep margin uninvolved", "Deep margin involved", "Closest margin distance (specify)", "Cannot be assessed"] },
            { id: "closestMarginDistance", label: "Closest Margin Distance (mm)", type: "text" },
            { id: "associatedEpithelialAbnormality", label: "Associated Epithelial Abnormality", type: "select", options: ["None identified", "Vulvar HSIL (VIN, usual type)", "Differentiated VIN (dVIN)", "Lichen sclerosus", "Lichen planus", "Vulvar HSIL and lichen sclerosus", "Paget disease", "See Comment"] },
            { id: "hpvAssociation", label: "HPV Association", type: "select", options: ["HPV-associated (p16 positive)", "HPV-independent (p16 negative)", "Not determined", "See Comment"] },
            { id: "lymphNodesExamined", label: "Number of Lymph Nodes Examined", type: "text" },
            { id: "lymphNodesPositive", label: "Number of Lymph Nodes Positive", type: "text" },
            { id: "sentinelLymphNode", label: "Sentinel Lymph Node Findings", type: "select", options: ["Not performed", "Negative", "Isolated tumor cells (0.2 mm)", "Micrometastasis (>0.2 mm but 2.0 mm)", "Macrometastasis (>2.0 mm)", "See Comment"] },
            { id: "pT", label: "Pathologic Stage (pT)", type: "select", options: ["pT1a: Lesion 2 cm or less in size, confined to the vulva and/or perineum, with stromal invasion 1.0 mm or less", "pT1b: Lesion more than 2 cm in size, or any size with stromal invasion more than 1.0 mm, confined to the vulva and/or perineum", "pT2: Tumor of any size with extension to adjacent perineal structures (lower 1/3 urethra, lower 1/3 vagina, anus)", "pT3: Tumor of any size with extension to any of the following: upper 2/3 urethra, upper 2/3 vagina, bladder mucosa, rectal mucosa, or fixed to pelvic bone", "pTX: Primary tumor cannot be assessed", "See Comment"] },
            { id: "pN", label: "Pathologic Stage (pN)", type: "select", options: ["pN0: No regional lymph node metastasis", "pN0(i+): Isolated tumor cells in regional lymph node(s)", "pN1a: One or two lymph node metastases each less than 5 mm", "pN1b: One lymph node metastasis 5 mm or greater", "pN2a: Three or more lymph node metastases each less than 5 mm", "pN2b: Two or more lymph node metastases 5 mm or greater", "pN2c: Lymph node metastasis with extranodal extension", "pN3: Fixed or ulcerated regional lymph node metastasis", "pNX: Regional lymph nodes cannot be assessed", "See Comment"] },
            { id: "pM", label: "Pathologic Stage (pM)", type: "select", options: ["Not applicable", "pM1: Distant metastasis (including pelvic lymph node metastasis)", "See Comment"] },
            { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["None identified", "Lichen sclerosus", "Lichen planus", "Vulvar HSIL (VIN, usual type)", "Differentiated VIN (dVIN)", "Paget disease", "Other (specify)"] },
            { id: "comments", label: "Comments", type: "textarea" }
        ]
    }
],
"Skin": [
        {
            name: "Invasive Melanoma of the Skin: Biopsy",
            pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-March-2025/Skin.Inv_Melanoma.Bx_1.1.0.0.REL.CAPCP.pdf",
            fields: [
                { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Head/Neck", "Upper extremity", "Lower extremity", "Trunk (anterior)", "Trunk (posterior)", "Acral (palm/sole)", "Subungual", "Other"] },
                { id: "histologicType", label: "Histologic Type (WHO 5th Edition)", type: "select", options: ["Low-CSD melanoma (superficial spreading)", "High-CSD melanoma (lentigo maligna type)", "Desmoplastic melanoma", "Acral melanoma", "Mucosal melanoma", "Melanoma arising in blue nevus", "Melanoma arising in giant congenital nevus", "Spitzoid melanoma", "Nevoid melanoma", "Nodular melanoma", "Melanoma, NOS", "Other (specify)", "See Comment"] },
                { id: "breslowThickness", label: "Breslow Thickness (mm)", type: "text" },
                { id: "ulceration", label: "Ulceration", type: "select", options: ["Not identified", "Present", "Indeterminate", "See Comment"] },
                { id: "mitoticRate", label: "Mitotic Rate (mitoses/mm2)", type: "text" },
                { id: "microsatellitosis", label: "Microsatellitosis", type: "select", options: ["Not identified", "Present", "See Comment"] },
                { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
                { id: "neurotropism", label: "Neurotropism", type: "select", options: ["Not identified", "Present", "See Comment"] },
                { id: "tils", label: "Tumor-Infiltrating Lymphocytes (TILs)", type: "select", options: ["Absent", "Nonbrisk", "Brisk", "See Comment"] },
                { id: "regression", label: "Regression", type: "select", options: ["Not identified", "Present, <75%", "Present, >=75%", "Indeterminate", "See Comment"] },
                { id: "growthPhase", label: "Growth Phase", type: "select", options: ["Radial", "Vertical", "Both", "Indeterminate", "See Comment"] },
                { id: "margins", label: "Margins", type: "checkbox", options: ["Peripheral margin uninvolved", "Peripheral margin involved", "Deep margin uninvolved", "Deep margin involved", "Margin cannot be assessed"] },
                { id: "peripheralMarginDist", label: "Peripheral Margin Distance (mm)", type: "text" },
                { id: "deepMarginDist", label: "Deep Margin Distance (mm)", type: "text" },
                { id: "clarkLevel", label: "Anatomic Level (Clark Level)", type: "select", options: ["Level I: Confined to epidermis (in situ)", "Level II: Invasion into papillary dermis", "Level III: Filling papillary dermis", "Level IV: Invasion into reticular dermis", "Level V: Invasion into subcutaneous fat", "See Comment"] },
                { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Associated nevus", "Solar elastosis", "Satellitosis", "In-transit metastasis"] },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        },
        {
            name: "Invasive Melanoma of the Skin: Excision, Re-Excision",
            pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-March-2025/Skin.Inv_Melanoma.Res_1.2.0.0.REL.CAPCP.pdf",
            fields: [
                { id: "procedure", label: "Procedure", type: "select", options: ["Wide local excision", "Re-excision", "See Comment"] },
                { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Head/Neck", "Upper extremity", "Lower extremity", "Trunk (anterior)", "Trunk (posterior)", "Acral (palm/sole)", "Subungual", "Other"] },
                { id: "histologicType", label: "Histologic Type (WHO 5th Edition)", type: "select", options: ["Low-CSD melanoma (superficial spreading)", "High-CSD melanoma (lentigo maligna type)", "Desmoplastic melanoma", "Acral melanoma", "Mucosal melanoma", "Spitzoid melanoma", "Nevoid melanoma", "Nodular melanoma", "Melanoma, NOS", "Other (specify)", "See Comment"] },
                { id: "breslowThickness", label: "Breslow Thickness (mm)", type: "text" },
                { id: "ulceration", label: "Ulceration", type: "select", options: ["Not identified", "Present", "Indeterminate", "See Comment"] },
                { id: "mitoticRate", label: "Mitotic Rate (mitoses/mm2)", type: "text" },
                { id: "microsatellitosis", label: "Microsatellitosis", type: "select", options: ["Not identified", "Present", "See Comment"] },
                { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
                { id: "neurotropism", label: "Neurotropism", type: "select", options: ["Not identified", "Present", "See Comment"] },
                { id: "tils", label: "Tumor-Infiltrating Lymphocytes (TILs)", type: "select", options: ["Absent", "Nonbrisk", "Brisk", "See Comment"] },
                { id: "regression", label: "Regression", type: "select", options: ["Not identified", "Present, <75%", "Present, >=75%", "Indeterminate", "See Comment"] },
                { id: "residualMelanoma", label: "Residual Melanoma (re-excision)", type: "select", options: ["Present (invasive)", "Present (in situ only)", "Not identified", "Not applicable", "See Comment"] },
                { id: "margins", label: "Margins", type: "checkbox", options: ["Peripheral margin uninvolved", "Peripheral margin involved", "Deep margin uninvolved", "Deep margin involved", "Margin cannot be assessed"] },
                { id: "peripheralMarginDist", label: "Peripheral Margin Distance (mm)", type: "text" },
                { id: "deepMarginDist", label: "Deep Margin Distance (mm)", type: "text" },
                { id: "sentinelLN", label: "Sentinel Lymph Node", type: "select", options: ["Not submitted", "Negative for melanoma", "Positive for melanoma", "See Comment"] },
                { id: "slnPositiveCount", label: "Number of Positive Sentinel Nodes", type: "text" },
                { id: "slnTotalCount", label: "Total Sentinel Nodes Examined", type: "text" },
                { id: "pT", label: "pT Stage", type: "select", options: [
                    "pTis: Melanoma in situ",
                    "pT1a: <0.8 mm, no ulceration",
                    "pT1b: 0.8-1.0 mm without ulceration, or <0.8 mm with ulceration",
                    "pT2a: >1.0-2.0 mm, no ulceration",
                    "pT2b: >1.0-2.0 mm, with ulceration",
                    "pT3a: >2.0-4.0 mm, no ulceration",
                    "pT3b: >2.0-4.0 mm, with ulceration",
                    "pT4a: >4.0 mm, no ulceration",
                    "pT4b: >4.0 mm, with ulceration",
                    "See Comment"
                ] },
                { id: "pN", label: "pN Stage", type: "select", options: [
                    "pN0: No regional node metastasis",
                    "pN1a: 1 clinically occult node (SLN)",
                    "pN1b: 1 clinically detected node",
                    "pN1c: No nodes; in-transit, satellite, or microsatellite metastasis",
                    "pN2a: 2-3 clinically occult nodes",
                    "pN2b: 2-3 nodes, at least 1 clinically detected",
                    "pN2c: 1 node (occult or detected) + in-transit/satellite/microsatellite",
                    "pN3a: >=4 clinically occult nodes",
                    "pN3b: >=4 nodes, at least 1 clinically detected, or matted nodes",
                    "pN3c: >=2 nodes + in-transit/satellite/microsatellite",
                    "pNX: Cannot be assessed",
                    "See Comment"
                ] },
                { id: "pM", label: "pM Stage", type: "select", options: ["Not applicable", "pM1a: Distant skin/subcutaneous/nodal metastasis, normal LDH", "pM1b: Lung metastasis, normal LDH", "pM1c: Non-CNS visceral metastasis, normal LDH", "pM1d: CNS metastasis", "See Comment"] },
                { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Associated nevus", "Solar elastosis", "Prior biopsy site changes"] },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        },
        {
            name: "Merkel Cell Carcinoma",
            pdf: "https://documents.cap.org/protocols/Skin.Merkel_4.1.0.0.REL_CAPCP.pdf",
            fields: [
                { id: "procedure", label: "Procedure", type: "select", options: ["Excision", "Re-excision", "Wide local excision", "See Comment"] },
                { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Head/Neck", "Upper extremity", "Lower extremity", "Trunk", "Other"] },
                { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
                { id: "tumorThickness", label: "Tumor Thickness (mm)", type: "text" },
                { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
                { id: "margins", label: "Margins", type: "checkbox", options: ["Peripheral margin uninvolved", "Peripheral margin involved", "Deep margin uninvolved", "Deep margin involved", "Cannot be assessed"] },
                { id: "marginDistance", label: "Closest Margin Distance (mm)", type: "text" },
                { id: "sentinelLN", label: "Sentinel Lymph Node", type: "select", options: ["Not submitted", "Negative", "Positive (macrometastasis)", "Positive (micrometastasis)", "Positive (isolated tumor cells)", "See Comment"] },
                { id: "lnExamined", label: "Lymph Nodes Examined", type: "text" },
                { id: "lnPositive", label: "Lymph Nodes Positive", type: "text" },
                { id: "pT", label: "pT Stage", type: "select", options: [
                    "pT1: Maximum tumor dimension <=2 cm",
                    "pT2: Maximum tumor dimension >2 cm but <=5 cm",
                    "pT3: Maximum tumor dimension >5 cm",
                    "pT4: Primary tumor invades fascia, muscle, cartilage, or bone",
                    "See Comment"
                ] },
                { id: "pN", label: "pN Stage", type: "select", options: [
                    "pN0: No regional lymph node metastasis",
                    "pN1a(sn): Clinically occult, detected by SLN biopsy",
                    "pN1a: Clinically occult, detected after lymphadenectomy",
                    "pN1b: Clinically and/or radiologically detected",
                    "pN2: In-transit metastasis without lymph node metastasis",
                    "pN3: In-transit metastasis with lymph node metastasis",
                    "See Comment"
                ] },
                { id: "pM", label: "pM Stage", type: "select", options: ["Not applicable", "pM1a: Metastasis to skin, subcutaneous tissue, or distant lymph nodes", "pM1b: Metastasis to lung", "pM1c: Metastasis to all other visceral sites", "See Comment"] },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        }
    ],
"Thorax": [
        {
            name: "Lung, Resection",
            pdf: "https://documents.cap.org/protocols/Lung_5.1.0.0.REL_CAPCP.pdf",
            fields: [
                { id: "procedure", label: "Procedure", type: "select", options: ["Wedge resection", "Segmentectomy", "Lobectomy", "Bilobectomy", "Pneumonectomy", "Sleeve resection", "Other", "See Comment"] },
                { id: "specimenLaterality", label: "Specimen Laterality", type: "select", options: ["Right", "Left", "See Comment"] },
                { id: "tumorSite", label: "Tumor Site", type: "checkbox", options: ["Right upper lobe", "Right middle lobe", "Right lower lobe", "Left upper lobe", "Left lower lobe", "Main bronchus", "Carina", "Other"] },
                { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
                { id: "tumorFocality", label: "Tumor Focality", type: "select", options: ["Unifocal", "Multifocal", "See Comment"] },
                { id: "histologicType", label: "Histologic Type", type: "select", options: [
                    "Adenocarcinoma, lepidic predominant",
                    "Adenocarcinoma, acinar predominant",
                    "Adenocarcinoma, papillary predominant",
                    "Adenocarcinoma, micropapillary predominant",
                    "Adenocarcinoma, solid predominant",
                    "Invasive mucinous adenocarcinoma",
                    "Colloid adenocarcinoma",
                    "Fetal adenocarcinoma",
                    "Enteric-type adenocarcinoma",
                    "Minimally invasive adenocarcinoma (nonmucinous)",
                    "Minimally invasive adenocarcinoma (mucinous)",
                    "Adenocarcinoma in situ (nonmucinous)",
                    "Adenocarcinoma in situ (mucinous)",
                    "Squamous cell carcinoma, keratinizing",
                    "Squamous cell carcinoma, nonkeratinizing",
                    "Squamous cell carcinoma, basaloid",
                    "Squamous cell carcinoma in situ",
                    "Large cell carcinoma",
                    "Adenosquamous carcinoma",
                    "Sarcomatoid carcinoma (pleomorphic)",
                    "Sarcomatoid carcinoma (spindle cell)",
                    "Sarcomatoid carcinoma (giant cell)",
                    "Carcinosarcoma",
                    "Pulmonary blastoma",
                    "Large cell neuroendocrine carcinoma",
                    "Small cell carcinoma",
                    "Combined small cell carcinoma",
                    "Typical carcinoid",
                    "Atypical carcinoid",
                    "Other",
                    "See Comment"
                ] },
                { id: "grade", label: "Histologic Grade", type: "select", options: ["G1: Well differentiated", "G2: Moderately differentiated", "G3: Poorly differentiated", "GX: Cannot be assessed", "Not applicable (small cell, carcinoid)", "See Comment"] },
                { id: "visceralPleura", label: "Visceral Pleura Invasion", type: "select", options: ["PL0: No pleural invasion", "PL1: Invasion beyond elastic layer", "PL2: Invasion to pleural surface", "PL3: Invasion into parietal pleura", "Cannot be assessed", "See Comment"] },
                { id: "margins", label: "Margins", type: "checkbox", options: ["Bronchial margin uninvolved", "Bronchial margin involved", "Vascular margin uninvolved", "Vascular margin involved", "Parenchymal margin uninvolved", "Parenchymal margin involved", "Chest wall margin uninvolved", "Chest wall margin involved"] },
                { id: "marginDistance", label: "Distance to Closest Margin (cm)", type: "text" },
                { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
                { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
                { id: "treatmentEffect", label: "Treatment Effect (if neoadjuvant)", type: "select", options: ["No prior treatment", "No residual tumor (complete response)", "Minimal residual tumor", "Moderate response", "Poor or no response", "See Comment"] },
                { id: "lnExamined", label: "Lymph Nodes Examined", type: "text" },
                { id: "lnPositive", label: "Lymph Nodes Positive", type: "text" },
                { id: "pT", label: "pT Stage", type: "select", options: [
                    "pTis: Carcinoma in situ / adenocarcinoma in situ",
                    "pT1mi: Minimally invasive adenocarcinoma (<=3 cm, <=5 mm invasion)",
                    "pT1a: Tumor <=1 cm (or superficial spreading in central airways)",
                    "pT1b: Tumor >1 cm but <=2 cm",
                    "pT1c: Tumor >2 cm but <=3 cm",
                    "pT2a: Tumor >3 cm but <=4 cm; or involves main bronchus without carina; or invades visceral pleura; or associated atelectasis/pneumonitis",
                    "pT2b: Tumor >4 cm but <=5 cm",
                    "pT3: Tumor >5 cm but <=7 cm; or invades chest wall, phrenic nerve, parietal pericardium; or separate tumor nodule(s) in same lobe",
                    "pT4: Tumor >7 cm; or invades diaphragm, mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina; or separate tumor nodule(s) in different ipsilateral lobe",
                    "See Comment"
                ] },
                { id: "pN", label: "pN Stage (AJCC 9th Edition)", type: "select", options: [
                    "pN0: No regional lymph node metastasis",
                    "pN1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar nodes and intrapulmonary nodes",
                    "pN2a: Metastasis in single ipsilateral mediastinal station (including subcarinal)",
                    "pN2b: Metastasis in multiple ipsilateral mediastinal stations (including subcarinal)",
                    "pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes",
                    "pNX: Regional lymph nodes cannot be assessed",
                    "See Comment"
                ] },
                { id: "pM", label: "pM Stage (AJCC 9th Edition)", type: "select", options: ["Not applicable", "pM1a: Separate tumor nodule in contralateral lobe; pleural/pericardial nodules or malignant effusion", "pM1b: Single extrathoracic metastasis in a single organ", "pM1c1: Multiple extrathoracic metastases in a single organ system", "pM1c2: Multiple extrathoracic metastases in multiple organ systems", "See Comment"] },
                { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Obstructive pneumonia", "Atelectasis", "Emphysema", "Fibrosis", "Granulomas", "STAS (spread through air spaces)"] },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        },
        {
            name: "Lung Biomarker Reporting",
            pdf: "https://documents.cap.org/protocols/Lung.Bmk_2.2.0.0.REL_CAPCP.pdf",
            fields: [
                { id: "egfr", label: "EGFR Mutation", type: "select", options: ["Not detected", "Exon 19 deletion", "L858R (exon 21)", "T790M (exon 20)", "Exon 20 insertion", "Other EGFR mutation", "Not tested", "See Comment"] },
                { id: "alk", label: "ALK Rearrangement", type: "select", options: ["Not detected", "Detected", "Not tested", "See Comment"] },
                { id: "ros1", label: "ROS1 Rearrangement", type: "select", options: ["Not detected", "Detected", "Not tested", "See Comment"] },
                { id: "braf", label: "BRAF Mutation", type: "select", options: ["Not detected", "V600E", "Other BRAF mutation", "Not tested", "See Comment"] },
                { id: "kras", label: "KRAS Mutation", type: "select", options: ["Not detected", "G12C", "Other KRAS mutation", "Not tested", "See Comment"] },
                { id: "met", label: "MET Alteration", type: "select", options: ["Not detected", "MET exon 14 skipping", "MET amplification", "Not tested", "See Comment"] },
                { id: "ret", label: "RET Rearrangement", type: "select", options: ["Not detected", "Detected", "Not tested", "See Comment"] },
                { id: "ntrk", label: "NTRK Fusion", type: "select", options: ["Not detected", "Detected", "Not tested", "See Comment"] },
                { id: "her2", label: "HER2 (ERBB2) Mutation", type: "select", options: ["Not detected", "Detected", "Not tested", "See Comment"] },
                { id: "pdl1", label: "PD-L1 TPS (%)", type: "text" },
                { id: "pdl1Result", label: "PD-L1 Interpretation", type: "select", options: ["Negative (TPS <1%)", "Low positive (TPS 1-49%)", "High positive (TPS >=50%)", "See Comment"] },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        },
        {
            name: "Diffuse Pleural Mesothelioma",
            pdf: "https://documents.cap.org/documents/New-Cancer-Protocols-June-2025/PleuraPericard_5.0.1.0.REL_CAPCP.pdf",
            fields: [
                { id: "procedure", label: "Procedure", type: "select", options: ["Pleurectomy/decortication", "Extrapleural pneumonectomy", "Biopsy", "Other", "See Comment"] },
                { id: "laterality", label: "Laterality", type: "select", options: ["Right", "Left", "See Comment"] },
                { id: "tumorSize", label: "Tumor Size/Thickness (cm)", type: "text" },
                { id: "histologicType", label: "Histologic Type", type: "select", options: ["Epithelioid mesothelioma", "Sarcomatoid mesothelioma", "Biphasic (mixed) mesothelioma", "Desmoplastic mesothelioma", "See Comment"] },
                { id: "epithelioidSubtype", label: "Epithelioid Subtype (if applicable)", type: "select", options: ["Not applicable", "Tubulopapillary", "Trabecular", "Solid", "Micropapillary", "Pleomorphic", "Transitional", "See Comment"] },
                { id: "margins", label: "Margins", type: "checkbox", options: ["Chest wall margin uninvolved", "Chest wall margin involved", "Diaphragmatic margin uninvolved", "Diaphragmatic margin involved", "Mediastinal margin uninvolved", "Mediastinal margin involved"] },
                { id: "lnExamined", label: "Lymph Nodes Examined", type: "text" },
                { id: "lnPositive", label: "Lymph Nodes Positive", type: "text" },
                { id: "pT", label: "pT Stage", type: "select", options: [
                    "pT1: Tumor limited to ipsilateral parietal pleura, with or without mediastinal or diaphragmatic pleural involvement",
                    "pT2: Tumor involves ipsilateral pleural surfaces with at least one of: diaphragmatic muscle invasion, pulmonary parenchyma invasion",
                    "pT3: Locally advanced, potentially resectable: endothoracic fascia, mediastinal fat, chest wall (solitary focus), pericardium (non-transmural)",
                    "pT4: Locally advanced, unresectable: diffuse/multifocal chest wall, peritoneum via diaphragm, contralateral pleura, spine, internal pericardial surface, myocardium, brachial plexus, mediastinal organs",
                    "See Comment"
                ] },
                { id: "pN", label: "pN Stage", type: "select", options: [
                    "pN0: No regional lymph node metastasis",
                    "pN1: Metastasis in ipsilateral intrathoracic nodes (bronchopulmonary, hilar, or mediastinal including internal mammary, peridiaphragmatic, pericardial fat pad, or intercostal)",
                    "pN2: Metastasis in contralateral intrathoracic nodes or ipsilateral/contralateral supraclavicular nodes",
                    "See Comment"
                ] },
                { id: "pM", label: "pM Stage", type: "select", options: ["Not applicable", "pM1: Distant metastasis", "See Comment"] },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        },
        {
            name: "Thymus",
            pdf: "https://documents.cap.org/protocols/Thymus_5.0.0.0.REL.CAPCP.pdf",
            fields: [
                { id: "procedure", label: "Procedure", type: "select", options: ["Thymectomy", "Biopsy", "Debulking", "Other", "See Comment"] },
                { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
                { id: "histologicType", label: "Histologic Type", type: "select", options: [
                    "Thymoma, Type A",
                    "Thymoma, Type AB",
                    "Thymoma, Type B1",
                    "Thymoma, Type B2",
                    "Thymoma, Type B3",
                    "Thymic carcinoma, squamous cell",
                    "Thymic carcinoma, basaloid",
                    "Thymic carcinoma, mucoepidermoid",
                    "Thymic carcinoma, lymphoepithelioma-like",
                    "Thymic carcinoma, NOS",
                    "Thymic neuroendocrine tumor",
                    "Other",
                    "See Comment"
                ] },
                { id: "encapsulation", label: "Capsule/Invasion", type: "select", options: ["Encapsulated, intact capsule", "Minimally invasive (into but not through capsule)", "Invasion through capsule into surrounding fat", "Invasion into adjacent structures", "See Comment"] },
                { id: "margins", label: "Margins", type: "checkbox", options: ["Margin uninvolved", "Margin involved", "Cannot be assessed"] },
                { id: "lnExamined", label: "Lymph Nodes Examined", type: "text" },
                { id: "lnPositive", label: "Lymph Nodes Positive", type: "text" },
                { id: "pT", label: "pT Stage (AJCC 8th / Masaoka-Koga)", type: "select", options: [
                    "pT1a: Encapsulated or extending into mediastinal fat; may involve mediastinal pleura",
                    "pT1b: Extension through mediastinal pleura to involve adjacent pericardium (partial or full thickness)",
                    "pT2: Tumor with direct invasion of the lung",
                    "pT3: Direct invasion of great vessels, chest wall, phrenic nerve, or hilar pulmonary structures",
                    "pT4: Invasion of aorta, arch vessels, main pulmonary artery, myocardium, trachea, or esophagus",
                    "See Comment"
                ] },
                { id: "pN", label: "pN Stage", type: "select", options: [
                    "pN0: No regional lymph node metastasis",
                    "pN1: Metastasis in anterior (perithymic) nodes",
                    "pN2: Metastasis in deep intrathoracic or cervical nodes",
                    "See Comment"
                ] },
                { id: "pM", label: "pM Stage", type: "select", options: ["Not applicable", "pM1a: Separate pleural or pericardial nodule(s)", "pM1b: Pulmonary intraparenchymal nodule or distant organ metastasis", "See Comment"] },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        }
    ],
"Bone and Soft Tissue": [
        {
            name: "Bone, Biopsy",
            pdf: "https://documents.cap.org/protocols/Bone.Bx_4.2.0.0.REL_CAPCP.pdf",
            fields: [
                { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Long bones (upper extremity)", "Long bones (lower extremity)", "Pelvis", "Spine", "Ribs", "Skull", "Scapula", "Other", "See Comment"] },
                { id: "histologicType", label: "Histologic Type", type: "select", options: [
                    "Osteosarcoma, conventional (osteoblastic)",
                    "Osteosarcoma, conventional (chondroblastic)",
                    "Osteosarcoma, conventional (fibroblastic)",
                    "Osteosarcoma, telangiectatic",
                    "Osteosarcoma, small cell",
                    "Osteosarcoma, parosteal (low grade)",
                    "Osteosarcoma, periosteal",
                    "Chondrosarcoma, conventional",
                    "Chondrosarcoma, dedifferentiated",
                    "Chondrosarcoma, mesenchymal",
                    "Chondrosarcoma, clear cell",
                    "Chordoma",
                    "Giant cell tumor of bone",
                    "Ewing sarcoma",
                    "Adamantinoma",
                    "Undifferentiated pleomorphic sarcoma of bone",
                    "Fibrosarcoma of bone",
                    "Osteofibrous dysplasia-like adamantinoma",
                    "Metastatic carcinoma",
                    "Lymphoma of bone",
                    "Other",
                    "See Comment"
                ] },
                { id: "grade", label: "Histologic Grade", type: "select", options: ["G1: Well differentiated (low grade)", "G2: Moderately differentiated", "G3: Poorly differentiated (high grade)", "GX: Cannot be assessed", "See Comment"] },
                { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Necrosis", "Pathologic fracture", "Soft tissue extension"] },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        },
        {
            name: "Bone, Resection",
            pdf: "https://documents.cap.org/protocols/Bone_4.2.0.0.REL_CAPCP.pdf",
            fields: [
                { id: "procedure", label: "Procedure", type: "select", options: ["Intralesional curettage", "Marginal excision", "Wide excision", "Radical resection", "Amputation", "Other", "See Comment"] },
                { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Long bones (upper extremity)", "Long bones (lower extremity)", "Pelvis", "Spine", "Ribs", "Skull", "Scapula", "Other", "See Comment"] },
                { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
                { id: "histologicType", label: "Histologic Type", type: "select", options: [
                    "Osteosarcoma, conventional",
                    "Osteosarcoma, telangiectatic",
                    "Osteosarcoma, small cell",
                    "Osteosarcoma, parosteal",
                    "Osteosarcoma, periosteal",
                    "Chondrosarcoma, conventional",
                    "Chondrosarcoma, dedifferentiated",
                    "Chondrosarcoma, mesenchymal",
                    "Chordoma",
                    "Giant cell tumor of bone",
                    "Ewing sarcoma",
                    "Adamantinoma",
                    "Undifferentiated pleomorphic sarcoma of bone",
                    "Other",
                    "See Comment"
                ] },
                { id: "grade", label: "Histologic Grade", type: "select", options: ["G1: Well differentiated (low grade)", "G2: Moderately differentiated", "G3: Poorly differentiated (high grade)", "GX: Cannot be assessed", "See Comment"] },
                { id: "necrosis", label: "Tumor Necrosis (post-treatment)", type: "select", options: ["Not applicable (no prior treatment)", ">=90% necrosis (good response)", "<90% necrosis (poor response)", "Cannot be assessed", "See Comment"] },
                { id: "margins", label: "Margins", type: "checkbox", options: ["Bone margin uninvolved", "Bone margin involved", "Soft tissue margin uninvolved", "Soft tissue margin involved", "Cannot be assessed"] },
                { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
                { id: "pT", label: "pT Stage", type: "select", options: [
                    "pT1: Tumor <=8 cm in greatest dimension",
                    "pT2: Tumor >8 cm in greatest dimension",
                    "pT3: Discontinuous tumors in primary bone site",
                    "See Comment"
                ] },
                { id: "pN", label: "pN Stage", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Regional lymph node metastasis", "See Comment"] },
                { id: "pM", label: "pM Stage", type: "select", options: ["Not applicable", "pM1a: Lung metastasis", "pM1b: Other distant metastasis", "See Comment"] },
                { id: "additionalFindings", label: "Additional Findings", type: "checkbox", options: ["Pathologic fracture", "Skip metastasis", "Soft tissue extension"] },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        },
        {
            name: "Soft Tissue, Biopsy",
            pdf: "https://documents.cap.org/protocols/Soft.Tissue.Bx_4.2.0.0.REL_CAPCP.pdf",
            fields: [
                { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Upper extremity", "Lower extremity", "Trunk wall", "Retroperitoneum", "Head/Neck", "Intra-abdominal", "Other", "See Comment"] },
                { id: "tumorDepth", label: "Tumor Depth", type: "select", options: ["Superficial (above fascia)", "Deep (below fascia)", "Both", "Cannot be determined", "See Comment"] },
                { id: "histologicType", label: "Histologic Type", type: "select", options: [
                    "Undifferentiated pleomorphic sarcoma",
                    "Liposarcoma, well-differentiated/atypical lipomatous tumor",
                    "Liposarcoma, dedifferentiated",
                    "Liposarcoma, myxoid",
                    "Liposarcoma, pleomorphic",
                    "Leiomyosarcoma",
                    "Synovial sarcoma",
                    "Malignant peripheral nerve sheath tumor (MPNST)",
                    "Myxofibrosarcoma",
                    "Fibrosarcoma",
                    "Solitary fibrous tumor, malignant",
                    "Angiosarcoma",
                    "Epithelioid sarcoma",
                    "Alveolar soft part sarcoma",
                    "Clear cell sarcoma",
                    "Desmoplastic small round cell tumor",
                    "Extraskeletal osteosarcoma",
                    "Other",
                    "See Comment"
                ] },
                { id: "grade", label: "FNCLCC Grade", type: "select", options: ["Grade 1 (total score 2-3)", "Grade 2 (total score 4-5)", "Grade 3 (total score 6-8)", "Cannot be assessed", "See Comment"] },
                { id: "mitoticRate", label: "Mitotic Rate (per 10 HPF)", type: "text" },
                { id: "necrosis", label: "Tumor Necrosis", type: "select", options: ["None", "<50%", ">=50%", "See Comment"] },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        },
        {
            name: "Soft Tissue, Resection",
            pdf: "https://documents.cap.org/protocols/Soft.Tissue_4.2.0.0.REL_CAPCP.pdf",
            fields: [
                { id: "procedure", label: "Procedure", type: "select", options: ["Excision", "Wide excision", "Radical resection", "Amputation", "Other", "See Comment"] },
                { id: "tumorSite", label: "Tumor Site", type: "select", options: ["Upper extremity", "Lower extremity", "Trunk wall", "Retroperitoneum", "Head/Neck", "Intra-abdominal", "Other", "See Comment"] },
                { id: "tumorDepth", label: "Tumor Depth", type: "select", options: ["Superficial (above fascia)", "Deep (below fascia)", "Both", "See Comment"] },
                { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
                { id: "histologicType", label: "Histologic Type", type: "select", options: [
                    "Undifferentiated pleomorphic sarcoma",
                    "Liposarcoma, well-differentiated/atypical lipomatous tumor",
                    "Liposarcoma, dedifferentiated",
                    "Liposarcoma, myxoid",
                    "Liposarcoma, pleomorphic",
                    "Leiomyosarcoma",
                    "Synovial sarcoma",
                    "MPNST",
                    "Myxofibrosarcoma",
                    "Angiosarcoma",
                    "Epithelioid sarcoma",
                    "Other",
                    "See Comment"
                ] },
                { id: "grade", label: "FNCLCC Grade", type: "select", options: [
                    "Grade 1: Total score 2-3 (Differentiation 1-3, Mitoses 1-3, Necrosis 0-2)",
                    "Grade 2: Total score 4-5",
                    "Grade 3: Total score 6-8",
                    "Cannot be assessed",
                    "See Comment"
                ] },
                { id: "mitoticRate", label: "Mitotic Rate (per 10 HPF)", type: "text" },
                { id: "necrosis", label: "Tumor Necrosis", type: "select", options: ["None", "<50%", ">=50%", "See Comment"] },
                { id: "margins", label: "Margins", type: "checkbox", options: ["Margin uninvolved", "Margin involved (tumor at ink)", "Cannot be assessed"] },
                { id: "marginDistance", label: "Closest Margin Distance (cm)", type: "text" },
                { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "See Comment"] },
                { id: "pT", label: "pT Stage (Trunk/Extremities)", type: "select", options: [
                    "pT1: Tumor <=5 cm",
                    "pT2: Tumor >5 cm and <=10 cm",
                    "pT3: Tumor >10 cm and <=15 cm",
                    "pT4: Tumor >15 cm",
                    "See Comment"
                ] },
                { id: "pN", label: "pN Stage", type: "select", options: ["pN0: No regional lymph node metastasis", "pN1: Regional lymph node metastasis", "See Comment"] },
                { id: "pM", label: "pM Stage", type: "select", options: ["Not applicable", "pM1: Distant metastasis", "See Comment"] },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        }
    ],
    "General": [
        {
            name: "DNA Mismatch Repair Biomarker",
            pdf: "https://documents.cap.org/protocols/DNA.MMR.Bmk_1.0.0.2.REL_CAPCP.pdf",
            fields: [
                { id: "mlh1", label: "MLH1", type: "select", options: ["Intact (positive) nuclear staining", "Loss of nuclear staining", "Cannot be determined", "See Comment"] },
                { id: "pms2", label: "PMS2", type: "select", options: ["Intact (positive) nuclear staining", "Loss of nuclear staining", "Cannot be determined", "See Comment"] },
                { id: "msh2", label: "MSH2", type: "select", options: ["Intact (positive) nuclear staining", "Loss of nuclear staining", "Cannot be determined", "See Comment"] },
                { id: "msh6", label: "MSH6", type: "select", options: ["Intact (positive) nuclear staining", "Loss of nuclear staining", "Cannot be determined", "See Comment"] },
                { id: "msiResult", label: "MSI Status (if performed)", type: "select", options: ["MSS (microsatellite stable)", "MSI-Low", "MSI-High", "Not performed", "See Comment"] },
                { id: "brafV600E", label: "BRAF V600E (if MLH1/PMS2 loss)", type: "select", options: ["Not tested", "BRAF V600E detected", "BRAF V600E not detected", "Not applicable", "See Comment"] },
                { id: "mlh1Methylation", label: "MLH1 Promoter Methylation", type: "select", options: ["Not tested", "Methylated", "Unmethylated", "Not applicable", "See Comment"] },
                { id: "interpretation", label: "Overall Interpretation", type: "select", options: [
                    "No evidence of mismatch repair deficiency",
                    "Mismatch repair deficient (MLH1/PMS2 loss - consider sporadic vs Lynch)",
                    "Mismatch repair deficient (MSH2/MSH6 loss - suspect Lynch syndrome)",
                    "Mismatch repair deficient (PMS2 loss only)",
                    "Mismatch repair deficient (MSH6 loss only)",
                    "Indeterminate",
                    "See Comment"
                ] },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        },
        {
            name: "Generic Template, Biopsy",
            pdf: "https://documents.cap.org/protocols/Tumor.Bx_1.0.1.0.REL_CAPCP.pdf",
            fields: [
                { id: "specimenType", label: "Specimen Type", type: "text" },
                { id: "tumorSite", label: "Tumor Site", type: "text" },
                { id: "histologicType", label: "Histologic Type", type: "text" },
                { id: "grade", label: "Histologic Grade", type: "select", options: ["G1: Well differentiated", "G2: Moderately differentiated", "G3: Poorly differentiated", "G4: Undifferentiated", "GX: Cannot be assessed", "Not applicable", "See Comment"] },
                { id: "additionalFindings", label: "Additional Findings", type: "textarea" },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        },
        {
            name: "Generic Template, Resection",
            pdf: "https://documents.cap.org/protocols/Tumor_1.1.0.0.REL_CAPCP.pdf",
            fields: [
                { id: "specimenType", label: "Specimen Type", type: "text" },
                { id: "procedure", label: "Procedure", type: "text" },
                { id: "tumorSite", label: "Tumor Site", type: "text" },
                { id: "tumorSize", label: "Tumor Size (cm)", type: "text" },
                { id: "histologicType", label: "Histologic Type", type: "text" },
                { id: "grade", label: "Histologic Grade", type: "select", options: ["G1: Well differentiated", "G2: Moderately differentiated", "G3: Poorly differentiated", "G4: Undifferentiated", "GX: Cannot be assessed", "Not applicable", "See Comment"] },
                { id: "margins", label: "Margins", type: "checkbox", options: ["Margin(s) uninvolved", "Margin(s) involved", "Cannot be assessed"] },
                { id: "marginDistance", label: "Closest Margin Distance", type: "text" },
                { id: "lvi", label: "Lymphovascular Invasion", type: "select", options: ["Not identified", "Present", "Indeterminate", "See Comment"] },
                { id: "pni", label: "Perineural Invasion", type: "select", options: ["Not identified", "Present", "Indeterminate", "See Comment"] },
                { id: "lnExamined", label: "Lymph Nodes Examined", type: "text" },
                { id: "lnPositive", label: "Lymph Nodes Positive", type: "text" },
                { id: "pT", label: "Pathologic Stage (pT)", type: "text" },
                { id: "pN", label: "Pathologic Stage (pN)", type: "text" },
                { id: "pM", label: "Pathologic Stage (pM)", type: "select", options: ["Not applicable", "pM1: Distant metastasis", "See Comment"] },
                { id: "additionalFindings", label: "Additional Findings", type: "textarea" },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        },
        {
            name: "General IHC Quantitative Biomarkers",
            pdf: "https://documents.cap.org/protocols/IHC.Bmk_1.2.0.0.REL_CAPCP.pdf",
            fields: [
                { id: "antibody", label: "Antibody Name", type: "text" },
                { id: "clone", label: "Clone", type: "text" },
                { id: "vendor", label: "Vendor", type: "text" },
                { id: "result", label: "Result", type: "select", options: ["Positive", "Negative", "Equivocal", "Cannot be determined", "See Comment"] },
                { id: "percentage", label: "Percentage of Positive Cells (%)", type: "text" },
                { id: "intensity", label: "Staining Intensity", type: "select", options: ["Weak (1+)", "Moderate (2+)", "Strong (3+)", "See Comment"] },
                { id: "pattern", label: "Staining Pattern", type: "select", options: ["Nuclear", "Cytoplasmic", "Membranous", "Nuclear and cytoplasmic", "Other", "See Comment"] },
                { id: "additionalComments", label: "Additional Comments", type: "textarea" }
            ]
        }
    ]
    };

    // ========================================
    // APPLICATION LOGIC
    // ========================================
    function initApp() {
        populateOrganSystems();
        document.getElementById('organSystem').addEventListener('change', onOrganSystemChange);
        document.getElementById('protocol').addEventListener('change', onProtocolChange);
    }

    function populateOrganSystems() {
        const select = document.getElementById('organSystem');
        Object.keys(protocolData).sort().forEach(system => {
            const opt = document.createElement('option');
            opt.value = system;
            opt.textContent = system;
            select.appendChild(opt);
        });
    }

    function onOrganSystemChange() {
        const system = this.value;
        const protocolSelect = document.getElementById('protocol');
        protocolSelect.innerHTML = '<option value="">-- Select Protocol --</option>';
        protocolSelect.disabled = !system;
        document.getElementById('pdfLinkContainer').innerHTML = '';
        document.getElementById('formFieldsContainer').innerHTML = '<div class="no-protocol">Select a protocol to begin.</div>';
        updatePreview();

        if (system && protocolData[system]) {
            protocolData[system].forEach((p, idx) => {
                const opt = document.createElement('option');
                opt.value = idx;
                opt.textContent = p.name;
                protocolSelect.appendChild(opt);
            });
        }
    }

    function onProtocolChange() {
        const system = document.getElementById('organSystem').value;
        const idx = this.value;
        document.getElementById('pdfLinkContainer').innerHTML = '';

        if (system && idx !== '' && protocolData[system] && protocolData[system][idx]) {
            const protocol = protocolData[system][idx];

            // Add PDF link
            if (protocol.pdf) {
                document.getElementById('pdfLinkContainer').innerHTML =
                    '<a class="pdf-link" href="' + protocol.pdf + '" target="_blank">View CAP Protocol PDF</a>';
            }

            generateFormFields(protocol);
        } else {
            document.getElementById('formFieldsContainer').innerHTML = '<div class="no-protocol">Select a protocol to begin.</div>';
            updatePreview();
        }
    }

    function generateFormFields(protocol) {
        const container = document.getElementById('formFieldsContainer');
        container.innerHTML = '';

        protocol.fields.forEach(field => {
            const group = document.createElement('div');
            group.className = 'form-group';

            const label = document.createElement('label');
            label.textContent = field.label;
            label.setAttribute('for', field.id);
            group.appendChild(label);

            if (field.type === 'select') {
                const select = document.createElement('select');
                select.id = field.id;
                select.name = field.id;

                const defaultOpt = document.createElement('option');
                defaultOpt.value = '';
                defaultOpt.textContent = '-- Select --';
                select.appendChild(defaultOpt);

                if (field.options) {
                    field.options.forEach(opt => {
                        const option = document.createElement('option');
                        option.value = opt;
                        option.textContent = opt;
                        select.appendChild(option);
                    });
                }

                select.addEventListener('change', function() {
                    handleFieldChange(this, field.id);
                });
                group.appendChild(select);

                // Comment textarea for "See Comment"
                const commentTA = document.createElement('textarea');
                commentTA.id = field.id + '_comment';
                commentTA.className = 'comment-textarea';
                commentTA.placeholder = 'Enter comment...';
                commentTA.addEventListener('input', function() { updatePreview(); });
                group.appendChild(commentTA);

            } else if (field.type === 'checkbox') {
                const cbGroup = document.createElement('div');
                cbGroup.className = 'checkbox-group';
                cbGroup.id = field.id;

                if (field.options) {
                    field.options.forEach((opt, i) => {
                        const cbItem = document.createElement('label');
                        cbItem.className = 'checkbox-item';

                        const cb = document.createElement('input');
                        cb.type = 'checkbox';
                        cb.value = opt;
                        cb.name = field.id;
                        cb.id = field.id + '_' + i;
                        cb.addEventListener('change', function() {
                            cbItem.classList.toggle('checked', this.checked);
                            updatePreview();
                        });

                        const span = document.createElement('span');
                        span.textContent = opt;

                        cbItem.appendChild(cb);
                        cbItem.appendChild(span);
                        cbGroup.appendChild(cbItem);
                    });
                }
                group.appendChild(cbGroup);

            } else if (field.type === 'text') {
                const input = document.createElement('input');
                input.type = 'text';
                input.id = field.id;
                input.name = field.id;
                input.placeholder = field.placeholder || '';
                input.addEventListener('input', function() { updatePreview(); });
                group.appendChild(input);

            } else if (field.type === 'textarea') {
                const ta = document.createElement('textarea');
                ta.id = field.id;
                ta.name = field.id;
                ta.placeholder = field.placeholder || 'Enter details...';
                ta.addEventListener('input', function() { updatePreview(); });
                group.appendChild(ta);
            }

            container.appendChild(group);
        });

        updatePreview();
    }

    function handleFieldChange(selectEl, fieldId) {
        const commentTA = document.getElementById(fieldId + '_comment');
        if (commentTA) {
            if (selectEl.value === 'See Comment') {
                commentTA.classList.add('visible');
                commentTA.focus();
            } else {
                commentTA.classList.remove('visible');
                commentTA.value = '';
            }
        }
        updatePreview();
    }

    function updatePreview() {
        const system = document.getElementById('organSystem').value;
        const idx = document.getElementById('protocol').value;

        if (!system || idx === '' || !protocolData[system] || !protocolData[system][idx]) {
            document.getElementById('previewContent').textContent =
                'Select a protocol and fill in the fields to generate a synoptic report.';
            return;
        }

        const protocol = protocolData[system][idx];
        let lines = [];
        lines.push('CAP SYNOPTIC REPORT');
        lines.push('Protocol: ' + protocol.name);
        lines.push('========================================');
        lines.push('');

        protocol.fields.forEach(field => {
            let value = '';

            if (field.type === 'select') {
                const el = document.getElementById(field.id);
                if (el) value = el.value;
                if (value === 'See Comment') {
                    const commentEl = document.getElementById(field.id + '_comment');
                    if (commentEl && commentEl.value.trim()) {
                        value = commentEl.value.trim();
                    }
                }
            } else if (field.type === 'checkbox') {
                const checked = [];
                const cbs = document.querySelectorAll('input[name="' + field.id + '"]:checked');
                cbs.forEach(cb => checked.push(cb.value));
                value = checked.join('; ');
            } else if (field.type === 'text') {
                const el = document.getElementById(field.id);
                if (el) value = el.value.trim();
            } else if (field.type === 'textarea') {
                const el = document.getElementById(field.id);
                if (el) value = el.value.trim();
            }

            if (value) {
                lines.push(field.label + ': ' + value);
            }
        });

        document.getElementById('previewContent').textContent = lines.join('\n');
    }

    function clearForm() {
        const container = document.getElementById('formFieldsContainer');
        container.querySelectorAll('select').forEach(el => el.value = '');
        container.querySelectorAll('input[type="text"]').forEach(el => el.value = '');
        container.querySelectorAll('textarea').forEach(el => { el.value = ''; el.classList.remove('visible'); });
        container.querySelectorAll('input[type="checkbox"]').forEach(el => {
            el.checked = false;
            el.closest('.checkbox-item')?.classList.remove('checked');
        });
        updatePreview();
    }

    function copyReport() {
        const text = document.getElementById('previewContent').textContent;
        navigator.clipboard.writeText(text).then(() => {
            const btn = document.querySelector('.btn-copy');
            btn.textContent = 'Copied!';
            btn.classList.add('copied');
            setTimeout(() => {
                btn.textContent = 'Copy Report';
                btn.classList.remove('copied');
            }, 2000);
        });
    }

    document.addEventListener('DOMContentLoaded', initApp);
    </script>
</body>
</html>
